This is a Validated Antibody Database (VAD) review about human CD56, based on 441 published articles (read how Labome selects the articles), using CD56 antibody in all methods. It is aimed to help Labome visitors find the most suited CD56 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CD56 synonym: CD56; MSK39; NCAM

Knockout validation
BioLegend
mouse monoclonal (HCD56)
  • immunocytochemistry knockout validation; human; 1:100; loading ...; fig 5e
BioLegend CD56 antibody (Biolegend, 318314) was used in immunocytochemistry knockout validation on human samples at 1:100 (fig 5e). elife (2020) ncbi
Alomone Labs
domestic rabbit polyclonal
  • western blot knockout validation; mouse; 1:400; loading ...; fig 5a, s3
Alomone Labs CD56 antibody (Alomone, ANR-041) was used in western blot knockout validation on mouse samples at 1:400 (fig 5a, s3). Development (2021) ncbi
Cell Signaling Technology
mouse monoclonal (123C3)
  • western blot knockout validation; human; 1:1000; loading ...; fig 1a
Cell Signaling Technology CD56 antibody (Cell Signaling, 3576S) was used in western blot knockout validation on human samples at 1:1000 (fig 1a). elife (2020) ncbi
others
  • flow cytometry; human; loading ...; fig 1
 CD56 antibody (Biolegend, MEM-188) was used in flow cytometry on human samples (fig 1). BMC Res Notes (2020) ncbi
 CD56 antibody (BioLegend, MEM-188) was used . Nat Commun (2019) ncbi
BioLegend
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...
BioLegend CD56 antibody (Biolegend, 318336) was used in flow cytometry on human samples . J Immunother Cancer (2022) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...
BioLegend CD56 antibody (Biolegend, HCD56) was used in flow cytometry on human samples . J Exp Med (2022) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human; fig s4a
BioLegend CD56 antibody (BioLegend, 304610) was used in flow cytometry on human samples (fig s4a). J Clin Endocrinol Metab (2022) ncbi
mouse monoclonal (5.1H11)
  • flow cytometry; human; loading ...; fig 1b
BioLegend CD56 antibody (BioLegend, 5.1H11) was used in flow cytometry on human samples (fig 1b). Proc Natl Acad Sci U S A (2022) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human; loading ...; fig s1
BioLegend CD56 antibody (Biolegend, 304606) was used in flow cytometry on human samples (fig s1). Front Med (Lausanne) (2022) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human
BioLegend CD56 antibody (BioLegend, 318325) was used in flow cytometry on human samples . Front Immunol (2022) ncbi
mouse monoclonal (5.1H11)
  • flow cytometry; human; loading ...; fig 1f, s1b
BioLegend CD56 antibody (Biolegend, 5.1H11) was used in flow cytometry on human samples (fig 1f, s1b). MBio (2022) ncbi
mouse monoclonal (HCD56)
  • mass cytometry; human; loading ...; fig 2d
BioLegend CD56 antibody (Biolegend, 318345) was used in mass cytometry on human samples (fig 2d). Biomark Res (2022) ncbi
mouse monoclonal (5.1H11)
  • flow cytometry; human; 1:100; loading ...; fig 6b, s26
BioLegend CD56 antibody (Biolegend, 362524) was used in flow cytometry on human samples at 1:100 (fig 6b, s26). Nat Nanotechnol (2022) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; fig 3e
BioLegend CD56 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (fig 3e). J Immunother Cancer (2021) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...
BioLegend CD56 antibody (Biolegend, HCD56) was used in flow cytometry on human samples . Adv Sci (Weinh) (2021) ncbi
mouse monoclonal (5.1H11)
  • flow cytometry; human; loading ...
BioLegend CD56 antibody (BioLegend, 5.1H11) was used in flow cytometry on human samples . Aging Cell (2021) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 3b
BioLegend CD56 antibody (Biolegend, HCD56) was used in flow cytometry on human samples (fig 3b). Acta Neuropathol (2021) ncbi
mouse monoclonal (5.1H11)
  • flow cytometry; human; loading ...; fig 3b
BioLegend CD56 antibody (Biolegend, 5.1H11) was used in flow cytometry on human samples (fig 3b). Acta Neuropathol (2021) ncbi
mouse monoclonal (5.1H11)
  • flow cytometry; human; loading ...; fig s2
BioLegend CD56 antibody (Biolegend, 362519) was used in flow cytometry on human samples (fig s2). Am J Respir Crit Care Med (2021) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig s1
BioLegend CD56 antibody (Biolegend, HCD56) was used in flow cytometry on human samples (fig s1). Front Immunol (2020) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human; loading ...; fig 1
BioLegend CD56 antibody (Biolegend, MEM-188) was used in flow cytometry on human samples (fig 1). BMC Res Notes (2020) ncbi
mouse monoclonal (HCD56)
  • other; mouse
BioLegend CD56 antibody (BioLegend, HCD56) was used in other on mouse samples . Nat Commun (2020) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; 1:100; loading ...; fig 1s1e
BioLegend CD56 antibody (Biolegend, 318332) was used in flow cytometry on human samples at 1:100 (fig 1s1e). elife (2020) ncbi
mouse monoclonal (HCD56)
  • other; human; 1:100; loading ...
BioLegend CD56 antibody (Biolegend, HCD56) was used in other on human samples at 1:100. elife (2020) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; 1:200; loading ...; fig 1b, 6c
BioLegend CD56 antibody (Biolegend, 318334) was used in flow cytometry on human samples at 1:200 (fig 1b, 6c). elife (2020) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig s2
BioLegend CD56 antibody (Biolegend, 318348) was used in flow cytometry on human samples (fig s2). Cell (2020) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig s1a
BioLegend CD56 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (fig s1a). JCI Insight (2020) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 4b
BioLegend CD56 antibody (BioLegend, 318328) was used in flow cytometry on human samples (fig 4b). Stem Cell Reports (2020) ncbi
mouse monoclonal (5.1H11)
  • flow cytometry; human; loading ...; fig s14b
BioLegend CD56 antibody (Biolegend, 5.1H11) was used in flow cytometry on human samples (fig s14b). Science (2019) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig s2o
BioLegend CD56 antibody (Biolegend, 318318) was used in flow cytometry on human samples (fig s2o). JCI Insight (2019) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig s3
BioLegend CD56 antibody (BioLegend, 318303) was used in flow cytometry on human samples (fig s3). Stem Cell Res Ther (2019) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human; loading ...; fig 6
BioLegend CD56 antibody (BioLegend, 304603) was used in flow cytometry on human samples (fig 6). Gastroenterol Res Pract (2019) ncbi
mouse monoclonal (5.1H11)
  • other; human; loading ...; fig 4b
BioLegend CD56 antibody (BioLegend, 363557) was used in other on human samples (fig 4b). Cell (2019) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig ex1
BioLegend CD56 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (fig ex1). Nature (2019) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 1f
  • immunocytochemistry; human; loading ...; fig 1g
BioLegend CD56 antibody (BioLegend, 318306) was used in flow cytometry on human samples (fig 1f) and in immunocytochemistry on human samples (fig 1g). J Exp Med (2019) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD56 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (fig 1a). Front Immunol (2019) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human; loading ...; fig s8
BioLegend CD56 antibody (BioLegend, MEM-188) was used in flow cytometry on human samples (fig s8). Nat Commun (2019) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; 1:100; loading ...; fig s1a, s3b
BioLegend CD56 antibody (Biolegend, 318336) was used in flow cytometry on human samples at 1:100 (fig s1a, s3b). Cancer Cell (2019) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; 2 ug/ml; loading ...; fig s13
BioLegend CD56 antibody (BioLegend, 318305) was used in flow cytometry on human samples at 2 ug/ml (fig s13). Science (2019) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD56 antibody (BioLegend, 318322) was used in flow cytometry on human samples (fig 1a). Sci Rep (2019) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 2a
BioLegend CD56 antibody (Biolegend, 318317) was used in flow cytometry on human samples (fig 2a). elife (2019) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig s1a
BioLegend CD56 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (fig s1a). Aging (Albany NY) (2019) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 1b
BioLegend CD56 antibody (Biolegend, HCD56) was used in flow cytometry on human samples (fig 1b). Cell Stem Cell (2019) ncbi
mouse monoclonal (5.1H11)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CD56 antibody (Biolegend, 5.1H11) was used in flow cytometry on human samples (fig 3a). Transl Oncol (2019) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human; loading ...; fig 1c, 4a
BioLegend CD56 antibody (BioLegend, 304604) was used in flow cytometry on human samples (fig 1c, 4a). J Exp Med (2018) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig s3
BioLegend CD56 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (fig s3). PLoS Pathog (2018) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig s3
BioLegend CD56 antibody (Biolegend, HCD56) was used in flow cytometry on human samples (fig s3). J Infect Dis (2019) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 4a
BioLegend CD56 antibody (Biolegend, HCD56) was used in flow cytometry on human samples (fig 4a). J Immunol (2018) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 1a, 5b
BioLegend CD56 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (fig 1a, 5b). Front Immunol (2018) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 4a
BioLegend CD56 antibody (Biolegend, 318332) was used in flow cytometry on human samples (fig 4a). Stem Cell Reports (2018) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 2a
BioLegend CD56 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (fig 2a). J Cell Biol (2018) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; mouse; 1:60; loading ...; fig 7a
BioLegend CD56 antibody (BioLegend, HCD56) was used in flow cytometry on mouse samples at 1:60 (fig 7a). J Virol (2018) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human; loading ...; fig s1
BioLegend CD56 antibody (BioLegend, MEM-188) was used in flow cytometry on human samples (fig s1). J Clin Invest (2018) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; rhesus macaque; loading ...; fig 1b
BioLegend CD56 antibody (Biolegend, HCD56) was used in flow cytometry on rhesus macaque samples (fig 1b). AIDS (2018) ncbi
mouse monoclonal (5.1H11)
  • flow cytometry; human; loading ...; fig 14
BioLegend CD56 antibody (BioLegend, 5.1H11) was used in flow cytometry on human samples (fig 14). Front Immunol (2018) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CD56 antibody (BioLegend, 318306) was used in flow cytometry on human samples (fig 3a). Biol Reprod (2018) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; fig e1b
BioLegend CD56 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (fig e1b). J Allergy Clin Immunol (2018) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 5j
BioLegend CD56 antibody (Biolegend, HCD56) was used in flow cytometry on human samples (fig 5j). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; fig 1a
BioLegend CD56 antibody (Biolegend, HCD56) was used in flow cytometry on human samples (fig 1a). Immun Inflamm Dis (2018) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig s1
BioLegend CD56 antibody (Biolegend, HCD56) was used in flow cytometry on human samples (fig s1). Eur J Immunol (2018) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 6
BioLegend CD56 antibody (Biolegend, HCD56) was used in flow cytometry on human samples (fig 6). PLoS ONE (2017) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; fig 1a
In order to study the involvement of Notch signaling in NK cell lineage determination, BioLegend CD56 antibody (biolegend, HCD56) was used in flow cytometry on human samples (fig 1a). J Immunol (2017) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 2e
In order to identify cellular changes induced by IL-2, BioLegend CD56 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (fig 2e). J Immunol (2017) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 4b
In order to evaluate the role of IL-32alpha in NK cell inhibition, BioLegend CD56 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (fig 4b). J Immunol (2017) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human; loading ...; fig s6
In order to study the role of leukocyte antigen F in and antigen presentation and immune response, BioLegend CD56 antibody (BioLegend, 304610) was used in flow cytometry on human samples (fig s6). Immunity (2017) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig s1
BioLegend CD56 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (fig s1). J Exp Med (2017) ncbi
mouse monoclonal (SHM14)
  • flow cytometry; human; loading ...; fig 4a
BioLegend CD56 antibody (BioLegend, 352702) was used in flow cytometry on human samples (fig 4a). Scand J Immunol (2017) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig st12
In order to identify new types of human blood dendritic cells, monocytes, and progenitors through single-cell RNA-seq, BioLegend CD56 antibody (Biolegend, HCD56) was used in flow cytometry on human samples (fig st12). Science (2017) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD56 antibody (Biolegend, 318310) was used in flow cytometry on human samples (fig 1a). F1000Res (2016) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 1
BioLegend CD56 antibody (Biolegend, 318310) was used in flow cytometry on human samples (fig 1). PLoS ONE (2017) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig s1a
In order to determine the localization of FcgammaRI, FcgammaRII, and SIRPalpha in macrophages, BioLegend CD56 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (fig s1a). J Cell Biol (2017) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 1
In order to examine the potential of IL-2 to enhance T regulatory cell therapy, BioLegend CD56 antibody (Biolegend, HCD56) was used in flow cytometry on human samples (fig 1). Clin Exp Immunol (2017) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig s2a
BioLegend CD56 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (fig s2a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...
In order to discuss how mutations in PIK3CD and PIK3R1 cause activated PI3K-delta syndrome, BioLegend CD56 antibody (Biolegend, HCD56) was used in flow cytometry on human samples . Clin Immunol (2017) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human; 1:20; loading ...; fig 2b
BioLegend CD56 antibody (BioLegend, MEM-188) was used in flow cytometry on human samples at 1:20 (fig 2b). JCI Insight (2017) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; fig 4b
In order to propose that decidual stromal cells are a cellular source of BAFF for B cells present in decidua during pregnancy, BioLegend CD56 antibody (Biolegend, 318328) was used in flow cytometry on human samples (fig 4b). Sci Rep (2017) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig s2
In order to search for compounds that suppress pro-inflammatory cytokine production in the context of protein kinase C activation, BioLegend CD56 antibody (Biolegend, 31805) was used in flow cytometry on human samples (fig s2). Retrovirology (2016) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; 1:20; loading ...; fig 2a
In order to measure CD11d expression on lymphocyte subsets using flow cytometry, BioLegend CD56 antibody (BioLegend, HCD56) was used in flow cytometry on human samples at 1:20 (fig 2a). J Leukoc Biol (2017) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; fig 1b
BioLegend CD56 antibody (Biolegend, 318340) was used in flow cytometry on human samples (fig 1b). Front Physiol (2016) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 4a
In order to characterize CD8 positive alpha beta gamma delta T cells, BioLegend CD56 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (fig 4a). J Immunol (2016) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig s1b
In order to determine which cells express CD83, BioLegend CD56 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (fig s1b). J Immunol (2016) ncbi
mouse monoclonal (SHM14)
  • flow cytometry; human; fig 3
BioLegend CD56 antibody (Biolegend, 352702) was used in flow cytometry on human samples (fig 3). Sci Rep (2016) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human; fig 3
BioLegend CD56 antibody (BioLegend, 304604) was used in flow cytometry on human samples (fig 3). Stem Cell Reports (2016) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human; loading ...; fig 1
In order to identify cells that respond to interferon lambda, BioLegend CD56 antibody (Biolegend, MEM-188) was used in flow cytometry on human samples (fig 1). J Interferon Cytokine Res (2016) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human; loading ...; fig s1c
In order to compare expression and function of the CD300 family of receptors between neonatal and adult immune cells, BioLegend CD56 antibody (BioLegend, MEM-188) was used in flow cytometry on human samples (fig s1c). Sci Rep (2016) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; fig 1a
BioLegend CD56 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (fig 1a). J Immunol (2016) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human; loading ...
BioLegend CD56 antibody (Biolegend, MEM188) was used in flow cytometry on human samples . J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; fig 7
In order to study the functions of WASp knock out natural killer cells, BioLegend CD56 antibody (Biolegend, 318334) was used in flow cytometry on human samples (fig 7). Sci Rep (2016) ncbi
mouse monoclonal (5.1H11)
  • flow cytometry; human
BioLegend CD56 antibody (Biolegend, 5.1H11) was used in flow cytometry on human samples . elife (2016) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 1b
In order to ask if CD2 is involved in the response of adaptive natural killer cells to HCMV, BioLegend CD56 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (fig 1b). Eur J Immunol (2016) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; fig 1a
In order to assess the effects of platelet-derived ectosomes on natural killer cells, BioLegend CD56 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (fig 1a). J Immunol (2016) ncbi
mouse monoclonal (HCD56)
  • immunocytochemistry; human; loading ...; fig 3a
In order to explore targeting NKA as a means to treat cancer, BioLegend CD56 antibody (BioLegend, HCD56) was used in immunocytochemistry on human samples (fig 3a). Mol Ther (2016) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 6a
BioLegend CD56 antibody (Biolegend, HCD56) was used in flow cytometry on human samples (fig 6a). J Immunol (2016) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; fig 6a
BioLegend CD56 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (fig 6a). J Biol Chem (2016) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human
In order to develop an artificial niche to maintain muscle stem cells in a potent and quiescent state, BioLegend CD56 antibody (BioLegend, 318319) was used in flow cytometry on human samples . Nat Biotechnol (2016) ncbi
mouse monoclonal (5.1H11)
  • flow cytometry; human; 1:25; fig s2e
In order to develop and characterize a humanized ossicle xenotransplantation approach, BioLegend CD56 antibody (Biolegend, 5.1H11) was used in flow cytometry on human samples at 1:25 (fig s2e). Nat Med (2016) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 6a
BioLegend CD56 antibody (Biolegend, 318310) was used in flow cytometry on human samples (fig 6a). J Immunol (2016) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; fig 2
BioLegend CD56 antibody (Biolegend, HCD56) was used in flow cytometry on human samples (fig 2). J Virol (2016) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; mouse; 1:100; fig s2
In order to assess the role of NLRC5 to NK-T-cell crosstalk, BioLegend CD56 antibody (BioLegend, HCD56) was used in flow cytometry on mouse samples at 1:100 (fig s2). Nat Commun (2016) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 3c
BioLegend CD56 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (fig 3c). Clin Cancer Res (2016) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig s4a
In order to characterize innate lymphoid cell subpopulations isolated from patients with systemic sclerosis, BioLegend CD56 antibody (biolegend, HCD56) was used in flow cytometry on human samples (fig s4a). J Immunol (2016) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; fig s1
In order to describe a highly sensitive microfluidic assay to detect acute myeloid leukemia, BioLegend CD56 antibody (Biolegend, HCD56) was used in flow cytometry on human samples (fig s1). Analyst (2016) ncbi
mouse monoclonal (SHM14)
  • flow cytometry; human; fig 2
BioLegend CD56 antibody (BioLegend, SHM14) was used in flow cytometry on human samples (fig 2). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig s1b
In order to study age-related changes in human immunity during a primary virus infection experimentally induced by immunization with live-attenuated yellow fever vaccine, BioLegend CD56 antibody (Biolegend, HCD56) was used in flow cytometry on human samples (fig s1b). J Immunol (2015) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; tbl 1
In order to compare the use of CD229, CD54, and CD319 expression for the identification of normal and aberrant plasma cells, BioLegend CD56 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (tbl 1). Cytometry B Clin Cytom (2016) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; 1:200; fig s3
BioLegend CD56 antibody (Biolegend, HCD56) was used in flow cytometry on human samples at 1:200 (fig s3). Nat Commun (2015) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human; fig 3
In order to investigate the dynamics and characteristics of natural killer cell types in the human ocular mucosal surface in situ during infection with group D human adenoviruses, BioLegend CD56 antibody (Biolegend, MEM-188) was used in flow cytometry on human samples (fig 3). Mucosal Immunol (2016) ncbi
mouse monoclonal (MEM-188)
  • immunohistochemistry - paraffin section; human; fig 7
BioLegend CD56 antibody (BioLegend, MEM188) was used in immunohistochemistry - paraffin section on human samples (fig 7). Mol Cancer (2015) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; 1:200
In order to develop a system to determine human DC development and differentiation, BioLegend CD56 antibody (Biolegend, HCD56) was used in flow cytometry on human samples at 1:200. J Immunol Methods (2015) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human
BioLegend CD56 antibody (Biolegend, 318332) was used in flow cytometry on human samples . Blood Cancer J (2015) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human
BioLegend CD56 antibody (BioLegend, 318331) was used in flow cytometry on human samples . J Exp Med (2015) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human
  • immunocytochemistry; roundworm
In order to investigate the primary inflammatory and regulatory T cell responses induced by BCG vaccination in adults, BioLegend CD56 antibody (Biolegend, clone HCD56) was used in flow cytometry on human samples and in immunocytochemistry on roundworm samples . Clin Vaccine Immunol (2015) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human
In order to describe an Fc engineering approach that specifically affects antibody-dependent cytokine release, BioLegend CD56 antibody (Biolegend, 304612) was used in flow cytometry on human samples . MAbs (2015) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human
BioLegend CD56 antibody (BioLegend, HCD 56) was used in flow cytometry on human samples . J Immunol (2015) ncbi
mouse monoclonal (SHM14)
  • flow cytometry; human
In order to use a multi-omics strategy to elucidate the cellular programs altered by Staphylococcus aureus alpha-toxin, BioLegend CD56 antibody (Biolegend, 352704) was used in flow cytometry on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; fig 4
BioLegend CD56 antibody (Biolegend, HCD56) was used in flow cytometry on human samples (fig 4). Infect Immun (2015) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; fig 4
In order to study human cord blood and bone marrow for restricted dendritic cell and monocyte progenitors, BioLegend CD56 antibody (Biolegend, HCD56) was used in flow cytometry on human samples (fig 4). J Exp Med (2015) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; 1:25; fig s1
BioLegend CD56 antibody (BioLegend, HCD56) was used in flow cytometry on human samples at 1:25 (fig s1). Nat Commun (2015) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human
BioLegend CD56 antibody (BioLegend, HCD56) was used in flow cytometry on human samples . Clin Immunol (2015) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human
BioLegend CD56 antibody (Biolegend, HCD56) was used in flow cytometry on human samples . PLoS Pathog (2014) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human
BioLegend CD56 antibody (BioLegend, MEM-188) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human
BioLegend CD56 antibody (BioLegend, HCD56) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human
BioLegend CD56 antibody (BioLegend, HCD56) was used in flow cytometry on human samples . Rheumatology (Oxford) (2015) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; fig 2
BioLegend CD56 antibody (Biolegend, HCD56) was used in flow cytometry on human samples (fig 2). J Infect Dis (2015) ncbi
Invitrogen
mouse monoclonal (56C04)
  • immunohistochemistry; mouse; loading ...; fig 5f
Invitrogen CD56 antibody (ThermoFisher, 56C04) was used in immunohistochemistry on mouse samples (fig 5f). elife (2022) ncbi
mouse monoclonal (56C04)
  • immunocytochemistry; mouse; 1:200; loading ...; fig 1b
  • western blot; human; 1:1000; loading ...; fig 2d
Invitrogen CD56 antibody (Thermo Fisher, MA5-11563) was used in immunocytochemistry on mouse samples at 1:200 (fig 1b) and in western blot on human samples at 1:1000 (fig 2d). Cell Rep Med (2022) ncbi
mouse monoclonal (CMSSB)
  • flow cytometry; human
Invitrogen CD56 antibody (Thermo Fisher Scientific, 17-0567-42) was used in flow cytometry on human samples . Cell Rep (2021) ncbi
mouse monoclonal (TULY56)
  • flow cytometry; human; fig 6a, s11, s12c
Invitrogen CD56 antibody (eBiosciences, 17-0566-42) was used in flow cytometry on human samples (fig 6a, s11, s12c). Nat Commun (2019) ncbi
mouse monoclonal (TULY56)
  • flow cytometry; human; loading ...; fig s2
Invitrogen CD56 antibody (eBioscience, 11-0566-42) was used in flow cytometry on human samples (fig s2). BMC Cancer (2019) ncbi
mouse monoclonal (CMSSB)
  • flow cytometry; human; 1:50; fig 3a, 3b
Invitrogen CD56 antibody (eBioscience/Thermo, 12-0567-42) was used in flow cytometry on human samples at 1:50 (fig 3a, 3b). Stem Cells (2019) ncbi
mouse monoclonal (MEM-188)
  • immunocytochemistry; human; 1:200; loading ...; fig s1b
Invitrogen CD56 antibody (Thermo Fisher Scientific, MHCD5620) was used in immunocytochemistry on human samples at 1:200 (fig s1b). Mol Ther Nucleic Acids (2019) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human; loading ...; fig s5a
Invitrogen CD56 antibody (Thermo Fisher Scientific, MEM-188) was used in flow cytometry on human samples (fig s5a). Sci Immunol (2018) ncbi
mouse monoclonal (CMSSB)
  • flow cytometry; human; loading ...; fig 1a
Invitrogen CD56 antibody (eBioscience, CMSSB) was used in flow cytometry on human samples (fig 1a). J Immunol (2018) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human; loading ...; fig 3a
In order to characterize the periferal blood lymphocytes phenotype in tacrolimus-treated liver transplanted patients., Invitrogen CD56 antibody (eBioscience, MEM188) was used in flow cytometry on human samples (fig 3a). Med Princ Pract (2017) ncbi
mouse monoclonal (CMSSB)
  • flow cytometry; human; loading ...; fig 2k
In order to establish a method to isolate apoptotic bodies from cultured cells to 99% purity, Invitrogen CD56 antibody (eBioscience, 15-0567-42) was used in flow cytometry on human samples (fig 2k). Sci Rep (2017) ncbi
mouse monoclonal (CMSSB)
  • flow cytometry; human; loading ...; fig 2c
Invitrogen CD56 antibody (eBiosciences, CMSSB) was used in flow cytometry on human samples (fig 2c). PLoS Pathog (2016) ncbi
mouse monoclonal (123C3)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1d
In order to assess the use of CD56, HBME-1, cytokeratin 19 expression in papillary thyroid carcinoma and thyroid nodular lesions for differential diagnosis, Invitrogen CD56 antibody (Thermo Fisher, 123C3.D5) was used in immunohistochemistry - paraffin section on human samples (fig 1d). J Res Med Sci (2016) ncbi
mouse monoclonal (56C04)
  • immunohistochemistry; human; fig 1c
In order to profile the infiltration levels of immune cell populations in 19 cancer types, Invitrogen CD56 antibody (Thermo scientific, MS-1149-P1) was used in immunohistochemistry on human samples (fig 1c). Genome Biol (2016) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human; 1:5; loading ...
In order to find that leukocyte cell-derived chemotaxin 2 promotes expansion and mobilization of hematopoietic stem cells, Invitrogen CD56 antibody (eBioscience, MEM188) was used in flow cytometry on human samples at 1:5. Nat Commun (2016) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; rhesus macaque; loading ...; fig 4a
In order to report the effect of IL-15 inhibition on T and natural killer cell dynamics in rhesus macaques, Invitrogen CD56 antibody (Invitrogen, MEM-188) was used in flow cytometry on rhesus macaque samples (fig 4a). J Immunol (2016) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human; loading ...; fig 1
Invitrogen CD56 antibody (eBioscience, MEM188) was used in flow cytometry on human samples (fig 1). J Immunol Res (2016) ncbi
mouse monoclonal (CMSSB)
  • flow cytometry; human; fig 5
In order to study chronic hepatitis C virus infections and the functional dichotomy of V-delta2 gamma-delta T cells and their role in cytotoxicity and not IFN-gamma production, Invitrogen CD56 antibody (eBioscience, CMSSB) was used in flow cytometry on human samples (fig 5). Sci Rep (2016) ncbi
mouse monoclonal (CMSSB)
  • flow cytometry; human; loading ...; fig 1a
In order to examine the expression of CD300 molecules on natural killer cells, Invitrogen CD56 antibody (eBiosciences, CMSSB) was used in flow cytometry on human samples (fig 1a). Sci Rep (2016) ncbi
mouse monoclonal (56C04)
  • immunohistochemistry - paraffin section; human; fig 1d
In order to show that reversal cells colonizing bone surfaces right after resorption are osteoblast-lineage cells, Invitrogen CD56 antibody (Thermo Fisher Scientific, 56C04) was used in immunohistochemistry - paraffin section on human samples (fig 1d). Histochem Cell Biol (2016) ncbi
mouse monoclonal (CMSSB)
  • flow cytometry; human; fig 7.45.3
In order to validate a single-cell measurement, simultaneously, for cell surface proteins, messenger RNA, and intracellular proteins, Invitrogen CD56 antibody (eBioscience, 12-0567-41) was used in flow cytometry on human samples (fig 7.45.3). Curr Protoc Cytom (2016) ncbi
mouse monoclonal (CMSSB)
  • flow cytometry; human; fig 5
Invitrogen CD56 antibody (eBioscience, CMSSB) was used in flow cytometry on human samples (fig 5). PLoS Pathog (2015) ncbi
mouse monoclonal (123C3)
  • immunohistochemistry - paraffin section; human; loading ...
In order to assess the relationship between the results of the octreotide test and somatostatin receptor 2 expression in insulinoma patients to predict insulinomas in Japanese patients, Invitrogen CD56 antibody (Zymed, 123C3) was used in immunohistochemistry - paraffin section on human samples . Endocr J (2016) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; mouse; loading ...
In order to assess the effects of allosteric inhibitors on different mutant forms of isocitrate dehydrogenase 1 in leukemia, Invitrogen CD56 antibody (invitrogen, MEM-188) was used in flow cytometry on mouse samples . Nat Chem Biol (2015) ncbi
mouse monoclonal (123C3)
  • immunohistochemistry - paraffin section; human; fig 1
In order to learn the possible role of incipient renal fibrosis by variable expression of neural cell adhesion molecule isoforms in renal tissue, Invitrogen CD56 antibody (LabVision, 123C3.D5) was used in immunohistochemistry - paraffin section on human samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (CMSSB)
  • flow cytometry; human; fig 8
In order to investigate the contribution of lymphocytes to primary percutaneous coronary intervention, Invitrogen CD56 antibody (eBioscience, 42-0567-42) was used in flow cytometry on human samples (fig 8). J Clin Invest (2015) ncbi
mouse monoclonal (123C3)
  • immunohistochemistry - paraffin section; human; 1:50-1:100; fig 4
In order to discuss how to distinguish follicular variant of PTC from other follicular-patterned lesions of the thyroid, Invitrogen CD56 antibody (Thermo Scientific, 123C3.D5) was used in immunohistochemistry - paraffin section on human samples at 1:50-1:100 (fig 4). Int J Clin Exp Pathol (2015) ncbi
mouse monoclonal (123C3)
  • immunohistochemistry; mouse; 1:400; fig 1,2,4,5
In order to characterize human dorsal root ganglia xenografts in vivo for satellite cell tropism and neuronal subtype which are determinants of varicella-zoster virus virulence, Invitrogen CD56 antibody (Invitrogen, 07-C5603) was used in immunohistochemistry on mouse samples at 1:400 (fig 1,2,4,5). PLoS Pathog (2015) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human
In order to elucidate regulation of gamma-globin expression in F-cells, Invitrogen CD56 antibody (Life Technologies, MEM-188) was used in flow cytometry on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (123C3)
  • immunohistochemistry; human; 1:100
Invitrogen CD56 antibody (Zymed Laboratories, 123C3) was used in immunohistochemistry on human samples at 1:100. Virchows Arch (2015) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human; loading ...; fig 1
In order to elucidate Th17 cell polarization, depletion, and restoration in response to HIV infection and antiretroviral therapy, Invitrogen CD56 antibody (eBioscience, MEM188) was used in flow cytometry on human samples (fig 1). Retrovirology (2015) ncbi
mouse monoclonal (123C3)
  • immunohistochemistry - paraffin section; human
In order to describe the clinicopathological features of 15 patients with Epstein-Barr virus-positive nodal T/NK-cell lymphoma, Invitrogen CD56 antibody (Zymed, 123C3) was used in immunohistochemistry - paraffin section on human samples . Hum Pathol (2015) ncbi
mouse monoclonal (CMSSB)
Invitrogen CD56 antibody (eBioscience, 25-0567-42) was used . Scand J Immunol (2015) ncbi
mouse monoclonal (123C3)
  • immunohistochemistry - paraffin section; human; 1:25
In order to determine if immunohistochemical analysis can be used to re-classify lung carcinomas that were originally diagnosed as squamous cell carcinoma, Invitrogen CD56 antibody (Lab Vision, 123C3.D5) was used in immunohistochemistry - paraffin section on human samples at 1:25. Am J Surg Pathol (2015) ncbi
mouse monoclonal (123C3)
  • immunohistochemistry; human; 1:300
Invitrogen CD56 antibody (Zymed, 123C3) was used in immunohistochemistry on human samples at 1:300. J Pediatr Hematol Oncol (2015) ncbi
mouse monoclonal (56C04)
  • immunohistochemistry - paraffin section; human
In order to describe the clinicopathologically features of two cases of kidney mucinous tubular and spindle cell carcinoma, Invitrogen CD56 antibody (THERMO, 56C04) was used in immunohistochemistry - paraffin section on human samples . Int J Clin Exp Pathol (2015) ncbi
mouse monoclonal (123C3)
  • immunohistochemistry; human; 1:100
In order to describe the gluteal lesions of a patient with pagetoid reticulosis, Invitrogen CD56 antibody (Thermo Scientific, 123C3.D5) was used in immunohistochemistry on human samples at 1:100. J Cutan Pathol (2015) ncbi
mouse monoclonal (CMSSB)
  • flow cytometry; human
Invitrogen CD56 antibody (eBioscience, CMSSB) was used in flow cytometry on human samples . J Immunol (2015) ncbi
mouse monoclonal (123C3)
  • immunohistochemistry; human; fig s4a
In order to establish a new method to transplant human fetal kidneys into adult rats, Invitrogen CD56 antibody (Life Technologies, 07-5603) was used in immunohistochemistry on human samples (fig s4a). Am J Transplant (2015) ncbi
mouse monoclonal (123C3)
  • immunohistochemistry - paraffin section; human; ready-to-use
In order to study the relationship between autophagy and anti-tumor immune responses using immunohistochemistry, Invitrogen CD56 antibody (Thermo Scientific, 123.C3.D5) was used in immunohistochemistry - paraffin section on human samples at ready-to-use. Cancer Sci (2015) ncbi
mouse monoclonal (123C3)
  • immunohistochemistry - paraffin section; human; 1:100
Invitrogen CD56 antibody (ZYMED, 123c 3) was used in immunohistochemistry - paraffin section on human samples at 1:100. Endocr Pathol (2014) ncbi
mouse monoclonal (123C3)
  • immunohistochemistry; human
In order to describe the histological features canalicular adenoma, Invitrogen CD56 antibody (Lab Vision, 123C3.D5) was used in immunohistochemistry on human samples . Head Neck Pathol (2015) ncbi
mouse monoclonal (123C3)
  • immunohistochemistry - paraffin section; human
Invitrogen CD56 antibody (Zymed, 123C3) was used in immunohistochemistry - paraffin section on human samples . Virchows Arch (2014) ncbi
mouse monoclonal (123C3)
  • immunohistochemistry - paraffin section; human; 1:50; fig 3
In order to present the case of a (123)I-MIBG negative pheochromocytoma, Invitrogen CD56 antibody (Invitrogen, 07-5603) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 3). Int J Clin Exp Pathol (2014) ncbi
mouse monoclonal (CMSSB)
  • flow cytometry; human
Invitrogen CD56 antibody (eBioscience, CMSSB) was used in flow cytometry on human samples . J Exp Med (2014) ncbi
mouse monoclonal (123C3)
  • immunohistochemistry - paraffin section; human; 1:100
In order to report on a case of CD30-positive extranodal natural killer/T-cell lymphoma, Invitrogen CD56 antibody (Zymed, 123C3) was used in immunohistochemistry - paraffin section on human samples at 1:100. Oncol Lett (2014) ncbi
mouse monoclonal (CMSSB)
  • flow cytometry; human; tbl 1
In order to study the effect of innate lymphoid cells on B cells, Invitrogen CD56 antibody (eBioscience, CMSSB) was used in flow cytometry on human samples (tbl 1). Nat Immunol (2014) ncbi
mouse monoclonal (123C3)
  • immunohistochemistry - paraffin section; human
Invitrogen CD56 antibody (Invitrogen, 123C3) was used in immunohistochemistry - paraffin section on human samples . Int J Gynecol Pathol (2014) ncbi
mouse monoclonal (123C3)
  • immunohistochemistry; human; 1:200; fig 1
In order to analyze regulation of endometrial bleeding in women and suppression by progesterone receptor modulator asoprisnil by uterine NK cells, Invitrogen CD56 antibody (Zymed, noca) was used in immunohistochemistry on human samples at 1:200 (fig 1). J Immunol (2013) ncbi
mouse monoclonal (123C3)
  • immunohistochemistry; human; 1:50
In order to characterize the case of a distal epithelioid sarcoma arising in the thumb of a 14-year-old girl, Invitrogen CD56 antibody (ZYMED, 123C3) was used in immunohistochemistry on human samples at 1:50. Case Rep Pathol (2013) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human; fig 2
In order to study the roles of the decidua-derived CCL2 in the Th2 predominance found at the maternal-fetal interface, Invitrogen CD56 antibody (CALTAG, MHCD5618) was used in flow cytometry on human samples (fig 2). Clin Immunol (2012) ncbi
mouse monoclonal (123C3)
  • immunohistochemistry - paraffin section; human
In order to determine the clinicopathologic features and diagnosis of extraosseous plasmacytomas, Invitrogen CD56 antibody (NeoMarker, 123C3) was used in immunohistochemistry - paraffin section on human samples . Diagn Pathol (2011) ncbi
mouse monoclonal (123C3)
  • flow cytometry; human; 1:100; tbl 3
In order to characterize extranodal natural killer/T-cell lymphoma, nasal type using patient samples, Invitrogen CD56 antibody (ZYMED, 123C3) was used in flow cytometry on human samples at 1:100 (tbl 3). Cytopathology (2012) ncbi
mouse monoclonal (123C3)
  • immunohistochemistry; human; fig 3
In order to study subcutaneous panniculitis-like T-cell lymphomas in Korean patients, Invitrogen CD56 antibody (Zymed, 123) was used in immunohistochemistry on human samples (fig 3). Ann Dermatol (2011) ncbi
mouse monoclonal (123C3)
  • immunohistochemistry - paraffin section; human
In order to investigate the clinical and pathological features in a girl with common variable immunodeficiency, Invitrogen CD56 antibody (Thermo, 123C3. D5) was used in immunohistochemistry - paraffin section on human samples . Int J Surg Pathol (2014) ncbi
mouse monoclonal (123C3)
  • immunohistochemistry - paraffin section; human; 1:100; fig 1
In order to report the clinicopathological and immunohistochemical features of goblet cell carcinoid, Invitrogen CD56 antibody (Zymed, 123C3) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1). Int J Surg Pathol (2010) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human; fig 1
In order to report that HSP70 activates human NK cells to kill target cells expressing MICA in a natural killer group 2 member D-dependent manner, Invitrogen CD56 antibody (Caltag, MEM 188) was used in flow cytometry on human samples (fig 1). J Cell Mol Med (2010) ncbi
mouse monoclonal (NKI-NBL-1)
  • flow cytometry; human
In order to assess the safety and feasibility of autologous bone marrow mononuclear cells transplantation in ST elevation myocardial infarction, Invitrogen CD56 antibody (Caltag Laboratories, NKI-nbl-1) was used in flow cytometry on human samples . Cell Transplant (2009) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human; loading ...; fig 2a
In order to demonstrate that aerosolized interferon-gamma results in the transient conversion of sputum smears in multidrug-resistant pulmonary tuberculosis, Invitrogen CD56 antibody (Invitrogen, MEM-188) was used in flow cytometry on human samples (fig 2a). Int J Tuberc Lung Dis (2008) ncbi
mouse monoclonal (MEM-188)
  • blocking or activating experiments; human; fig 3
In order to test whether CD44 aids in adhesion of human hematopoietic progenitor cells to mesenchymal stromal cells, Invitrogen CD56 antibody (Caltag, MEM-188) was used in blocking or activating experiments on human samples (fig 3). Cells Tissues Organs (2008) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human
In order to characterize natural killer cells from different tissues of the FRT, Invitrogen CD56 antibody (Caltag Laboratories, MEM-188) was used in flow cytometry on human samples . Clin Immunol (2007) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human
In order to test if the normally discarded bone marrow collection kits are a convenient source of large numbers of mesenchymal stem cells, Invitrogen CD56 antibody (Caltag, MEM-188) was used in flow cytometry on human samples . Transplantation (2007) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human
In order to assess TLR expression and signaling by uterine natural killer cells from the human endometrium, Invitrogen CD56 antibody (Caltag, MEM-188) was used in flow cytometry on human samples . J Immunol (2006) ncbi
mouse monoclonal (NKI-NBL-1)
  • flow cytometry; human
In order to assess the safety and efficacy of autologous bone marrow mononuclear cell injected into areas of ischemic myocardium in patients with end-stage ischemic cardiomyopathy, Invitrogen CD56 antibody (Caltag, NKI nbl-1) was used in flow cytometry on human samples . Circulation (2004) ncbi
mouse monoclonal (123C3)
  • immunohistochemistry; human; 1:200; fig 1
In order to analyze the infection by the varicella-zoster virus in human neural cells in vivo, Invitrogen CD56 antibody (Zymed, noca) was used in immunohistochemistry on human samples at 1:200 (fig 1). Proc Natl Acad Sci U S A (2004) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human; tbl 1
In order to compare human saphenous vein endothelial cells with human umbilical vein endothelial cells, Invitrogen CD56 antibody (Caltag, MEM-188) was used in flow cytometry on human samples (tbl 1). Atherosclerosis (2004) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human; fig 1
In order to characterize B7-H3, Invitrogen CD56 antibody (Caltag, MEM-188) was used in flow cytometry on human samples (fig 1). J Immunol (2004) ncbi
mouse monoclonal (123C3)
  • immunohistochemistry - paraffin section; human; fig 2
In order to show that MHC class 1 chain-related molecules expressing colon adenocarcinoma can evade NK cell immunity, Invitrogen CD56 antibody (Zymed, noca) was used in immunohistochemistry - paraffin section on human samples (fig 2). J Immunol (2003) ncbi
mouse monoclonal (123C3)
  • immunohistochemistry; human; 1:40
In order to study the sequence of Simian virus 40 in malignant lymphomas in Japan, Invitrogen CD56 antibody (Zymed Laboratories, noca) was used in immunohistochemistry on human samples at 1:40. Cancer Res (2003) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human
In order to describe a new raft-associated adaptor protein, Lck-interacting molecule, expressed predominantly in T lymphocytes, Invitrogen CD56 antibody (Caltag, MEM-188) was used in flow cytometry on human samples . J Exp Med (2003) ncbi
mouse monoclonal (NKI-NBL-1)
  • flow cytometry; human
In order to examine adhesion molecules in patients with restenosis, Invitrogen CD56 antibody (Caltag, NKI-nbl-1) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2003) ncbi
mouse monoclonal (NKI-NBL-1)
  • flow cytometry; human
In order to test if transendocardial injections of autologous mononuclear bone marrow cells in patients with end-stage ischemic heart disease promotes neovascularization and improves perfusion and myocardial contractility, Invitrogen CD56 antibody (Caltag, NKI nbl-1) was used in flow cytometry on human samples . Circulation (2003) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human
In order to report differential expression of chemokine receptors among NKT cell subsets, Invitrogen CD56 antibody (Caltag, MEM-188) was used in flow cytometry on human samples . Blood (2002) ncbi
mouse monoclonal (NKI-NBL-1)
  • flow cytometry; human; fig 2
In order to characterize the localization and function of STRL33/Bonzo, Invitrogen CD56 antibody (Caltag, NKI-nbl-1) was used in flow cytometry on human samples (fig 2). Blood (2000) ncbi
mouse monoclonal (NKI-NBL-1)
  • immunohistochemistry; human; tbl 4
In order to discuss the role of dendritic cells in human renal cell carcinoma, Invitrogen CD56 antibody (Caltag, NKI-nbl-1) was used in immunohistochemistry on human samples (tbl 4). J Urol (1999) ncbi
mouse monoclonal (NKI-NBL-1)
  • flow cytometry; human
In order to determine the number of CD4, CCR5, and CXCR4 antibody-binding sites on various T cells and macrophages, Invitrogen CD56 antibody (Caltag, NKI-nbl-1) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (1999) ncbi
mouse monoclonal (MEM-188)
  • immunoprecipitation; chicken; fig 5
In order to elucidate the function of neural cell adhesion molecule, Invitrogen CD56 antibody (noco, noca) was used in immunoprecipitation on chicken samples (fig 5). Science (1987) ncbi
mouse monoclonal (MEM-188)
  • immunoprecipitation; human; fig 1
In order to propose that the Leu-19 antigen on leukocytes contributes to cell adhesion and is analogous to N-CAM on neural cells, Invitrogen CD56 antibody (invitrogen, MEM-188) was used in immunoprecipitation on human samples (fig 1). J Exp Med (1989) ncbi
Abcam
domestic rabbit monoclonal (CAL53)
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig s4b
  • immunoprecipitation; mouse; 1:200; loading ...; fig 4b
  • western blot; mouse; 1:1000; loading ...; fig s1d
Abcam CD56 antibody (Abcam, ab237708) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig s4b), in immunoprecipitation on mouse samples at 1:200 (fig 4b) and in western blot on mouse samples at 1:1000 (fig s1d). Cell Rep Med (2022) ncbi
domestic rabbit monoclonal (EP2567Y)
  • immunohistochemistry; human; 1:300; loading ...; fig 1a
  • immunohistochemistry; mouse; 1:300; loading ...; fig 1b
Abcam CD56 antibody (Abcam, ab75813) was used in immunohistochemistry on human samples at 1:300 (fig 1a) and in immunohistochemistry on mouse samples at 1:300 (fig 1b). Cell Prolif (2021) ncbi
mouse monoclonal (123C3)
  • western blot; human; 1:500; loading ...; fig 2k
Abcam CD56 antibody (Abcam, ab9272) was used in western blot on human samples at 1:500 (fig 2k). Aging (Albany NY) (2021) ncbi
domestic rabbit monoclonal (EP2567Y)
  • western blot; rat; loading ...; fig 4
Abcam CD56 antibody (Abcam, ab75813) was used in western blot on rat samples (fig 4). Brain Pathol (2021) ncbi
domestic rabbit monoclonal (EP2567Y)
  • immunohistochemistry - frozen section; human; fig 3f
Abcam CD56 antibody (Abcam, ab75813) was used in immunohistochemistry - frozen section on human samples (fig 3f). Nat Commun (2019) ncbi
domestic rabbit monoclonal (EP2567Y)
  • immunohistochemistry - paraffin section; human; loading ...; fig 3c
Abcam CD56 antibody (Abcam, ab75813) was used in immunohistochemistry - paraffin section on human samples (fig 3c). Science (2018) ncbi
mouse monoclonal (MEM-188)
  • western blot; human; loading ...; fig 3a
Abcam CD56 antibody (Abcam, ab18277) was used in western blot on human samples (fig 3a). Nucleic Acids Res (2018) ncbi
mouse monoclonal (RNL-1)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 4b
Abcam CD56 antibody (Abcam, ab9018) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 4b). Free Radic Biol Med (2018) ncbi
mouse monoclonal (LT56)
  • flow cytometry; human; 1:1000; loading ...; tbl 1
Abcam CD56 antibody (Abcam, ab205500) was used in flow cytometry on human samples at 1:1000 (tbl 1). Exp Ther Med (2016) ncbi
mouse monoclonal (123C3)
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig 3a, 3b, 3c
Abcam CD56 antibody (Abcam, AB9272) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 3a, 3b, 3c). Neural Regen Res (2016) ncbi
mouse monoclonal (123C3)
  • immunohistochemistry - frozen section; human
Abcam CD56 antibody (Abcam, ab9272) was used in immunohistochemistry - frozen section on human samples . Scand J Med Sci Sports (2016) ncbi
domestic rabbit monoclonal (EPR2566)
  • immunohistochemistry - paraffin section; human; 1:100
Abcam CD56 antibody (Epitomics, 2690-1) was used in immunohistochemistry - paraffin section on human samples at 1:100. Acta Orthop (2013) ncbi
Santa Cruz Biotechnology
mouse monoclonal (ERIC 1)
  • immunohistochemistry - frozen section; human; 1:1000; fig 3a
Santa Cruz Biotechnology CD56 antibody (Santa Cruz, sc-106) was used in immunohistochemistry - frozen section on human samples at 1:1000 (fig 3a). Stem Cell Reports (2021) ncbi
mouse monoclonal (ERIC 1)
  • immunohistochemistry; rat; 1:100; loading ...; fig 5a
Santa Cruz Biotechnology CD56 antibody (Santa Cruz, sc-106) was used in immunohistochemistry on rat samples at 1:100 (fig 5a). NPJ Parkinsons Dis (2021) ncbi
mouse monoclonal (123C3)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig s4b
Santa Cruz Biotechnology CD56 antibody (Santa Cruz, sc-7326) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig s4b). Cancer Cell (2019) ncbi
mouse monoclonal (ERIC 1)
  • immunohistochemistry; mouse; loading ...; fig s3b
In order to evaluate host immune-mediated cell rejection in a retinal transplantation model, Santa Cruz Biotechnology CD56 antibody (Santa Cruz, SC-106) was used in immunohistochemistry on mouse samples (fig s3b). Cell Stem Cell (2017) ncbi
mouse monoclonal (ERIC 1)
  • immunocytochemistry; human; fig S1
Santa Cruz Biotechnology CD56 antibody (Santa cruz, sc-106) was used in immunocytochemistry on human samples (fig S1). J Clin Invest (2017) ncbi
mouse monoclonal (123C3)
  • other; human; 1:50; loading ...; fig 1a, 1c
Santa Cruz Biotechnology CD56 antibody (Santa Cruz, sc-7326) was used in other on human samples at 1:50 (fig 1a, 1c). Oncotarget (2015) ncbi
mouse monoclonal (123C3)
  • western blot; human; fig 1
Santa Cruz Biotechnology CD56 antibody (Santa Cruz, Sc7326) was used in western blot on human samples (fig 1). J Matern Fetal Neonatal Med (2016) ncbi
mouse monoclonal (123C3)
  • western blot; human; fig 1
Santa Cruz Biotechnology CD56 antibody (Santa Cruz, sc-7326) was used in western blot on human samples (fig 1). Physiol Rep (2015) ncbi
mouse monoclonal (ERIC 1)
  • ELISA; human
Santa Cruz Biotechnology CD56 antibody (Santa, sc-106) was used in ELISA on human samples . FASEB J (2015) ncbi
mouse monoclonal (123C3)
  • immunocytochemistry; human; 1:250; tbl 1
Santa Cruz Biotechnology CD56 antibody (Santa Cruz, sc-7326) was used in immunocytochemistry on human samples at 1:250 (tbl 1). Stem Cells Dev (2015) ncbi
mouse monoclonal (ERIC 1)
  • ELISA; human
Santa Cruz Biotechnology CD56 antibody (Santa Cruz Biotechnology, sc-106) was used in ELISA on human samples . Alzheimers Dement (2015) ncbi
Miltenyi Biotec
human monoclonal (REA196)
  • flow cytometry; human; 1:100; fig 2f
Miltenyi Biotec CD56 antibody (Miltenyi, 130-113-312) was used in flow cytometry on human samples at 1:100 (fig 2f). Nat Med (2021) ncbi
human monoclonal (REA196)
  • flow cytometry; human; loading ...; fig 1s1a
Miltenyi Biotec CD56 antibody (Miltenyi Biotec, 130-114-548) was used in flow cytometry on human samples (fig 1s1a). elife (2020) ncbi
mouse monoclonal (AF12-7H3)
  • flow cytometry; human; loading ...; fig 1a
Miltenyi Biotec CD56 antibody (Miltenyi, AF12-7H3) was used in flow cytometry on human samples (fig 1a). BMC Cancer (2019) ncbi
mouse monoclonal (AF12-7H3)
  • flow cytometry; human; loading ...
In order to assess the role of C1q in downregulating allergic inflammation, Miltenyi Biotec CD56 antibody (Miltenyi, AF12-7H3) was used in flow cytometry on human samples . Mucosal Immunol (2017) ncbi
Novus Biologicals
domestic rabbit monoclonal (JF1021)
  • western blot; mouse; 1:1000; loading ...; fig 7c
Novus Biologicals CD56 antibody (Novus, NBP2-66968) was used in western blot on mouse samples at 1:1000 (fig 7c). J Neurosci (2022) ncbi
OriGene
mouse monoclonal (UMAB83)
  • western blot; human; 1:1000; fig s1
OriGene CD56 antibody (Origene, UMAB83) was used in western blot on human samples at 1:1000 (fig s1). Biol Open (2016) ncbi
mouse monoclonal (OTI2D4)
  • western blot; cat; fig 1
OriGene CD56 antibody (OriGene, 2D4) was used in western blot on cat samples (fig 1). FEBS J (2015) ncbi
mouse monoclonal (OTI1G4)
  • immunohistochemistry - paraffin section; cat; fig 3
  • western blot; cat; fig 1
OriGene CD56 antibody (OriGene, 1G4) was used in immunohistochemistry - paraffin section on cat samples (fig 3) and in western blot on cat samples (fig 1). FEBS J (2015) ncbi
Abnova
mouse monoclonal (3G12)
  • western blot; pigs ; 2.5 ug/ml; fig 6
Abnova CD56 antibody (Abnova, H00004684-M01) was used in western blot on pigs samples at 2.5 ug/ml (fig 6). Glycoconj J (2015) ncbi
mouse monoclonal (MEM-188)
  • immunohistochemistry - frozen section; rhesus macaque; 1:80; fig 3
Abnova CD56 antibody (Abnova, MEM-188) was used in immunohistochemistry - frozen section on rhesus macaque samples at 1:80 (fig 3). FASEB J (2015) ncbi
mouse monoclonal (MEM 188)
  • immunohistochemistry - frozen section; rhesus macaque; 1:80; fig 3
Abnova CD56 antibody (Abnova, MEM-188) was used in immunohistochemistry - frozen section on rhesus macaque samples at 1:80 (fig 3). FASEB J (2015) ncbi
Sino Biological
mouse monoclonal (05)
  • flow cytometry; human; loading ...; fig 4a
  • flow cytometry; mouse
Sino Biological CD56 antibody (Sino Biological, 10673-MM05-P) was used in flow cytometry on human samples (fig 4a) and in flow cytometry on mouse samples . Nat Commun (2020) ncbi
Bio-Rad
mouse monoclonal (ERIC-1)
  • immunohistochemistry - frozen section; human
In order to characterize dermatomyositis with or without anti-melanoma differentiation-associated gene 5 antibodies that show distinct NOS2 expression but a common interferon signature, Bio-Rad CD56 antibody (AbD Serotec, ERIC-1) was used in immunohistochemistry - frozen section on human samples . Am J Pathol (2016) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human; fig 1
In order to discuss methods to detect fetomaternal hemorrhage, Bio-Rad CD56 antibody (Serotec, Clone MEM-188) was used in flow cytometry on human samples (fig 1). Transfusion (2014) ncbi
Alomone Labs
domestic rabbit polyclonal
  • western blot knockout validation; mouse; 1:400; loading ...; fig 5a, s3
Alomone Labs CD56 antibody (Alomone, ANR-041) was used in western blot knockout validation on mouse samples at 1:400 (fig 5a, s3). Development (2021) ncbi
Beckman Coulter
mouse monoclonal (N901)
  • flow cytometry; human; loading ...; fig 6c
Beckman Coulter CD56 antibody (Beckman Coulter, N901) was used in flow cytometry on human samples (fig 6c). Oncoimmunology (2022) ncbi
mouse monoclonal (N901)
  • flow cytometry; human; 1:25; loading ...
Beckman Coulter CD56 antibody (Beckman Coulter, N901) was used in flow cytometry on human samples at 1:25. elife (2020) ncbi
mouse monoclonal (N901)
  • flow cytometry; human; loading ...
Beckman Coulter CD56 antibody (Beckman Coulter, N901) was used in flow cytometry on human samples . elife (2020) ncbi
mouse monoclonal (N901)
  • flow cytometry; human; loading ...; fig s2
Beckman Coulter CD56 antibody (Beckman Coulter, N901) was used in flow cytometry on human samples (fig s2). EBioMedicine (2020) ncbi
mouse monoclonal (N901)
  • flow cytometry; human; loading ...; fig s4a, s8a
Beckman Coulter CD56 antibody (Beckman Coulter, N901) was used in flow cytometry on human samples (fig s4a, s8a). Nat Commun (2020) ncbi
mouse monoclonal (N901)
  • flow cytometry; human; loading ...; fig 3b
Beckman Coulter CD56 antibody (Beckman Coulter, N901 NKH-1) was used in flow cytometry on human samples (fig 3b). Front Immunol (2019) ncbi
mouse monoclonal (N901)
  • flow cytometry; human; loading ...; fig 1a
Beckman Coulter CD56 antibody (Beckman Coulter, N901) was used in flow cytometry on human samples (fig 1a). J Infect Dis (2019) ncbi
mouse monoclonal (N901)
  • flow cytometry; human; loading ...; fig s1
Beckman Coulter CD56 antibody (Beckman Coulter, A82943) was used in flow cytometry on human samples (fig s1). Eur J Immunol (2018) ncbi
mouse monoclonal (N901)
  • flow cytometry; human; loading ...; fig 5a
Beckman Coulter CD56 antibody (Beckman Coulter, N901) was used in flow cytometry on human samples (fig 5a). Proc Natl Acad Sci U S A (2018) ncbi
mouse monoclonal (N901)
  • flow cytometry; human; loading ...; fig 2a
Beckman Coulter CD56 antibody (Beckman Coulter, N901) was used in flow cytometry on human samples (fig 2a). Cancer Immunol Res (2018) ncbi
mouse monoclonal (N901)
  • flow cytometry; human; loading ...; fig 5c
Beckman Coulter CD56 antibody (Beckman Coulter, N901) was used in flow cytometry on human samples (fig 5c). J Biol Chem (2018) ncbi
mouse monoclonal (N901)
  • flow cytometry; human; fig 1a
In order to study the involvement of Notch signaling in NK cell lineage determination, Beckman Coulter CD56 antibody (Beckman Coulter, N901) was used in flow cytometry on human samples (fig 1a). J Immunol (2017) ncbi
mouse monoclonal (N901)
  • flow cytometry; human; loading ...; fig 3a
Beckman Coulter CD56 antibody (Beckman Coulter, N901) was used in flow cytometry on human samples (fig 3a). Immun Ageing (2017) ncbi
mouse monoclonal (N901)
  • flow cytometry; human; loading ...; fig 1c
Beckman Coulter CD56 antibody (Beckman-Coulter, N901) was used in flow cytometry on human samples (fig 1c). J Immunol (2016) ncbi
mouse monoclonal (N901)
  • flow cytometry; human; loading ...; fig 3b
Beckman Coulter CD56 antibody (Beckman Coulter, N901) was used in flow cytometry on human samples (fig 3b). J Immunol (2016) ncbi
mouse monoclonal (N901)
  • flow cytometry; human; loading ...; fig 6c
Beckman Coulter CD56 antibody (Beckman Coulter, N901) was used in flow cytometry on human samples (fig 6c). J Biol Chem (2016) ncbi
mouse monoclonal (N901)
  • flow cytometry; human; loading ...; tbl 1
Beckman Coulter CD56 antibody (Beckman Coulter, N901) was used in flow cytometry on human samples (tbl 1). Int J Lab Hematol (2016) ncbi
mouse monoclonal (N901)
  • flow cytometry; human
Beckman Coulter CD56 antibody (Beckman-Coulter, N901) was used in flow cytometry on human samples . Clin Cancer Res (2016) ncbi
mouse monoclonal (N901)
  • flow cytometry; human
In order to discuss using the infiltrate to diagnosis B-cell lymphomas, Beckman Coulter CD56 antibody (BC, N901) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2016) ncbi
mouse monoclonal (N901)
  • flow cytometry; human; loading ...; fig 1a
In order to investigate the effect of miRNA-155 in IL-21 signaling in white cells and it role in systemic lupues erythematosus., Beckman Coulter CD56 antibody (Beckman Coulter, A51078) was used in flow cytometry on human samples (fig 1a). Arthritis Res Ther (2015) ncbi
mouse monoclonal (N901)
  • flow cytometry; human
Beckman Coulter CD56 antibody (Beckman Coulter, N901/HLDA6) was used in flow cytometry on human samples . J Immunol (2015) ncbi
mouse monoclonal (N901)
  • flow cytometry; human; tbl 1
Beckman Coulter CD56 antibody (Beckman-Coulter, N901) was used in flow cytometry on human samples (tbl 1). Cancer Immunol Immunother (2015) ncbi
mouse monoclonal (N901)
  • flow cytometry; human
Beckman Coulter CD56 antibody (Beckman Coulter, N901) was used in flow cytometry on human samples . Eur J Immunol (2015) ncbi
mouse monoclonal (N901)
  • flow cytometry; human
Beckman Coulter CD56 antibody (Beckman Coulter, N901) was used in flow cytometry on human samples . J Leukoc Biol (2014) ncbi
mouse monoclonal (N901)
  • flow cytometry; human; fig 3
In order to characterize two cases of anaplastic large cell lymphoma using flow cytometry, Beckman Coulter CD56 antibody (Beckman Coulter, N901 (NKH-1)) was used in flow cytometry on human samples (fig 3). Cytometry B Clin Cytom (2015) ncbi
mouse monoclonal (N901)
  • immunocytochemistry; human
In order to analyze HIV-specific naive and memory CD4(+) T cells through two methods, Beckman Coulter CD56 antibody (Beckman Coulter, N901 [NHK-1]) was used in immunocytochemistry on human samples . J Exp Med (2014) ncbi
mouse monoclonal (N901)
  • flow cytometry; human
Beckman Coulter CD56 antibody (Beckman Coulter, N901) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (N901)
  • flow cytometry; human
Beckman Coulter CD56 antibody (Beckman Coulter, N901) was used in flow cytometry on human samples . J Clin Immunol (2014) ncbi
mouse monoclonal (N901)
  • flow cytometry; human
In order to study NK function in solid tumors, Beckman Coulter CD56 antibody (Beckman Coulter, N901) was used in flow cytometry on human samples . Int J Cancer (2014) ncbi
mouse monoclonal (N901)
  • flow cytometry; African green monkey; loading ...; fig 3
In order to examine the role of IL-15 in HIV-infected chimpanzees, Beckman Coulter CD56 antibody (Beckman Coulter, N901) was used in flow cytometry on African green monkey samples (fig 3). Cell Immunol (2014) ncbi
mouse monoclonal (N901)
  • flow cytometry; human
Beckman Coulter CD56 antibody (Beckman-Coulter, N901) was used in flow cytometry on human samples . J Infect Dis (2014) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (E7X9M)
  • immunohistochemistry - paraffin section; mouse; fig 6
Cell Signaling Technology CD56 antibody (CST, 99746) was used in immunohistochemistry - paraffin section on mouse samples (fig 6). Front Cell Dev Biol (2021) ncbi
domestic rabbit monoclonal (E7X9M)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 2d, 3a
Cell Signaling Technology CD56 antibody (CST, 99746S) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 2d, 3a). Cell Prolif (2021) ncbi
mouse monoclonal (123C3)
  • western blot; human; 1:1000; loading ...
Cell Signaling Technology CD56 antibody (Cell signaling Technology, 3576) was used in western blot on human samples at 1:1000. elife (2020) ncbi
mouse monoclonal (123C3)
  • western blot; human; loading ...; fig s8
Cell Signaling Technology CD56 antibody (Cell Signaling, 3576) was used in western blot on human samples (fig s8). Nat Commun (2020) ncbi
mouse monoclonal (123C3)
  • western blot knockout validation; human; 1:1000; loading ...; fig 1a
Cell Signaling Technology CD56 antibody (Cell Signaling, 3576S) was used in western blot knockout validation on human samples at 1:1000 (fig 1a). elife (2020) ncbi
domestic rabbit monoclonal (E7X9M)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 3c
  • immunocytochemistry; human; loading ...; fig 3b
  • western blot; human; 1:1000; loading ...; fig 3a
  • western blot; mouse; 1:1000; loading ...; fig 3a
Cell Signaling Technology CD56 antibody (CST, 99746s) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 3c), in immunocytochemistry on human samples (fig 3b), in western blot on human samples at 1:1000 (fig 3a) and in western blot on mouse samples at 1:1000 (fig 3a). Oncol Lett (2020) ncbi
mouse monoclonal (123C3)
  • immunohistochemistry - paraffin section; human; 1:400; loading ...; fig 3b
Cell Signaling Technology CD56 antibody (Cell Signaling, 3576) was used in immunohistochemistry - paraffin section on human samples at 1:400 (fig 3b). Oncol Lett (2017) ncbi
mouse monoclonal (123C3)
  • immunohistochemistry - paraffin section; human; 1:50; fig 1
  • western blot; human; 1:1000; fig 1
Cell Signaling Technology CD56 antibody (Cell Signaling, 123C3) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 1) and in western blot on human samples at 1:1000 (fig 1). Sci Rep (2016) ncbi
mouse monoclonal (123C3)
  • immunohistochemistry - paraffin section; human; 1:50; fig 3
Cell Signaling Technology CD56 antibody (Cell Signaling Tech, 3576) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 3). PLoS ONE (2016) ncbi
mouse monoclonal (123C3)
  • immunocytochemistry; human; fig 1
Cell Signaling Technology CD56 antibody (Cell Signaling, 3576) was used in immunocytochemistry on human samples (fig 1). Thyroid (2015) ncbi
Dako
mouse monoclonal (123C3)
  • immunohistochemistry - paraffin section; mouse; 1:30; fig 5a
Dako CD56 antibody (DAKO/Agilent, 123C3) was used in immunohistochemistry - paraffin section on mouse samples at 1:30 (fig 5a). J Immunother Cancer (2021) ncbi
mouse monoclonal (123C3)
  • immunohistochemistry; human; 1:150; loading ...; fig 4c
Dako CD56 antibody (DAKO, 123C3) was used in immunohistochemistry on human samples at 1:150 (fig 4c). BMC Cancer (2020) ncbi
mouse monoclonal (123C3)
  • immunohistochemistry - frozen section; human; loading ...; tbl 2
In order to characterize HLA class I-positive and negative tumors, Dako CD56 antibody (Dako, 123C3) was used in immunohistochemistry - frozen section on human samples (tbl 2). Int J Cancer (2017) ncbi
mouse monoclonal (123C3)
  • immunohistochemistry - paraffin section; human; 1:400; loading ...
Dako CD56 antibody (Dako, M7304) was used in immunohistochemistry - paraffin section on human samples at 1:400. Oncol Lett (2016) ncbi
mouse monoclonal (123C3)
  • immunohistochemistry - paraffin section; human; 1:50; tbl 1
Dako CD56 antibody (Dako, 123C3) was used in immunohistochemistry - paraffin section on human samples at 1:50 (tbl 1). Rom J Morphol Embryol (2016) ncbi
mouse monoclonal (123C3)
  • immunohistochemistry - paraffin section; human; fig 6
Dako CD56 antibody (Dako, 123C3) was used in immunohistochemistry - paraffin section on human samples (fig 6). Oncol Rep (2015) ncbi
mouse monoclonal (123C3)
  • immunohistochemistry; human; 1:100
In order to identify tissue origin of the granular cell tumor using immunohistochemistry, Dako CD56 antibody (Dako, 123C3) was used in immunohistochemistry on human samples at 1:100. Arch Dermatol Res (2015) ncbi
Cell Marque
domestic rabbit monoclonal (MRQ-42)
  • immunohistochemistry; human; fig 3c
Cell Marque CD56 antibody (Cell Marque, MRQ42) was used in immunohistochemistry on human samples (fig 3c). Nat Commun (2021) ncbi
domestic rabbit monoclonal (MRQ-42)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 2a
Cell Marque CD56 antibody (Cell Marque, MRQ-42) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 2a). Int J Mol Sci (2020) ncbi
domestic rabbit monoclonal (MRQ-42)
  • immunohistochemistry - paraffin section; human; 1:4; loading ...; fig 3a
Cell Marque CD56 antibody (Cell Marque, MRQ-42) was used in immunohistochemistry - paraffin section on human samples at 1:4 (fig 3a). Br J Cancer (2016) ncbi
BD Biosciences
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; loading ...; fig 1b
BD Biosciences CD56 antibody (BD Biosciences, NCAM16.2) was used in flow cytometry on human samples (fig 1b). Proc Natl Acad Sci U S A (2022) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; loading ...; fig 5a
BD Biosciences CD56 antibody (BD Biosciences, B159) was used in flow cytometry on human samples (fig 5a). Front Immunol (2021) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; 1:100
BD Biosciences CD56 antibody (BD Biosciences, 557919) was used in flow cytometry on human samples at 1:100. Nat Commun (2021) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; loading ...; fig 7
BD Biosciences CD56 antibody (BD Bioscience, 560842) was used in flow cytometry on human samples (fig 7). PLoS Negl Trop Dis (2021) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; 1:500; loading ...
BD Biosciences CD56 antibody (BD, 562794) was used in flow cytometry on human samples at 1:500. Cell (2021) ncbi
mouse monoclonal (MY31)
  • flow cytometry; human; 1:1000; loading ...; fig s1g
BD Biosciences CD56 antibody (BD Bioscience, 556647) was used in flow cytometry on human samples at 1:1000 (fig s1g). Cell (2021) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; loading ...; fig 3h
BD Biosciences CD56 antibody (BD Biosciences, NCAM16.2) was used in flow cytometry on human samples (fig 3h). elife (2020) ncbi
rat monoclonal (12F8)
  • flow cytometry; human; 1:50; loading ...; fig 2s2
BD Biosciences CD56 antibody (BD Biosciences, 556325) was used in flow cytometry on human samples at 1:50 (fig 2s2). elife (2020) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; loading ...; fig 9a
BD Biosciences CD56 antibody (BD, B159) was used in flow cytometry on human samples (fig 9a). J Exp Med (2020) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; 3:50; loading ...; fig 1c
BD Biosciences CD56 antibody (BD Biosciences, NCAM16.2) was used in flow cytometry on human samples at 3:50 (fig 1c). Science (2020) ncbi
mouse monoclonal (MY31)
  • flow cytometry; human; fig 1
BD Biosciences CD56 antibody (BD, 347747) was used in flow cytometry on human samples (fig 1). J Cancer (2020) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; loading ...; fig 4b
BD Biosciences CD56 antibody (BD, 560842) was used in flow cytometry on human samples (fig 4b). Stem Cell Reports (2020) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; loading ...; fig s6c
BD Biosciences CD56 antibody (BD, NCAM16.2) was used in flow cytometry on human samples (fig s6c). Science (2019) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; loading ...; fig s1
BD Biosciences CD56 antibody (BD Biosciences, NCAM16.2) was used in flow cytometry on human samples (fig s1). Eur J Immunol (2019) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; loading ...; fig 7c
BD Biosciences CD56 antibody (BD Biosciences, 557747) was used in flow cytometry on human samples (fig 7c). Cell (2019) ncbi
mouse monoclonal (B159)
  • immunocytochemistry; human; loading ...; fig s1a
BD Biosciences CD56 antibody (BD Biosciences, 555516) was used in immunocytochemistry on human samples (fig s1a). Cell (2019) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; loading ...; fig s1
BD Biosciences CD56 antibody (BD Biosciences, NCAM16.2) was used in flow cytometry on human samples (fig s1). Front Immunol (2019) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; 1:20; loading ...; fig 2e
BD Biosciences CD56 antibody (BD, 557711) was used in flow cytometry on human samples at 1:20 (fig 2e). Sci Rep (2019) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD56 antibody (BD, NAM16.2) was used in flow cytometry on human samples (fig 1a). J Virol (2019) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; loading ...; fig 5b
BD Biosciences CD56 antibody (BD, 560360) was used in flow cytometry on human samples (fig 5b). Cell (2018) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; loading ...; fig s6d
BD Biosciences CD56 antibody (BD Biosciences, NCAM16.2) was used in flow cytometry on human samples (fig s6d). Cell (2018) ncbi
mouse monoclonal (MY31)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD56 antibody (BD Biosciences, MY31) was used in flow cytometry on human samples (fig 1a). Int J Hematol (2018) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD56 antibody (BD Biosciences, 559043) was used in flow cytometry on human samples (fig 1a). Cell (2018) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; loading ...; fig s2d
BD Biosciences CD56 antibody (BD Biosciences, 557919) was used in flow cytometry on human samples (fig s2d). Nat Immunol (2018) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD56 antibody (BD Pharmingen, B159) was used in flow cytometry on human samples (fig 1a). Front Immunol (2018) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD56 antibody (BD Biosciences, 555518) was used in flow cytometry on human samples (fig 1a). Front Immunol (2018) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; fig 3a
BD Biosciences CD56 antibody (BD Pharmingen, B159) was used in flow cytometry on human samples (fig 3a). Sci Rep (2018) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; loading ...; fig 1
BD Biosciences CD56 antibody (BD Biosciences, 340410) was used in flow cytometry on human samples (fig 1). Oncotarget (2018) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences CD56 antibody (BD, NCAM16.2) was used in flow cytometry on human samples (fig 3a). J Exp Med (2018) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; loading ...; fig 1h
BD Biosciences CD56 antibody (BD Biosciences, B159) was used in flow cytometry on human samples (fig 1h). Nature (2018) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; fig s2a
BD Biosciences CD56 antibody (BD Biosciences, 557747) was used in flow cytometry on human samples (fig s2a). Cell (2018) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; loading ...; fig 5c
BD Biosciences CD56 antibody (BD Pharmingen, NCAM16.2) was used in flow cytometry on human samples (fig 5c). Obes Facts (2017) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; fig 1a
BD Biosciences CD56 antibody (BD Biosciences, B159) was used in flow cytometry on human samples (fig 1a). Front Immunol (2017) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; loading ...; fig s4a
BD Biosciences CD56 antibody (BD, NCAM16.2) was used in flow cytometry on human samples (fig s4a). J Immunol (2017) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; loading ...; fig 1b
BD Biosciences CD56 antibody (BD Bioscience, NCAM16.2) was used in flow cytometry on human samples (fig 1b). Sci Rep (2017) ncbi
mouse monoclonal (NCAM16.2)
  • mass cytometry; human; loading ...; fig 2a
In order to investigate the immune composition of tumor microenvironment in hepatocellular carcinoma, BD Biosciences CD56 antibody (BD Biosciences, NCAM16.2) was used in mass cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; loading ...; fig 5a
In order to detail MAIT cell responses to various microorganisms and cytokines, BD Biosciences CD56 antibody (BD Biosciences, NCAM16.2) was used in flow cytometry on human samples (fig 5a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; loading ...; fig 1c
BD Biosciences CD56 antibody (BD Biosciences, NCAM16.2) was used in flow cytometry on human samples (fig 1c). Sci Rep (2017) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; loading ...; fig 3a
In order to evaluate the effectiveness of adoptive natural killer cell therapy against the pulmonary metastasis of Ewing sarcoma, BD Biosciences CD56 antibody (BD Pharmingen, NCAM 16.2) was used in flow cytometry on human samples (fig 3a). Oncoimmunology (2017) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; loading ...; fig st1
BD Biosciences CD56 antibody (BD, B159) was used in flow cytometry on human samples (fig st1). J Exp Med (2017) ncbi
mouse monoclonal (NCAM16.2)
  • mass cytometry; human; loading ...; fig s3a
In order to map the lineage of human dendritic cells, BD Biosciences CD56 antibody (BD Biosciences, NCAM16.2) was used in mass cytometry on human samples (fig s3a). Science (2017) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; loading ...; fig 1
BD Biosciences CD56 antibody (BD Biosciences, 345811) was used in flow cytometry on human samples (fig 1). PLoS ONE (2017) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; loading ...; fig 5c
BD Biosciences CD56 antibody (BD, 340363) was used in flow cytometry on human samples (fig 5c). Blood (2017) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; loading ...
In order to examine AnxA1 in peripheral blood mononuclear cells from patients with coronary artery disease, BD Biosciences CD56 antibody (BD Biosciences, B159) was used in flow cytometry on human samples . PLoS ONE (2017) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; loading ...; fig s1a
In order to study the differentiation of innate lymphoid cells, BD Biosciences CD56 antibody (BD Bioscience, 557919) was used in flow cytometry on human samples (fig s1a). Cell (2017) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; loading ...; fig 4a
BD Biosciences CD56 antibody (Becton Dickinson, B159) was used in flow cytometry on human samples (fig 4a). Sci Rep (2017) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; loading ...; tbl s9
In order to optimize and assess potential malaria vaccine regimens, BD Biosciences CD56 antibody (BD, 563169) was used in flow cytometry on human samples (tbl s9). Nature (2017) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; loading ...; fig S1a
BD Biosciences CD56 antibody (BD, 562794) was used in flow cytometry on human samples (fig S1a). Sci Rep (2017) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; loading ...; fig s3a
BD Biosciences CD56 antibody (BD Bioscience, B159) was used in flow cytometry on human samples (fig s3a). Sci Rep (2017) ncbi
mouse monoclonal (MY31)
  • flow cytometry; human; loading ...
BD Biosciences CD56 antibody (Pharmingen, MY31) was used in flow cytometry on human samples . Oncol Lett (2017) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; loading ...
In order to show T cell immunoglobulin and ITIM domain expression increases over time despite early initiation of antiretroviral treatment, BD Biosciences CD56 antibody (BD Bioscience, B159) was used in flow cytometry on human samples . Sci Rep (2017) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; loading ...; fig 2
In order to develop a functional assay to assess the risk of developing acute graft-versus-host disease, BD Biosciences CD56 antibody (BD Biosciences, MCAM16.2) was used in flow cytometry on human samples (fig 2). J Immunol Res (2016) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; fig S3B
BD Biosciences CD56 antibody (BD Biosciences, 560360) was used in flow cytometry on human samples (fig S3B). J Clin Invest (2017) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; 1:25; loading ...; fig 1b
In order to explore the role of thrombopoietin signaling in the human primitive hematopoietic stem cell compartment, BD Biosciences CD56 antibody (BD Biosciences, NCAM16.2) was used in flow cytometry on human samples at 1:25 (fig 1b). Cell Transplant (2017) ncbi
mouse monoclonal (B159)
  • immunohistochemistry - frozen section; human; loading ...; fig 7c
In order to describe the perturbations in skeletal muscle morphology and progenitor cell activity following an anterior cruciate ligament injury, BD Biosciences CD56 antibody (BD Biosciences, 555514) was used in immunohistochemistry - frozen section on human samples (fig 7c). J Orthop Res (2017) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; 1:50; loading ...; fig 2a
In order to report that cell density deterministically alters anteroposterior patterning of primitive streak-like priming, BD Biosciences CD56 antibody (BD biosciences, B159) was used in flow cytometry on human samples at 1:50 (fig 2a). Nat Commun (2016) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; loading ...; fig 2c
In order to describe complete autosomal recessive IL-17RA deficiency in patients with chronic mucocutaneous candidiasis, BD Biosciences CD56 antibody (BD Biosciences, B159) was used in flow cytometry on human samples (fig 2c). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; loading ...; tbl 1
In order to demonstrate that freezing already-stained samples suspended in 10% DMSO in FBS is practical and efficient way to preserve already-stained samples for mass cytometry assessment, BD Biosciences CD56 antibody (BD Biosciences, NCAM16.2) was used in flow cytometry on human samples (tbl 1). Cytometry A (2017) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; fig 1b
In order to investigate the role of Eomes in the retention of liver natural killer cells, BD Biosciences CD56 antibody (BD Biosciences, NCAM16.2) was used in flow cytometry on human samples (fig 1b). J Immunol (2016) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; loading ...; fig 5b
In order to investigate the role of natural killer cells to lymphangioleiomyomatosis pathogenesis, BD Biosciences CD56 antibody (BD Biosciences, NCAM16.2) was used in flow cytometry on human samples (fig 5b). JCI Insight (2016) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; loading ...; fig 1a, 1e
In order to discuss targeting CD123 to treat systemic lupus erythematosus, BD Biosciences CD56 antibody (BD Biosciences, 340410) was used in flow cytometry on human samples (fig 1a, 1e). JCI Insight (2016) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; loading ...; fig 7b
In order to determine the contribution of CD16 positive monocytes to antibody-dependent cellular cytotoxicity, BD Biosciences CD56 antibody (BD Biosciences, NCAM16.2) was used in flow cytometry on human samples (fig 7b). Sci Rep (2016) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences CD56 antibody (BD Biosciences, 557747) was used in flow cytometry on human samples (fig 2a). Cell (2016) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; loading ...
In order to identify RLTPR in patients and determine the effects of these mutations on CD4 positive T cells, BD Biosciences CD56 antibody (BD, NCAM16.2) was used in flow cytometry on human samples . J Exp Med (2016) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; loading ...
In order to identify RLTPR in patients and determine the effects of these mutations on CD4 positive T cells, BD Biosciences CD56 antibody (BD, B159) was used in flow cytometry on human samples . J Exp Med (2016) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; loading ...; fig 1
In order to identify cells that respond to interferon lambda, BD Biosciences CD56 antibody (BD Bioscience, NCAM16.2) was used in flow cytometry on human samples (fig 1). J Interferon Cytokine Res (2016) ncbi
monoclonal (NCAM16.2)
  • flow cytometry; human; loading ...; fig 5a
BD Biosciences CD56 antibody (BD, 341027) was used in flow cytometry on human samples (fig 5a). Eur J Immunol (2016) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; fig 1
BD Biosciences CD56 antibody (BD Biosciences, 340410) was used in flow cytometry on human samples (fig 1). Mol Med Rep (2016) ncbi
mouse monoclonal (B159)
  • flow cytometry; human
In order to optimize the generation of therapeutic extracellular vesicles and identify molecules involved in their clearance, BD Biosciences CD56 antibody (BD Biosciences, B159) was used in flow cytometry on human samples . Biomaterials (2016) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; common marmoset; loading ...; fig 6a
BD Biosciences CD56 antibody (BD Biosciences, NCAM16.2) was used in flow cytometry on common marmoset samples (fig 6a). J Virol (2016) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; fig s4b
BD Biosciences CD56 antibody (BD Biosciences, B159) was used in flow cytometry on human samples (fig s4b). J Immunol (2016) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human
In order to assess the contribution of cytomorphology and flow cytometry to histopathological studies of brain biopsies, BD Biosciences CD56 antibody (BD Biosciences, NCAM16.2) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2018) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; loading ...; fig e2e
In order to report that patients with PTEN mutations experience autoimmunity and lymphoid hyperplasia, BD Biosciences CD56 antibody (BD, NCAM16.2) was used in flow cytometry on human samples (fig e2e). J Allergy Clin Immunol (2017) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; loading ...
In order to utilize humanized major histocompatibility class I- and class II-deficient NOG mice to assess the antitumor effect of an anti-programmed death-1 antibody, BD Biosciences CD56 antibody (BD Pharmingen, B159) was used in flow cytometry on human samples . Clin Cancer Res (2017) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; loading ...
BD Biosciences CD56 antibody (BD Biosciences, 340724) was used in flow cytometry on human samples . Oncol Lett (2016) ncbi
mouse monoclonal (MY31)
  • flow cytometry; human; fig 2a
In order to assess the inflammatory responses in the rectal mucosa of patients with well-defined non-celiac wheat sensitivity, BD Biosciences CD56 antibody (BD Biosciences, MY31) was used in flow cytometry on human samples (fig 2a). Clin Transl Gastroenterol (2016) ncbi
mouse monoclonal (B159)
  • flow cytometry; mouse; loading ...; fig st1
BD Biosciences CD56 antibody (BD Pharmingen, B159) was used in flow cytometry on mouse samples (fig st1). J Clin Invest (2016) ncbi
mouse monoclonal (B159)
  • flow cytometry; rhesus macaque; 1:50
In order to optimize vaccination with Aventis Pasteur's canarypox vector-HIV, BD Biosciences CD56 antibody (BD Biosciences, 557919) was used in flow cytometry on rhesus macaque samples at 1:50. Nat Med (2016) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD56 antibody (BD Biosciences, B159) was used in flow cytometry on human samples (fig 1a). J Immunol (2016) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD56 antibody (BD Biosciences, B159) was used in flow cytometry on human samples (fig 1a). J Immunol (2016) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; loading ...; fig s5b
In order to investigate NF-KB signaling in natural killer cells, BD Biosciences CD56 antibody (BD Bioscience, NCAM16.2) was used in flow cytometry on human samples (fig s5b). Nat Commun (2016) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; loading ...
In order to assess the ability of human cystatin C to alter pathogenic activated monocytes and modulate Crohn's disease, BD Biosciences CD56 antibody (BD Pharmingen, B159) was used in flow cytometry on human samples . J Leukoc Biol (2016) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; fig 2
In order to utilize flow cytometry to analyze intracellular Ca(2+) mobilization in human NK cell subsets, BD Biosciences CD56 antibody (BD Biosciences, NCAM 16.2) was used in flow cytometry on human samples (fig 2). Methods Mol Biol (2016) ncbi
mouse monoclonal (NCAM16.2)
  • mass cytometry; human; loading ...; tbl 1, 2
In order to use elemental metal isotopes conjugated to monoclonal antibodies and study intracellular functional markers and surface phenotypic markers on natural killer cells, BD Biosciences CD56 antibody (BD Biosciences, NCAM16.2) was used in mass cytometry on human samples (tbl 1, 2). Methods Mol Biol (2016) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; 1:100; fig 1
In order to elucidate the marked reduction of Nkp44/Nkp46-double positive natural killer cells by celiac disease-related inflammation, BD Biosciences CD56 antibody (Becton Dickinson, B159) was used in flow cytometry on human samples at 1:100 (fig 1). PLoS ONE (2016) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; loading ...; fig s2a
In order to test if the two hematopoietic systems in patients with mixed chimerism remain functional and study immunological differences, BD Biosciences CD56 antibody (BD Biosciences, NCAM16.2) was used in flow cytometry on human samples (fig s2a). PLoS ONE (2016) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; fig S1D
BD Biosciences CD56 antibody (BD, 560360) was used in flow cytometry on human samples (fig S1D). J Clin Invest (2016) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; fig 8
In order to assess the effects of lenalidomide on normal human plasma cell generation, BD Biosciences CD56 antibody (BD Biosciences, B159) was used in flow cytometry on human samples (fig 8). Oncotarget (2016) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; fig 4
In order to report the results of the rituximab by intravenous and Intrathecai injection versus placebo in patients with low-inflammatory secondary progressive multiple sclerosis study, BD Biosciences CD56 antibody (BD Biosciences, B159) was used in flow cytometry on human samples (fig 4). Ann Clin Transl Neurol (2016) ncbi
mouse monoclonal (MY31)
  • immunocytochemistry; human; tbl 1
BD Biosciences CD56 antibody (BD Biosciences, 347740) was used in immunocytochemistry on human samples (tbl 1). Stem Cells Int (2016) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences CD56 antibody (BD, 555516) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; fig 1
BD Biosciences CD56 antibody (BD, 335791) was used in flow cytometry on human samples (fig 1). Oncoimmunology (2016) ncbi
rat monoclonal (12F8)
  • western blot; African green monkey; fig 2
In order to characterize specific sequence needed for neuropilin-2 recognition by ST8SiaIV and polysialylation of its O-glycans, BD Biosciences CD56 antibody (BD Biosciences, 556325) was used in western blot on African green monkey samples (fig 2). J Biol Chem (2016) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; loading ...; tbl s1
In order to explore how junctional adhesion molecule family members differentially regulate CXCR4 function and CXCL12 secretion in the bone marrow niche, BD Biosciences CD56 antibody (BD Pharmingen, 555517) was used in flow cytometry on human samples (tbl s1). Stem Cells (2016) ncbi
mouse monoclonal (B159)
  • immunohistochemistry - frozen section; human; loading ...; fig 8a
In order to report the effects of bed rest on skeletal muscle satellite cell content and fiber type atrophy in middle-aged adults, BD Biosciences CD56 antibody (BD Biosciences, 555514) was used in immunohistochemistry - frozen section on human samples (fig 8a). J Appl Physiol (1985) (2016) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; fig 7.45.3
In order to validate a single-cell measurement, simultaneously, for cell surface proteins, messenger RNA, and intracellular proteins, BD Biosciences CD56 antibody (BD Biosciences, 335809) was used in flow cytometry on human samples (fig 7.45.3). Curr Protoc Cytom (2016) ncbi
rat monoclonal (12F8)
  • immunohistochemistry; human
In order to study the importance of basal autophagy in the maintenance of the stem-cell quiescent state, BD Biosciences CD56 antibody (BD Pharmingen, 556325) was used in immunohistochemistry on human samples . Nature (2016) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; tbl 2
In order to measure the expression of antigens on malignant human plasma cells that have exhibited promise in targeted cancer therapy, BD Biosciences CD56 antibody (BD, NCAM16.2) was used in flow cytometry on human samples (tbl 2). Cytometry B Clin Cytom (2017) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; loading ...; fig 1b
BD Biosciences CD56 antibody (BD, NCAM16) was used in flow cytometry on human samples (fig 1b). J Virol (2016) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; fig 4
In order to characterize the influence on NK cell cytotoxicity by differential expression of ligands for DNAM-1 and NKG2D receptors by epithelial ovarian cancer-derived exosomes, BD Biosciences CD56 antibody (BD Pharmingen, B159) was used in flow cytometry on human samples (fig 4). Tumour Biol (2016) ncbi
mouse monoclonal (B159)
  • other; human; fig 1
  • flow cytometry; human; fig 1
In order to study the use of bispecific T cell engager, BD Biosciences CD56 antibody (BD, B159) was used in other on human samples (fig 1) and in flow cytometry on human samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; 1:20; fig 1
BD Biosciences CD56 antibody (BD, 555518) was used in flow cytometry on human samples at 1:20 (fig 1). Development (2015) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; loading ...; fig s1e
In order to study age-related changes in human immunity during a primary virus infection experimentally induced by immunization with live-attenuated yellow fever vaccine, BD Biosciences CD56 antibody (BD Biosciences, NCAM16.2) was used in flow cytometry on human samples (fig s1e). J Immunol (2015) ncbi
mouse monoclonal (B159)
  • flow cytometry; human
In order to identify the cell surface markers in synovial mesenchymal stem cells, BD Biosciences CD56 antibody (BD Pharmingen, 555518) was used in flow cytometry on human samples . Cytometry A (2015) ncbi
mouse monoclonal (MY31)
  • other; human
BD Biosciences CD56 antibody (BD Biosciences, MY31) was used in other on human samples . Skelet Muscle (2015) ncbi
mouse monoclonal (B159)
  • flow cytometry; human
BD Biosciences CD56 antibody (BD Pharmingen, 560842) was used in flow cytometry on human samples . Am J Reprod Immunol (2015) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human
BD Biosciences CD56 antibody (BD Pharmingen, 341025) was used in flow cytometry on human samples . Cancer Lett (2015) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; marmosets; loading ...
In order to test a therapeutic antibody against CD127 in a mouse model of experimental autoimmune encephalomyelitis, BD Biosciences CD56 antibody (BD Biosciences, NCAM 16.2) was used in flow cytometry on marmosets samples . J Neuroimmune Pharmacol (2016) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; rhesus macaque; loading ...; fig 5a
In order to investigate the effects of microbial products on the liver, BD Biosciences CD56 antibody (BD Biosciences, NCAM16.2) was used in flow cytometry on rhesus macaque samples (fig 5a). J Infect Dis (2016) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; loading ...; tbl 1
In order to compare the use of CD229, CD54, and CD319 expression for the identification of normal and aberrant plasma cells, BD Biosciences CD56 antibody (BD, B159) was used in flow cytometry on human samples (tbl 1). Cytometry B Clin Cytom (2016) ncbi
mouse monoclonal (B159)
  • flow cytometry; human
In order to report that alefacept depletes both memory T cells and NK cells, BD Biosciences CD56 antibody (Becton Dickinson, B159) was used in flow cytometry on human samples . Biol Blood Marrow Transplant (2015) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; fig 3
In order to investigate the dynamics and characteristics of natural killer cell types in the human ocular mucosal surface in situ during infection with group D human adenoviruses, BD Biosciences CD56 antibody (BD Biosciences, B159) was used in flow cytometry on human samples (fig 3). Mucosal Immunol (2016) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; fig S1
BD Biosciences CD56 antibody (BD Biosciences, NCAM16.2) was used in flow cytometry on human samples (fig S1). J Neuroinflammation (2015) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; fig 1
BD Biosciences CD56 antibody (BD Bioscience, 557747) was used in flow cytometry on human samples (fig 1). J Hematol Oncol (2015) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; 1:100; fig 1
BD Biosciences CD56 antibody (BD, NCAM16.2) was used in flow cytometry on human samples at 1:100 (fig 1). Nat Commun (2015) ncbi
mouse monoclonal (B159)
  • flow cytometry; human
BD Biosciences CD56 antibody (BD Biosciences, B159) was used in flow cytometry on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (B159)
  • flow cytometry; human
BD Biosciences CD56 antibody (BD Biosciences, B159) was used in flow cytometry on human samples . J Infect Dis (2015) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; fig 3
BD Biosciences CD56 antibody (BD Biosciences, B159) was used in flow cytometry on human samples (fig 3). J Virol (2015) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; 2:100; fig s7
In order to show that hepatitis B virus exposure in utero enhances immunity to bacterial infections, BD Biosciences CD56 antibody (Becton Dickinson, B159) was used in flow cytometry on human samples at 2:100 (fig s7). Nat Commun (2015) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; fig 1e
BD Biosciences CD56 antibody (BD Biosciences, B159) was used in flow cytometry on human samples (fig 1e). J Immunol (2015) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; tbl s2
In order to examine the early impact of viral replicative capacity on HIV-1 immunopathogenesis, BD Biosciences CD56 antibody (BD Biosciences, B159) was used in flow cytometry on human samples (tbl s2). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; mouse; fig s1a
BD Biosciences CD56 antibody (BD Biosciences, NCAM16.2) was used in flow cytometry on mouse samples (fig s1a). J Infect Dis (2015) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; fig 4
BD Biosciences CD56 antibody (BD biosciences, 555514) was used in flow cytometry on human samples (fig 4). PLoS ONE (2015) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; loading ...; fig 6
In order to study transmigration of melanoma cells in an in vitro model of blood brain barrier., BD Biosciences CD56 antibody (BD Biosciences, 345811) was used in flow cytometry on human samples (fig 6). Biomed Res Int (2015) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; fig 1
In order to study human cord blood and bone marrow for restricted dendritic cell and monocyte progenitors, BD Biosciences CD56 antibody (Pacific Blue, BD, B159) was used in flow cytometry on human samples (fig 1). J Exp Med (2015) ncbi
mouse monoclonal (MY31)
  • immunocytochemistry; human; 1:100; tbl 4
BD Biosciences CD56 antibody (BD, 347740) was used in immunocytochemistry on human samples at 1:100 (tbl 4). J Vis Exp (2015) ncbi
mouse monoclonal (B159)
  • flow cytometry; human
BD Biosciences CD56 antibody (BD Pharmingen, B159) was used in flow cytometry on human samples . Clin Cancer Res (2015) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; fig 1
BD Biosciences CD56 antibody (BD Biosciences, B159) was used in flow cytometry on human samples (fig 1). Diabetes (2015) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human
BD Biosciences CD56 antibody (BD Horizon, 562751) was used in flow cytometry on human samples . Alcohol (2015) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human
BD Biosciences CD56 antibody (Becton Dickinson, NCAM16.2) was used in flow cytometry on human samples . J Leukoc Biol (2015) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human
BD Biosciences CD56 antibody (BD Biosciences, NCAM16.2) was used in flow cytometry on human samples . Arthritis Rheumatol (2015) ncbi
mouse monoclonal (B159)
  • flow cytometry; human
BD Biosciences CD56 antibody (BD, B159) was used in flow cytometry on human samples . Eur J Cancer (2015) ncbi
mouse monoclonal (B159)
  • flow cytometry; human
In order to assess the efficacy of using flow cytometry immunophenotyping with fine-needle aspiration cytology for the diagnosis of thyroid lymphoma, BD Biosciences CD56 antibody (BD, B159) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2015) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; fig 1
BD Biosciences CD56 antibody (BD Biosciences, B159) was used in flow cytometry on human samples (fig 1). J Leukoc Biol (2015) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human
BD Biosciences CD56 antibody (BD, NCAM16.2) was used in flow cytometry on human samples . Genes Immun (2015) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; 1:50
BD Biosciences CD56 antibody (BD Biosciences, NCAM16.2) was used in flow cytometry on human samples at 1:50. Nat Commun (2014) ncbi
mouse monoclonal (MY31)
  • flow cytometry; human; fig 4
BD Biosciences CD56 antibody (BD, MY31) was used in flow cytometry on human samples (fig 4). J Infect Dis (2015) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; fig s3
BD Biosciences CD56 antibody (Becton Dickinson, NCAM16.2) was used in flow cytometry on human samples (fig s3). Blood (2015) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; rhesus macaque
BD Biosciences CD56 antibody (BD Biosciences, NCAM16) was used in flow cytometry on rhesus macaque samples . J Immunol (2014) ncbi
mouse monoclonal (B159)
  • flow cytometry; human
BD Biosciences CD56 antibody (BD Biosciences, B159) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (MY31)
  • flow cytometry; human
BD Biosciences CD56 antibody (BD Biosciences, MY31) was used in flow cytometry on human samples . Cancer Immunol Immunother (2015) ncbi
mouse monoclonal (B159)
  • flow cytometry; human
BD Biosciences CD56 antibody (BD Biosciences, B159) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (B159)
  • flow cytometry; human
BD Biosciences CD56 antibody (BD Biosciences, B159) was used in flow cytometry on human samples . Cytotherapy (2015) ncbi
mouse monoclonal (B159)
  • flow cytometry; human
In order to study the effect of mesenchymal stem cells on the anti-bacterial activity of neutrophil granulocytes, BD Biosciences CD56 antibody (BD Bioscience, B159) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (B159)
  • immunocytochemistry; mouse
BD Biosciences CD56 antibody (PharMingen, B159) was used in immunocytochemistry on mouse samples . Hum Pathol (2014) ncbi
mouse monoclonal (MY31)
  • flow cytometry; human
BD Biosciences CD56 antibody (BD Biosciences, 556647) was used in flow cytometry on human samples . Xenotransplantation (2015) ncbi
mouse monoclonal (B159)
  • flow cytometry; human
BD Biosciences CD56 antibody (BD, 557747) was used in flow cytometry on human samples . J Vis Exp (2014) ncbi
mouse monoclonal (B159)
  • flow cytometry; human
BD Biosciences CD56 antibody (BD PharMingen, B159) was used in flow cytometry on human samples . J Leukoc Biol (2014) ncbi
mouse monoclonal (B159)
  • flow cytometry; human
BD Biosciences CD56 antibody (BD Biosciences, B159) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human
In order to describe a novel, non-invasive, and adaptable method for the capture and genetic analysis of single tumor cells from cancer patients, BD Biosciences CD56 antibody (BD Biosciences, BD340723) was used in flow cytometry on human samples . Front Oncol (2014) ncbi
mouse monoclonal (NCAM16.2)
  • immunohistochemistry - frozen section; human; 1:100
BD Biosciences CD56 antibody (BD Pharmingen, 559043) was used in immunohistochemistry - frozen section on human samples at 1:100. Muscle Nerve (2015) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human
BD Biosciences CD56 antibody (BD Biosciences, NCAM16.2) was used in flow cytometry on human samples . Am J Transplant (2014) ncbi
mouse monoclonal (B159)
  • immunocytochemistry; human
In order to analyze HIV-specific naive and memory CD4(+) T cells through two methods, BD Biosciences CD56 antibody (BD, B159) was used in immunocytochemistry on human samples . J Exp Med (2014) ncbi
mouse monoclonal (B159)
  • flow cytometry; human
BD Biosciences CD56 antibody (BD Pharmingen, B159) was used in flow cytometry on human samples . Int J Cancer (2015) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; loading ...; fig 3b
In order to elucidate the relationship between female genital schistosomiasis and HIV infection, BD Biosciences CD56 antibody (BD, B159) was used in flow cytometry on human samples (fig 3b). PLoS ONE (2014) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; African green monkey
BD Biosciences CD56 antibody (BD Biosciences, NCAM16.2) was used in flow cytometry on African green monkey samples . Int Immunol (2014) ncbi
mouse monoclonal (B159)
  • flow cytometry; human
BD Biosciences CD56 antibody (BD Biosciences, B159) was used in flow cytometry on human samples . J Infect Dis (2014) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human
BD Biosciences CD56 antibody (BD Bioscience, clone NCAM16.2) was used in flow cytometry on human samples . Mol Ther (2014) ncbi
mouse monoclonal (B159)
  • flow cytometry; human
In order to study NK function in solid tumors, BD Biosciences CD56 antibody (BD Biosciences, B159) was used in flow cytometry on human samples . Int J Cancer (2014) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; 1:50
BD Biosciences CD56 antibody (BD Bioscience, NCAM16.2) was used in flow cytometry on human samples at 1:50. PLoS ONE (2014) ncbi
rat monoclonal (12F8)
  • immunohistochemistry - frozen section; mouse
In order to show that geriatric satellite cells do not maintain their normal quiescent state in muscle homeostatic conditions and that this irreversibly affects their intrinsic regenerative and self-renewal capacities, BD Biosciences CD56 antibody (BD, 556325) was used in immunohistochemistry - frozen section on mouse samples . Nature (2014) ncbi
mouse monoclonal (B159)
  • flow cytometry; human
BD Biosciences CD56 antibody (BD Biosciences, clone B159) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (B159)
  • flow cytometry; human
BD Biosciences CD56 antibody (BD Biosciences, B159) was used in flow cytometry on human samples . PLoS Pathog (2014) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; loading ...; fig 1
In order to discuss the importance of assessing immune competence in cancer patients, BD Biosciences CD56 antibody (BD, NCAM16.2) was used in flow cytometry on human samples (fig 1). Cancer Immunol Immunother (2014) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD56 antibody (Becton Dickinson, NCAM16.2) was used in flow cytometry on human samples (fig 1a). Clin Immunol (2014) ncbi
mouse monoclonal (NCAM16.2)
  • flow cytometry; human; loading ...; fig 9
BD Biosciences CD56 antibody (BD, NCAM16.2) was used in flow cytometry on human samples (fig 9). J Immunol (2014) ncbi
mouse monoclonal (B159)
  • flow cytometry; human
BD Biosciences CD56 antibody (BD/Pharmingen, B159) was used in flow cytometry on human samples . J Infect Dis (2014) ncbi
mouse monoclonal (MY31)
  • immunohistochemistry - frozen section; human
BD Biosciences CD56 antibody (Becton Dickinson, 347740) was used in immunohistochemistry - frozen section on human samples . Acta Physiol (Oxf) (2014) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; loading ...
In order to correlate biomarkers associated with coagulation, monocyte activation, and inflammation in elite controllers of HIV infection, BD Biosciences CD56 antibody (BD Bioscience, B159) was used in flow cytometry on human samples . J Infect Dis (2014) ncbi
rat monoclonal (12F11)
  • western blot; mouse
  • western blot; African green monkey
BD Biosciences CD56 antibody (BD Transduction Laboratories, 556323) was used in western blot on mouse samples and in western blot on African green monkey samples . J Biol Chem (2013) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; 1:100
In order to evaluate a cell culture system for long-term passaging of human pluripotent stem cells, BD Biosciences CD56 antibody (BD Biosciences, 557699) was used in flow cytometry on human samples at 1:100. J Neurosci Res (2013) ncbi
mouse monoclonal (B159)
  • flow cytometry; human; tbl 1
In order to compare fine needle aspiration cytology with flow cytometry immunophenotyping for the diagnosis of lymphoproliferative processes in the salivary glands, BD Biosciences CD56 antibody (BD, clone B159) was used in flow cytometry on human samples (tbl 1). Cytopathology (2014) ncbi
mouse monoclonal (B159)
  • flow cytometry; human
BD Biosciences CD56 antibody (BD Pharmingen, 555518) was used in flow cytometry on human samples . Stem Cells (2013) ncbi
Leica Biosystems
mouse monoclonal
  • immunohistochemistry; human; loading ...; fig 4g, 5d
Leica Biosystems CD56 antibody (Leica Biosystems, 1B6) was used in immunohistochemistry on human samples (fig 4g, 5d). Medicine (Baltimore) (2020) ncbi
  • immunohistochemistry - paraffin section; human; fig 1a
In order to present patient cases of nasal natural killer/T cell tumors in the central nervous system, Leica Biosystems CD56 antibody (Novocastra, 1B6) was used in immunohistochemistry - paraffin section on human samples (fig 1a). Histopathology (2017) ncbi
  • immunohistochemistry; human; tbl 3
Leica Biosystems CD56 antibody (Leica Biosysytems, CD56-1B6-R-7) was used in immunohistochemistry on human samples (tbl 3). PLoS ONE (2017) ncbi
mouse monoclonal
  • immunohistochemistry - paraffin section; human; 1:100; fig 3a
In order to discuss the relevance of vasculogenic mimicry in small cell lung cancer, Leica Biosystems CD56 antibody (Novocastra, NCL-CD56-aB6) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 3a). Nat Commun (2016) ncbi
  • immunohistochemistry; human; 1:100; fig 2a
In order to characterize and present the features observed in sixteen cases of solid pseudopapillary neoplasm of the pancreas, Leica Biosystems CD56 antibody (Novocastra, NCL-L-CD56-1B6) was used in immunohistochemistry on human samples at 1:100 (fig 2a). Kaohsiung J Med Sci (2016) ncbi
  • immunohistochemistry; human; 1:400; fig s1g
  • western blot; human; loading ...; fig s9b
In order to discuss mechanisms involved in the resistance of androgen receptor-targeted therapies, Leica Biosystems CD56 antibody (Leica Biosystems, NCL-SD56-504) was used in immunohistochemistry on human samples at 1:400 (fig s1g) and in western blot on human samples (fig s9b). Nat Med (2016) ncbi
mouse monoclonal
  • immunohistochemistry - paraffin section; mouse; 1:50; loading ...; fig 4A
  • immunocytochemistry; human; 1:50; loading ...; fig 3D
  • western blot; human; 1:1000; loading ...; fig 1B
In order to determine the role of INSM1 in lung cancer, Leica Biosystems CD56 antibody (Novocastra, NCL-CD56-1B6) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 4A), in immunocytochemistry on human samples at 1:50 (fig 3D) and in western blot on human samples at 1:1000 (fig 1B). Am J Pathol (2015) ncbi
monoclonal (CD564)
  • immunohistochemistry - paraffin section; human
In order to describe an unusual case of a recurrent dural neoplasm, Leica Biosystems CD56 antibody (Novocastra, CD564) was used in immunohistochemistry - paraffin section on human samples . Hum Pathol (2015) ncbi
Developmental Studies Hybridoma Bank
mouse monoclonal (5A5)
  • immunohistochemistry; mouse; 1:700; loading ...; fig 2f
Developmental Studies Hybridoma Bank CD56 antibody (DSHB, 5A5) was used in immunohistochemistry on mouse samples at 1:700 (fig 2f). J Comp Neurol (2019) ncbi
mouse monoclonal (5.1H11)
  • immunoprecipitation; human; fig 2
Developmental Studies Hybridoma Bank CD56 antibody (Developmental Studies Hybridoma Bank,, 5.1H11) was used in immunoprecipitation on human samples (fig 2). BMC Biotechnol (2016) ncbi
Articles Reviewed
  1. Schiapparelli L, Xie Y, Sharma P, McClatchy D, Ma Y, Yates J, et al. Activity-Induced Cortical Glutamatergic Neuron Nascent Proteins. J Neurosci. 2022;42:7900-7920 pubmed publisher
  2. Kaminski M, Bendzick L, Hopps R, Kauffman M, Kodal B, Soignier Y, et al. TEM8 Tri-specific Killer Engager binds both tumor and tumor stroma to specifically engage natural killer cell anti-tumor activity. J Immunother Cancer. 2022;10: pubmed publisher
  3. Amaral E, Foreman T, Namasivayam S, Hilligan K, Kauffman K, Barbosa Bomfim C, et al. GPX4 regulates cellular necrosis and host resistance in Mycobacterium tuberculosis infection. J Exp Med. 2022;219: pubmed publisher
  4. Secchiari F, Nu xf1 ez S, Sierra J, Ziblat A, Regge M, Raffo Iraolagoitia X, et al. The MICA-NKG2D axis in clear cell renal cell carcinoma bolsters MICA as target in immuno-oncology. Oncoimmunology. 2022;11:2104991 pubmed publisher
  5. Chambers A, Lupo K, Wang J, Cao J, Utturkar S, Lanman N, et al. Engineered natural killer cells impede the immunometabolic CD73-adenosine axis in solid tumors. elife. 2022;11: pubmed publisher
  6. Iwahashi N, Umakoshi H, Seki T, Gomez Sanchez C, Mukai K, Suematsu M, et al. Characterization of Aldosterone-producing Cell Cluster (APCC) at Single-cell Resolution. J Clin Endocrinol Metab. 2022;107:2439-2448 pubmed publisher
  7. Laffey K, Stiles R, Ludescher M, Davis T, Khwaja S, Bram R, et al. Early expression of mature αβ TCR in CD4-CD8- T cell progenitors enables MHC to drive development of T-ALL bearing NOTCH mutations. Proc Natl Acad Sci U S A. 2022;119:e2118529119 pubmed publisher
  8. Rosa T, Mendes M, Linhares N, Rodrigues T, Dias A, Leal Calvo T, et al. The Type I Interferon Pathway Is Upregulated in the Cutaneous Lesions and Blood of Multibacillary Leprosy Patients With Erythema Nodosum Leprosum. Front Med (Lausanne). 2022;9:899998 pubmed publisher
  9. Eikmans M, van der Keur C, Anholts J, Drabbels J, van Beelen E, de Sousa Lopes S, et al. Primary Trophoblast Cultures: Characterization of HLA Profiles and Immune Cell Interactions. Front Immunol. 2022;13:814019 pubmed publisher
  10. Shiwaku H, Katayama S, Kondo K, Nakano Y, Tanaka H, Yoshioka Y, et al. Autoantibodies against NCAM1 from patients with schizophrenia cause schizophrenia-related behavior and changes in synapses in mice. Cell Rep Med. 2022;3:100597 pubmed publisher
  11. Wu X, Xia T, Shin W, Yu K, Jung W, Herrmann A, et al. Viral Mimicry of Interleukin-17A by SARS-CoV-2 ORF8. MBio. 2022;13:e0040222 pubmed publisher
  12. Jiang Z, Qin L, Tang Y, Liao R, Shi J, He B, et al. Human induced-T-to-natural killer cells have potent anti-tumour activities. Biomark Res. 2022;10:13 pubmed publisher
  13. Muraro E, De Zorzi M, Miolo G, Lombardi D, Scalone S, Spazzapan S, et al. KIR-HLA Functional Repertoire Influences Trastuzumab Efficiency in Patients With HER2-Positive Breast Cancer. Front Immunol. 2021;12:791958 pubmed publisher
  14. Aldrin Kirk P, Akerblom M, Cardoso T, Nolbrant S, Adler A, Liu X, et al. A novel two-factor monosynaptic TRIO tracing method for assessment of circuit integration of hESC-derived dopamine transplants. Stem Cell Reports. 2021;: pubmed publisher
  15. Liu Y, Wang L, Song Q, Ali M, Crowe W, Kucera G, et al. Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion. Nat Nanotechnol. 2022;17:206-216 pubmed publisher
  16. Yang Q, Ma Y, LIU Y, Shao X, Jia W, Yu X, et al. MNSFβ regulates placental development by conjugating IGF2BP2 to enhance trophoblast cell invasiveness. Cell Prolif. 2021;54:e13145 pubmed publisher
  17. Xu B, Tian L, Chen J, Wang J, Ma R, Dong W, et al. An oncolytic virus expressing a full-length antibody enhances antitumor innate immune response to glioblastoma. Nat Commun. 2021;12:5908 pubmed publisher
  18. Risbridger G, Clark A, Porter L, Toivanen R, Bakshi A, Lister N, et al. The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology. Nat Commun. 2021;12:5049 pubmed publisher
  19. Guo T, Gu C, Li B, Xu C. Dual inhibition of FGFR4 and BCL-xL inhibits multi-resistant ovarian cancer with BCL2L1 gain. Aging (Albany NY). 2021;13:19750-19759 pubmed publisher
  20. Spiegel J, Patel S, Muffly L, Hossain N, Oak J, Baird J, et al. CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial. Nat Med. 2021;27:1419-1431 pubmed publisher
  21. Yoo J, Lee D, Park S, Shin H, Lee K, Kim D, et al. Trophoblast glycoprotein is a marker for efficient sorting of ventral mesencephalic dopaminergic precursors derived from human pluripotent stem cells. NPJ Parkinsons Dis. 2021;7:61 pubmed publisher
  22. Dalla Pietà A, Cappuzzello E, Palmerini P, Ventura A, Visentin A, Astori G, et al. Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells. J Immunother Cancer. 2021;9: pubmed publisher
  23. Bohannon C, Ende Z, Cao W, Mboko W, Ranjan P, Kumar A, et al. Influenza Virus Infects and Depletes Activated Adaptive Immune Responders. Adv Sci (Weinh). 2021;8:e2100693 pubmed publisher
  24. Hibl B, Dailey Garnes N, Kneubehl A, Vogt M, Spencer Clinton J, Rico Hesse R. Mosquito-bite infection of humanized mice with chikungunya virus produces systemic disease with long-term effects. PLoS Negl Trop Dis. 2021;15:e0009427 pubmed publisher
  25. Delgado C, Bu L, Zhang J, Liu F, Sall J, Liang F, et al. Neural cell adhesion molecule is required for ventricular conduction system development. Development. 2021;148: pubmed publisher
  26. Zhang J, Qi J, Wei H, Lei Y, Yu H, Liu N, et al. TGFβ1 in Cancer-Associated Fibroblasts Is Associated With Progression and Radiosensitivity in Small-Cell Lung Cancer. Front Cell Dev Biol. 2021;9:667645 pubmed publisher
  27. Liu K, Jing N, Wang D, Xu P, Wang J, Chen X, et al. A novel mouse model for liver metastasis of prostate cancer reveals dynamic tumour-immune cell communication. Cell Prolif. 2021;54:e13056 pubmed publisher
  28. Tichy E, Ma N, Sidibe D, Loro E, Kocan J, Chen D, et al. Persistent NF-κB activation in muscle stem cells induces proliferation-independent telomere shortening. Cell Rep. 2021;35:109098 pubmed publisher
  29. Martínez Zamudio R, Dewald H, Vasilopoulos T, Gittens Williams L, Fitzgerald Bocarsly P, Herbig U. Senescence-associated β-galactosidase reveals the abundance of senescent CD8+ T cells in aging humans. Aging Cell. 2021;20:e13344 pubmed publisher
  30. Ingelfinger F, Krishnarajah S, Kramer M, Utz S, Galli E, Lutz M, et al. Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signature. Acta Neuropathol. 2021;141:901-915 pubmed publisher
  31. Dejnirattisai W, Zhou D, Ginn H, Duyvesteyn H, Supasa P, Case J, et al. The antigenic anatomy of SARS-CoV-2 receptor binding domain. Cell. 2021;184:2183-2200.e22 pubmed publisher
  32. Almeida M, Piehler T, Carstens K, Zhao M, Samadi M, Dudek S, et al. Distinct and dementia-related synaptopathy in the hippocampus after military blast exposures. Brain Pathol. 2021;31:e12936 pubmed publisher
  33. Sokal A, Chappert P, Barba Spaeth G, Roeser A, Fourati S, Azzaoui I, et al. Maturation and persistence of the anti-SARS-CoV-2 memory B cell response. Cell. 2021;184:1201-1213.e14 pubmed publisher
  34. Gregorova M, Morse D, Brignoli T, Steventon J, Hamilton F, Albur M, et al. Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumonia. elife. 2020;9: pubmed publisher
  35. Snyder M, Sembrat J, Noda K, MYERBURG M, Craig A, Mitash N, et al. Human Lung-Resident Macrophages Colocalize with and Provide Costimulation to PD1hi Tissue-Resident Memory T Cells. Am J Respir Crit Care Med. 2021;203:1230-1244 pubmed publisher
  36. Noz M, Bekkering S, Groh L, Nielen T, Lamfers E, Schlitzer A, et al. Reprogramming of bone marrow myeloid progenitor cells in patients with severe coronary artery disease. elife. 2020;9: pubmed publisher
  37. Katano I, Ito R, Kawai K, Takahashi T. Improved Detection of in vivo Human NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity Using a Novel NOG-FcγR-Deficient Human IL-15 Transgenic Mouse. Front Immunol. 2020;11:532684 pubmed publisher
  38. Huang Y, Liang C, Ritz D, Coelho R, Septiadi D, Estermann M, et al. Collagen-rich omentum is a premetastatic niche for integrin α2-mediated peritoneal metastasis. elife. 2020;9: pubmed publisher
  39. Deeba E, Lambrianides A, Pantzaris M, Krashias G, Christodoulou C. The expression profile of virus-recognizing toll-like receptors in natural killer cells of Cypriot multiple sclerosis patients. BMC Res Notes. 2020;13:460 pubmed publisher
  40. Tseng H, Xiong W, Badeti S, Yang Y, Ma M, Liu T, et al. Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma. Nat Commun. 2020;11:4810 pubmed publisher
  41. Srivastava M, Zhang Y, Chen J, Sirohi D, Miller A, Zhang Y, et al. Chemical proteomics tracks virus entry and uncovers NCAM1 as Zika virus receptor. Nat Commun. 2020;11:3896 pubmed publisher
  42. Hood S, Cosma G, Foulds G, Johnson C, Reeder S, McArdle S, et al. Identifying prostate cancer and its clinical risk in asymptomatic men using machine learning of high dimensional peripheral blood flow cytometric natural killer cell subset phenotyping data. elife. 2020;9: pubmed publisher
  43. Bennstein S, Weinhold S, Manser A, Scherenschlich N, Noll A, Raba K, et al. Umbilical cord blood-derived ILC1-like cells constitute a novel precursor for mature KIR+NKG2A- NK cells. elife. 2020;9: pubmed publisher
  44. Camu W, Mickunas M, Veyrune J, Payan C, Garlanda C, Locati M, et al. Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a randomised, double-blind, placebo-controlled trial. EBioMedicine. 2020;59:102844 pubmed publisher
  45. Leelatian N, Sinnaeve J, Mistry A, Barone S, Brockman A, Diggins K, et al. Unsupervised machine learning reveals risk stratifying glioblastoma tumor cells. elife. 2020;9: pubmed publisher
  46. Gunesch J, Dixon A, Ebrahim T, Berrien Elliott M, Tatineni S, Kumar T, et al. CD56 regulates human NK cell cytotoxicity through Pyk2. elife. 2020;9: pubmed publisher
  47. Grifoni A, Weiskopf D, Ramirez S, Mateus J, Dan J, Moderbacher C, et al. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell. 2020;181:1489-1501.e15 pubmed publisher
  48. Barruet E, Garcia S, Striedinger K, Wu J, Lee S, Byrnes L, et al. Functionally heterogeneous human satellite cells identified by single cell RNA sequencing. elife. 2020;9: pubmed publisher
  49. Zhao J, Xiang C, Zhao R, Guo P, Zheng J, Han Zhang H, et al. Clinicopathologic features and genomic analysis of pulmonary blastomatoid carcinosarcoma. BMC Cancer. 2020;20:248 pubmed publisher
  50. Beziat V, Tavernier S, Chen Y, Ma C, Materna M, Laurence A, et al. Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome. J Exp Med. 2020;217: pubmed publisher
  51. Dong Y, Li Y, Liu R, Li Y, Zhang H, Liu H, et al. Secretagogin, a marker for neuroendocrine cells, is more sensitive and specific in large cell neuroendocrine carcinoma compared with the markers CD56, CgA, Syn and Napsin A. Oncol Lett. 2020;19:2223-2230 pubmed publisher
  52. Martin E, Minet N, Boschat A, Sanquer S, Sobrino S, Lenoir C, et al. Impaired lymphocyte function and differentiation in CTPS1-deficient patients result from a hypomorphic homozygous mutation. JCI Insight. 2020;5: pubmed publisher
  53. Park J, Botting R, Domínguez Conde C, Popescu D, Lavaert M, Kunz D, et al. A cell atlas of human thymic development defines T cell repertoire formation. Science. 2020;367: pubmed publisher
  54. Kővári B, Turkevi Nagy S, Báthori Á, Fekete Z, Krenacs L. Syntaxin 1: A Novel Robust Immunophenotypic Marker of Neuroendocrine Tumors. Int J Mol Sci. 2020;21: pubmed publisher
  55. Li D, Zhu R, Zhou L, Zhong D. Clinical, histopathologic, subtype, and immunohistochemical analysis of jaw phosphaturic mesenchymal tumors. Medicine (Baltimore). 2020;99:e19090 pubmed publisher
  56. Schafflick D, Xu C, Hartlehnert M, Cole M, Schulte Mecklenbeck A, Lautwein T, et al. Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis. Nat Commun. 2020;11:247 pubmed publisher
  57. Song S, Li Y, Zhang K, Zhang X, Huang Y, Xu M, et al. Cancer Stem Cells of Diffuse Large B Cell Lymphoma Are Not Enriched in the CD45+CD19- cells but in the ALDHhigh Cells. J Cancer. 2020;11:142-152 pubmed publisher
  58. Suzuki D, Flahou C, Yoshikawa N, Stirblyte I, Hayashi Y, Sawaguchi A, et al. iPSC-Derived Platelets Depleted of HLA Class I Are Inert to Anti-HLA Class I and Natural Killer Cell Immunity. Stem Cell Reports. 2020;14:49-59 pubmed publisher
  59. Carceller H, Guirado R, Nacher J. Dark exposure affects plasticity-related molecules and interneurons throughout the visual system during adulthood. J Comp Neurol. 2019;: pubmed publisher
  60. Stewart B, Ferdinand J, Young M, Mitchell T, Loudon K, Riding A, et al. Spatiotemporal immune zonation of the human kidney. Science. 2019;365:1461-1466 pubmed publisher
  61. Zou F, Lu L, Liu J, Xia B, Zhang W, Hu Q, et al. Engineered triple inhibitory receptor resistance improves anti-tumor CAR-T cell performance via CD56. Nat Commun. 2019;10:4109 pubmed publisher
  62. Choi J, Lee E, Kim S, Park S, Oh S, Kang J, et al. Cytotoxic effects of ex vivo-expanded natural killer cell-enriched lymphocytes (MYJ1633) against liver cancer. BMC Cancer. 2019;19:817 pubmed publisher
  63. Menon V, Thomas R, Elgueta C, Horl M, Osborn T, Hallett P, et al. Comprehensive Cell Surface Antigen Analysis Identifies Transferrin Receptor Protein-1 (CD71) as a Negative Selection Marker for Human Neuronal Cells. Stem Cells. 2019;37:1293-1306 pubmed publisher
  64. Wirsching H, Zhang H, Szulzewsky F, Arora S, Grandi P, Cimino P, et al. Arming oHSV with ULBP3 drives abscopal immunity in lymphocyte-depleted glioblastoma. JCI Insight. 2019;4: pubmed publisher
  65. Inagaki Katashiba N, Ito T, Inaba M, Azuma Y, Tanaka A, Phan V, et al. Statins can suppress DC-mediated Th2 responses through the repression of OX40-ligand and CCL17 expression. Eur J Immunol. 2019;49:2051-2062 pubmed publisher
  66. Okumura T, Horie Y, Lai C, Lin H, Shoda H, Natsumoto B, et al. Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34+ cells using the auto-erasable Sendai virus vector. Stem Cell Res Ther. 2019;10:185 pubmed publisher
  67. Jennewein M, Goldfarb I, Dolatshahi S, Cosgrove C, Noelette F, Krykbaeva M, et al. Fc Glycan-Mediated Regulation of Placental Antibody Transfer. Cell. 2019;: pubmed publisher
  68. Xia Y, Gao Y, Wang B, Zhang H, Zhang Q. Optimizing the Method of Cell Separation from Bile of Patients with Cholangiocarcinoma for Flow Cytometry. Gastroenterol Res Pract. 2019;2019:5436961 pubmed publisher
  69. Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck W, et al. Comprehensive Integration of Single-Cell Data. Cell. 2019;: pubmed publisher
  70. Ardain A, Domingo Gonzalez R, Das S, Kazer S, Howard N, Singh A, et al. Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis. Nature. 2019;: pubmed publisher
  71. Ingegnere T, Mariotti F, Pelosi A, Quintarelli C, De Angelis B, Tumino N, et al. Human CAR NK Cells: A New Non-viral Method Allowing High Efficient Transfection and Strong Tumor Cell Killing. Front Immunol. 2019;10:957 pubmed publisher
  72. Fernandez I, Baxter R, Garcia Perez J, Vendrame E, Ranganath T, Kong D, et al. A novel human IL2RB mutation results in T and NK cell-driven immune dysregulation. J Exp Med. 2019;216:1255-1267 pubmed publisher
  73. Lim S, Kim J, Jeon S, Shin M, Kwon J, Kim T, et al. Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Cancer Patients. Front Immunol. 2019;10:496 pubmed publisher
  74. Nakanishi M, Mitchell R, Benoit Y, Orlando L, Reid J, Shimada K, et al. Human Pluripotency Is Initiated and Preserved by a Unique Subset of Founder Cells. Cell. 2019;177:910-924.e22 pubmed publisher
  75. Pavel Dinu M, Wiebking V, Dejene B, Srifa W, Mantri S, Nicolas C, et al. Gene correction for SCID-X1 in long-term hematopoietic stem cells. Nat Commun. 2019;10:1634 pubmed publisher
  76. Cassetta L, Fragkogianni S, Sims A, Swierczak A, Forrester L, Zhang H, et al. Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets. Cancer Cell. 2019;35:588-602.e10 pubmed publisher
  77. Sweere J, Van Belleghem J, Ishak H, Bach M, Popescu M, Sunkari V, et al. Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection. Science. 2019;363: pubmed publisher
  78. de Jonge K, Ebering A, Nassiri S, Maby El Hajjami H, Ouertatani Sakouhi H, Baumgaertner P, et al. Circulating CD56bright NK cells inversely correlate with survival of melanoma patients. Sci Rep. 2019;9:4487 pubmed publisher
  79. Ruan J, Hirai H, Yang D, Ma L, Hou X, Jiang H, et al. Efficient Gene Editing at Major CFTR Mutation Loci. Mol Ther Nucleic Acids. 2019;16:73-81 pubmed publisher
  80. Dosch M, Zindel J, Jebbawi F, Melin N, Sánchez Taltavull D, Stroka D, et al. Connexin-43-dependent ATP release mediates macrophage activation during sepsis. elife. 2019;8: pubmed publisher
  81. Boscheinen J, Thomann S, Knipe D, Deluca N, Schuler Thurner B, Gross S, et al. Generation of an Oncolytic Herpes Simplex Virus 1 Expressing Human MelanA. Front Immunol. 2019;10:2 pubmed publisher
  82. Nixon A, Duque A, Yelle N, McLaughlin M, Davoudi S, Pedley N, et al. A rapid in vitro methodology for simultaneous target discovery and antibody generation against functional cell subpopulations. Sci Rep. 2019;9:842 pubmed publisher
  83. Muller Durovic B, Grählert J, Devine O, Akbar A, Hess C. CD56-negative NK cells with impaired effector function expand in CMV and EBV co-infected healthy donors with age. Aging (Albany NY). 2019;11:724-740 pubmed publisher
  84. Montel Hagen A, Seet C, Li S, Chick B, Zhu Y, Chang P, et al. Organoid-Induced Differentiation of Conventional T Cells from Human Pluripotent Stem Cells. Cell Stem Cell. 2019;24:376-389.e8 pubmed publisher
  85. Chi V, Garaud S, De Silva P, Thibaud V, Stamatopoulos B, Berehad M, et al. Age-related changes in the BACH2 and PRDM1 genes in lymphocytes from healthy donors and chronic lymphocytic leukemia patients. BMC Cancer. 2019;19:81 pubmed publisher
  86. Jegaskanda S, Vanderven H, Tan H, Alcantara S, Wragg K, Parsons M, et al. Influenza Virus Infection Enhances Antibody-Mediated NK Cell Functions via Type I Interferon-Dependent Pathways. J Virol. 2019;93: pubmed publisher
  87. Andre P, Denis C, Soulas C, Bourbon Caillet C, Lopez J, Arnoux T, et al. Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells. Cell. 2018;175:1731-1743.e13 pubmed publisher
  88. Wiedemann G, Aithal C, Kraechan A, Heise C, Cadilha B, Zhang J, et al. Microphthalmia-Associated Transcription Factor (MITF) Regulates Immune Cell Migration into Melanoma. Transl Oncol. 2019;12:350-360 pubmed publisher
  89. Kelly A, Günaltay S, McEntee C, Shuttleworth E, Smedley C, Houston S, et al. Human monocytes and macrophages regulate immune tolerance via integrin αvβ8-mediated TGFβ activation. J Exp Med. 2018;215:2725-2736 pubmed publisher
  90. Park J, Lee J, Sheu K, Wang L, Balanis N, Nguyen K, et al. Reprogramming normal human epithelial tissues to a common, lethal neuroendocrine cancer lineage. Science. 2018;362:91-95 pubmed publisher
  91. Ye W, Chew M, Hou J, Lai F, Leopold S, Loo H, et al. Microvesicles from malaria-infected red blood cells activate natural killer cells via MDA5 pathway. PLoS Pathog. 2018;14:e1007298 pubmed publisher
  92. Bradley T, Peppa D, Pedroza Pacheco I, Li D, Cain D, Henao R, et al. RAB11FIP5 Expression and Altered Natural Killer Cell Function Are Associated with Induction of HIV Broadly Neutralizing Antibody Responses. Cell. 2018;175:387-399.e17 pubmed publisher
  93. van Erp E, Feyaerts D, Duijst M, Mulder H, Wicht O, Luytjes W, et al. Respiratory Syncytial Virus Infects Primary Neonatal and Adult Natural Killer Cells and Affects Their Antiviral Effector Function. J Infect Dis. 2019;219:723-733 pubmed publisher
  94. Watanabe N, Takaku T, Takeda K, Shirane S, Toyota T, Koike M, et al. Dasatinib-induced anti-leukemia cellular immunity through a novel subset of CD57 positive helper/cytotoxic CD4 T cells in chronic myelogenous leukemia patients. Int J Hematol. 2018;108:588-597 pubmed publisher
  95. Olin A, Henckel E, Chen Y, Lakshmikanth T, Pou C, Mikes J, et al. Stereotypic Immune System Development in Newborn Children. Cell. 2018;174:1277-1292.e14 pubmed publisher
  96. Kong X, Martinez Barricarte R, Kennedy J, Mele F, Lazarov T, Deenick E, et al. Disruption of an antimycobacterial circuit between dendritic and helper T cells in human SPPL2a deficiency. Nat Immunol. 2018;19:973-985 pubmed publisher
  97. Walwyn Brown K, Guldevall K, Saeed M, Pende D, Önfelt B, MacDonald A, et al. Human NK Cells Lyse Th2-Polarizing Dendritic Cells via NKp30 and DNAM-1. J Immunol. 2018;201:2028-2041 pubmed publisher
  98. Cooper G, Ostridge K, Khakoo S, Wilkinson T, Staples K. Human CD49a+ Lung Natural Killer Cell Cytotoxicity in Response to Influenza A Virus. Front Immunol. 2018;9:1671 pubmed publisher
  99. Desimio M, Giuliani E, Ferraro A, Adorno G, Doria M. In Vitro Exposure to Prostratin but Not Bryostatin-1 Improves Natural Killer Cell Functions Including Killing of CD4+ T Cells Harboring Reactivated Human Immunodeficiency Virus. Front Immunol. 2018;9:1514 pubmed publisher
  100. Voigt J, Malone D, Dias J, Leeansyah E, Björkström N, Ljunggren H, et al. Proteome analysis of human CD56neg NK cells reveals a homogeneous phenotype surprisingly similar to CD56dim NK cells. Eur J Immunol. 2018;48:1456-1469 pubmed publisher
  101. Yang X, Zhou J, He J, Liu J, Wang H, Liu Y, et al. An Immune System-Modified Rat Model for Human Stem Cell Transplantation Research. Stem Cell Reports. 2018;11:514-521 pubmed publisher
  102. Srpan K, Ambrose A, Karampatzakis A, Saeed M, Cartwright A, Guldevall K, et al. Shedding of CD16 disassembles the NK cell immune synapse and boosts serial engagement of target cells. J Cell Biol. 2018;217:3267-3283 pubmed publisher
  103. Lambert M, Terrone S, Giraud G, Benoit Pilven C, Cluet D, Combaret V, et al. The RNA helicase DDX17 controls the transcriptional activity of REST and the expression of proneural microRNAs in neuronal differentiation. Nucleic Acids Res. 2018;46:7686-7700 pubmed publisher
  104. Galperin M, Farenc C, Mukhopadhyay M, Jayasinghe D, Decroos A, Benati D, et al. CD4+ T cell-mediated HLA class II cross-restriction in HIV controllers. Sci Immunol. 2018;3: pubmed publisher
  105. Capuano C, Battella S, Pighi C, Franchitti L, Turriziani O, Morrone S, et al. Tumor-Targeting Anti-CD20 Antibodies Mediate In Vitro Expansion of Memory Natural Killer Cells: Impact of CD16 Affinity Ligation Conditions and In Vivo Priming. Front Immunol. 2018;9:1031 pubmed publisher
  106. Kiener R, Fleischmann M, Wiegand M, Lemmermann N, Schwegler C, Kaufmann C, et al. Efficient Delivery of Human Cytomegalovirus T Cell Antigens by Attenuated Sendai Virus Vectors. J Virol. 2018;92: pubmed publisher
  107. Risnes L, Christophersen A, Dahal Koirala S, Neumann R, Sandve G, Sarna V, et al. Disease-driving CD4+ T cell clonotypes persist for decades in celiac disease. J Clin Invest. 2018;128:2642-2650 pubmed publisher
  108. Manickam C, Nwanze C, Ram D, Shah S, Smith S, Jones R, et al. Progressive lentivirus infection induces natural killer cell receptor-expressing B cells in the gastrointestinal tract. AIDS. 2018;32:1571-1578 pubmed publisher
  109. Sakai Takemura F, Narita A, Masuda S, Wakamatsu T, Watanabe N, Nishiyama T, et al. Premyogenic progenitors derived from human pluripotent stem cells expand in floating culture and differentiate into transplantable myogenic progenitors. Sci Rep. 2018;8:6555 pubmed publisher
  110. Wang E, Pjechova M, Nightingale K, Vlahava V, Patel M, Růcková E, et al. Suppression of costimulation by human cytomegalovirus promotes evasion of cellular immune defenses. Proc Natl Acad Sci U S A. 2018;115:4998-5003 pubmed publisher
  111. Shi Y, Zhang P, Wang G, Liu X, Sun X, Zhang X, et al. Description of organ-specific phenotype, and functional characteristics of tissue resident lymphocytes from liver transplantation donor and research on immune tolerance mechanism of liver. Oncotarget. 2018;9:15552-15565 pubmed publisher
  112. Li N, van Unen V, Höllt T, Thompson A, van Bergen J, Pezzotti N, et al. Mass cytometry reveals innate lymphoid cell differentiation pathways in the human fetal intestine. J Exp Med. 2018;215:1383-1396 pubmed publisher
  113. Messlinger H, Sebald H, Heger L, Dudziak D, Bogdan C, Schleicher U. Monocyte-Derived Signals Activate Human Natural Killer Cells in Response to Leishmania Parasites. Front Immunol. 2018;9:24 pubmed publisher
  114. Oei V, Siernicka M, Graczyk Jarzynka A, Hoel H, Yang W, Palacios D, et al. Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen Receptors. Cancer Immunol Res. 2018;6:467-480 pubmed publisher
  115. Wilson R, Drake J, Cui D, Lewellen B, Fisher C, Zhang M, et al. Mitochondrial protein S-nitrosation protects against ischemia reperfusion-induced denervation at neuromuscular junction in skeletal muscle. Free Radic Biol Med. 2018;117:180-190 pubmed publisher
  116. Sun Q, Xie C, Niu Z, Su L, Wang X, Fang Z, et al. Diagnosis and treatment of a carotid body tumor: A case report of a rare bilateral tumor. Oncol Lett. 2017;14:6417-6420 pubmed publisher
  117. Vo L, Kinney M, Liu X, Zhang Y, Barragan J, Sousa P, et al. Regulation of embryonic haematopoietic multipotency by EZH1. Nature. 2018;553:506-510 pubmed publisher
  118. Warthan M, Washington S, Franzese S, Ramus R, Kim K, York T, et al. The role of endoplasmic reticulum aminopeptidase 2 in modulating immune detection of choriocarcinoma. Biol Reprod. 2018;98:309-322 pubmed publisher
  119. Cribbs A, Hookway E, Wells G, Lindow M, Obad S, Oerum H, et al. Inhibition of histone H3K27 demethylases selectively modulates inflammatory phenotypes of natural killer cells. J Biol Chem. 2018;293:2422-2437 pubmed publisher
  120. Barrow A, Edeling M, Trifonov V, Luo J, Goyal P, Bohl B, et al. Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor. Cell. 2018;172:534-548.e19 pubmed publisher
  121. Pugh J, Nemat Gorgani N, Norman P, Guethlein L, Parham P. Human NK Cells Downregulate Zap70 and Syk in Response to Prolonged Activation or DNA Damage. J Immunol. 2018;200:1146-1158 pubmed publisher
  122. Maric J, Ravindran A, Mazzurana L, Björklund Ã, Van Acker A, Rao A, et al. Prostaglandin E2 suppresses human group 2 innate lymphoid cell function. J Allergy Clin Immunol. 2018;141:1761-1773.e6 pubmed publisher
  123. Jasinski Bergner S, Büttner M, Quandt D, Seliger B, Kielstein H. Adiponectin and Its Receptors Are Differentially Expressed in Human Tissues and Cell Lines of Distinct Origin. Obes Facts. 2017;10:569-583 pubmed publisher
  124. Herndler Brandstetter D, Shan L, Yao Y, Stecher C, Plajer V, Lietzenmayer M, et al. Humanized mouse model supports development, function, and tissue residency of human natural killer cells. Proc Natl Acad Sci U S A. 2017;114:E9626-E9634 pubmed publisher
  125. Jeong J, Hong S, Kwon O, Ghang B, Hwang I, Kim Y, et al. CD14+ Cells with the Phenotype of Infiltrated Monocytes Consist of Distinct Populations Characterized by Anti-inflammatory as well as Pro-inflammatory Activity in Gouty Arthritis. Front Immunol. 2017;8:1260 pubmed publisher
  126. Hydes T, Noll A, Salinas Riester G, Abuhilal M, Armstrong T, Hamady Z, et al. IL-12 and IL-15 induce the expression of CXCR6 and CD49a on peripheral natural killer cells. Immun Inflamm Dis. 2018;6:34-46 pubmed publisher
  127. Chan Y, Zuo J, Inman C, Croft W, Begum J, Croudace J, et al. NK cells produce high levels of IL-10 early after allogeneic stem cell transplantation and suppress development of acute GVHD. Eur J Immunol. 2018;48:316-329 pubmed publisher
  128. Jackson E, Zhang C, Kiani Z, Lisovsky I, Tallon B, Del Corpo A, et al. HIV exposed seronegative (HESN) compared to HIV infected individuals have higher frequencies of telomeric Killer Immunoglobulin-like Receptor (KIR) B motifs; Contribution of KIR B motif encoded genes to NK cell responsiveness. PLoS ONE. 2017;12:e0185160 pubmed publisher
  129. Kyoizumi S, Kubo Y, Kajimura J, Yoshida K, Hayashi T, Nakachi K, et al. Fate Decision Between Group 3 Innate Lymphoid and Conventional NK Cell Lineages by Notch Signaling in Human Circulating Hematopoietic Progenitors. J Immunol. 2017;199:2777-2793 pubmed publisher
  130. Salio M, Gasser O, González López C, Martens A, Veerapen N, Gileadi U, et al. Activation of Human Mucosal-Associated Invariant T Cells Induces CD40L-Dependent Maturation of Monocyte-Derived and Primary Dendritic Cells. J Immunol. 2017;199:2631-2638 pubmed publisher
  131. Jensen H, Potempa M, Gotthardt D, Lanier L. Cutting Edge: IL-2-Induced Expression of the Amino Acid Transporters SLC1A5 and CD98 Is a Prerequisite for NKG2D-Mediated Activation of Human NK Cells. J Immunol. 2017;199:1967-1972 pubmed publisher
  132. Lunemann S, Martrus G, Goebels H, Kautz T, Langeneckert A, Salzberger W, et al. Hobit expression by a subset of human liver-resident CD56bright Natural Killer cells. Sci Rep. 2017;7:6676 pubmed publisher
  133. Gorvel L, Korenfeld D, Tung T, Klechevsky E. Dendritic Cell-Derived IL-32?: A Novel Inhibitory Cytokine of NK Cell Function. J Immunol. 2017;199:1290-1300 pubmed publisher
  134. Chew V, Lai L, Pan L, Lim C, Li J, Ong R, et al. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses. Proc Natl Acad Sci U S A. 2017;114:E5900-E5909 pubmed publisher
  135. Dulberger C, McMurtrey C, Hölzemer A, Neu K, Liu V, Steinbach A, et al. Human Leukocyte Antigen F Presents Peptides and Regulates Immunity through Interactions with NK Cell Receptors. Immunity. 2017;46:1018-1029.e7 pubmed publisher
  136. Dias J, Leeansyah E, Sandberg J. Multiple layers of heterogeneity and subset diversity in human MAIT cell responses to distinct microorganisms and to innate cytokines. Proc Natl Acad Sci U S A. 2017;114:E5434-E5443 pubmed publisher
  137. Allan D, Cerdeira A, Ranjan A, Kirkham C, Aguilar O, Tanaka M, et al. Transcriptome analysis reveals similarities between human blood CD3- CD56bright cells and mouse CD127+ innate lymphoid cells. Sci Rep. 2017;7:3501 pubmed publisher
  138. Tong A, Hashem H, Eid S, Allen F, Kingsley D, Huang A. Adoptive natural killer cell therapy is effective in reducing pulmonary metastasis of Ewing sarcoma. Oncoimmunology. 2017;6:e1303586 pubmed publisher
  139. Cerboni S, Jeremiah N, Gentili M, Gehrmann U, Conrad C, Stolzenberg M, et al. Intrinsic antiproliferative activity of the innate sensor STING in T lymphocytes. J Exp Med. 2017;214:1769-1785 pubmed publisher
  140. See P, Dutertre C, Chen J, Günther P, McGovern N, Irac S, et al. Mapping the human DC lineage through the integration of high-dimensional techniques. Science. 2017;356: pubmed publisher
  141. Djaoud Z, Guethlein L, Horowitz A, Azzi T, Nemat Gorgani N, Olive D, et al. Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and ?? T cells. J Exp Med. 2017;214:1827-1841 pubmed publisher
  142. Pérez Martínez C, Maravillas Montero J, Meza Herrera I, Vences Catalan F, Zlotnik A, Santos Argumedo L. Tspan33 is Expressed in Transitional and Memory B Cells, but is not Responsible for High ADAM10 Expression. Scand J Immunol. 2017;86:23-30 pubmed publisher
  143. Villani A, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science. 2017;356: pubmed publisher
  144. Llibre A, Garner L, Partridge A, Freeman G, Klenerman P, Willberg C. Expression of lectin-like transcript-1 in human tissues. F1000Res. 2016;5:2929 pubmed publisher
  145. Kaczmarek D, Kokordelis P, Kramer B, Glässner A, Wolter F, Goeser F, et al. Alterations of the NK cell pool in HIV/HCV co-infection. PLoS ONE. 2017;12:e0174465 pubmed publisher
  146. Cooper A, Lill G, Shaw K, Carbonaro Sarracino D, Davila A, Sokolic R, et al. Cytoreductive conditioning intensity predicts clonal diversity in ADA-SCID retroviral gene therapy patients. Blood. 2017;129:2624-2635 pubmed publisher
  147. Miyata Takata T, Takata K, Kato S, Hu L, Noujima Harada M, Chuang S, et al. Clinicopathological analysis of primary central nervous system NK/T cell lymphoma: rare and localized aggressive tumour among extranasal NK/T cell tumours. Histopathology. 2017;71:287-295 pubmed publisher
  148. Bergström I, Lundberg A, Jonsson S, Särndahl E, Ernerudh J, Jonasson L. Annexin A1 in blood mononuclear cells from patients with coronary artery disease: Its association with inflammatory status and glucocorticoid sensitivity. PLoS ONE. 2017;12:e0174177 pubmed publisher
  149. Lopes F, Bálint Å, Valvo S, Felce J, Hessel E, Dustin M, et al. Membrane nanoclusters of FcγRI segregate from inhibitory SIRPα upon activation of human macrophages. J Cell Biol. 2017;216:1123-1141 pubmed publisher
  150. Egashira A, Morita M, Kumagai R, Taguchi K, Ueda M, Yamaguchi S, et al. Neuroendocrine carcinoma of the esophagus: Clinicopathological and immunohistochemical features of 14 cases. PLoS ONE. 2017;12:e0173501 pubmed publisher
  151. Lim A, Li Y, Lopez Lastra S, Stadhouders R, Paul F, Casrouge A, et al. Systemic Human ILC Precursors Provide a Substrate for Tissue ILC Differentiation. Cell. 2017;168:1086-1100.e10 pubmed publisher
  152. van der Geest K, Wang Q, Eijsvogels T, Koenen H, Joosten I, Brouwer E, et al. Changes in peripheral immune cell numbers and functions in octogenarian walkers - an acute exercise study. Immun Ageing. 2017;14:5 pubmed publisher
  153. Malnati M, Ugolotti E, Monti M, Battista D, Vanni I, Bordo D, et al. Activating Killer Immunoglobulin Receptors and HLA-C: a successful combination providing HIV-1 control. Sci Rep. 2017;7:42470 pubmed publisher
  154. Mordmuller B, Surat G, Lagler H, Chakravarty S, Ishizuka A, Lalremruata A, et al. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature. 2017;542:445-449 pubmed publisher
  155. Wouters K, Gaens K, Bijnen M, Verboven K, Jocken J, Wetzels S, et al. Circulating classical monocytes are associated with CD11c+ macrophages in human visceral adipose tissue. Sci Rep. 2017;7:42665 pubmed publisher
  156. Jeffery H, Jeffery L, Lutz P, Corrigan M, Webb G, Hirschfield G, et al. Low-dose interleukin-2 promotes STAT-5 phosphorylation, Treg survival and CTLA-4-dependent function in autoimmune liver diseases. Clin Exp Immunol. 2017;188:394-411 pubmed publisher
  157. Jensen H, Chen S, Folkersen L, Nolan G, Lanier L. EBI3 regulates the NK cell response to mouse cytomegalovirus infection. Proc Natl Acad Sci U S A. 2017;114:1625-1630 pubmed publisher
  158. Aagaard K, Lahon A, Suter M, Arya R, Seferovic M, Vogt M, et al. Primary Human Placental Trophoblasts are Permissive for Zika Virus (ZIKV) Replication. Sci Rep. 2017;7:41389 pubmed publisher
  159. Salvatori G, Foligno S, Sirleto P, Genovese S, Russo S, Coletti V, et al. Sometimes it is better to wait: First Italian case of a newborn with transient abnormal myelopoiesis and a favorable prognosis. Oncol Lett. 2017;13:191-195 pubmed publisher
  160. An Q, Wang Y, Hu S, Fang D, Xuan C, Xu S, et al. Clinical significance of lymphocyte subset changes in hemophagocytic lymphohistiocytosis of children. Exp Ther Med. 2016;12:3549-3552 pubmed publisher
  161. Wentink M, Dalm V, Lankester A, van Schouwenburg P, Schölvinck L, Kalina T, et al. Genetic defects in PI3K? affect B-cell differentiation and maturation leading to hypogammaglobulineamia and recurrent infections. Clin Immunol. 2017;176:77-86 pubmed publisher
  162. Raposo R, de Mulder Rougvie M, Paquin Proulx D, Brailey P, Cabido V, Zdinak P, et al. IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis. JCI Insight. 2017;2:e85811 pubmed publisher
  163. Kim J, Kwon C, Joh J, Sinn D, Choi G, Park J, et al. Differences in Peripheral Blood Lymphocytes between Brand-Name and Generic Tacrolimus Used in Stable Liver Transplant Recipients. Med Princ Pract. 2017;26:221-228 pubmed publisher
  164. Zhu J, Cifuentes H, Reynolds J, Lamba D. Immunosuppression via Loss of IL2rγ Enhances Long-Term Functional Integration of hESC-Derived Photoreceptors in the Mouse Retina. Cell Stem Cell. 2017;20:374-384.e5 pubmed publisher
  165. Tauriainen J, Scharf L, Frederiksen J, Naji A, Ljunggren H, Sonnerborg A, et al. Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals. Sci Rep. 2017;7:40354 pubmed publisher
  166. Lundell A, Nordström I, Andersson K, Lundqvist C, Telemo E, Nava S, et al. IFN type I and II induce BAFF secretion from human decidual stromal cells. Sci Rep. 2017;7:39904 pubmed publisher
  167. Atkin Smith G, Paone S, Zanker D, Duan M, Phan T, Chen W, et al. Isolation of cell type-specific apoptotic bodies by fluorescence-activated cell sorting. Sci Rep. 2017;7:39846 pubmed publisher
  168. Spivak A, Larragoite E, Coletti M, Macedo A, Martins L, Bosque A, et al. Janus kinase inhibition suppresses PKC-induced cytokine release without affecting HIV-1 latency reversal ex vivo. Retrovirology. 2016;13:88 pubmed publisher
  169. Sairafi D, Stikvoort A, Gertow J, Mattsson J, Uhlin M. Donor Cell Composition and Reactivity Predict Risk of Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. J Immunol Res. 2016;2016:5601204 pubmed
  170. Burnett L, LeDuc C, Sulsona C, Paull D, Rausch R, Eddiry S, et al. Deficiency in prohormone convertase PC1 impairs prohormone processing in Prader-Willi syndrome. J Clin Invest. 2017;127:293-305 pubmed publisher
  171. Matsuoka Y, Takahashi M, Sumide K, Kawamura H, Nakatsuka R, Fujioka T, et al. CD34 Antigen and the MPL Receptor Expression Defines a Novel Class of Human Cord Blood-Derived Primitive Hematopoietic Stem Cells. Cell Transplant. 2017;26:1043-1058 pubmed publisher
  172. Fry C, Johnson D, Ireland M, Noehren B. ACL injury reduces satellite cell abundance and promotes fibrogenic cell expansion within skeletal muscle. J Orthop Res. 2017;35:1876-1885 pubmed publisher
  173. Kempf H, Olmer R, Haase A, Franke A, Bolesani E, Schwanke K, et al. Bulk cell density and Wnt/TGFbeta signalling regulate mesendodermal patterning of human pluripotent stem cells. Nat Commun. 2016;7:13602 pubmed publisher
  174. Lévy R, Okada S, Béziat V, Moriya K, Liu C, Chai L, et al. Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency. Proc Natl Acad Sci U S A. 2016;113:E8277-E8285 pubmed publisher
  175. Tomic A, Varanasi P, Golemac M, Malic S, Riese P, Borst E, et al. Activation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D Ligand. PLoS Pathog. 2016;12:e1006015 pubmed publisher
  176. Erdogan Durmus S, Ozcan D, Yarikkaya E, Kurt A, Arslan A. CD56, HBME-1 and cytokeratin 19 expressions in papillary thyroid carcinoma and nodular thyroid lesions. J Res Med Sci. 2016;21:49 pubmed
  177. Siegers G, Barreira C, Postovit L, Dekaban G. CD11d ?2 integrin expression on human NK, B, and ?? T cells. J Leukoc Biol. 2017;101:1029-1035 pubmed publisher
  178. Ducret M, Fabre H, Degoul O, Atzeni G, McGuckin C, Forraz N, et al. Immunophenotyping Reveals the Diversity of Human Dental Pulp Mesenchymal Stromal Cells In vivo and Their Evolution upon In vitro Amplification. Front Physiol. 2016;7:512 pubmed
  179. Senbabaoglu Y, Gejman R, Winer A, Liu M, Van Allen E, de Velasco G, et al. Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures. Genome Biol. 2016;17:231 pubmed
  180. Kadivar M, Petersson J, Svensson L, Marsal J. CD8??+ ?? T Cells: A Novel T Cell Subset with a Potential Role in Inflammatory Bowel Disease. J Immunol. 2016;197:4584-4592 pubmed
  181. Ju X, Silveira P, Hsu W, Elgundi Z, Alingcastre R, Verma N, et al. The Analysis of CD83 Expression on Human Immune Cells Identifies a Unique CD83+-Activated T Cell Population. J Immunol. 2016;197:4613-4625 pubmed
  182. Williamson S, Metcalf R, Trapani F, Mohan S, Antonello J, Abbott B, et al. Vasculogenic mimicry in small cell lung cancer. Nat Commun. 2016;7:13322 pubmed publisher
  183. Sumatoh H, Teng K, Cheng Y, Newell E. Optimization of mass cytometry sample cryopreservation after staining. Cytometry A. 2017;91:48-61 pubmed publisher
  184. Cuff A, Robertson F, Stegmann K, Pallett L, Maini M, Davidson B, et al. Eomeshi NK Cells in Human Liver Are Long-Lived and Do Not Recirculate but Can Be Replenished from the Circulation. J Immunol. 2016;197:4283-4291 pubmed
  185. Perea F, Bernal M, Sánchez Palencia A, Carretero J, Torres C, Bayarri C, et al. The absence of HLA class I expression in non-small cell lung cancer correlates with the tumor tissue structure and the pattern of T cell infiltration. Int J Cancer. 2017;140:888-899 pubmed publisher
  186. Osterburg A, Nelson R, Yaniv B, Foot R, Donica W, Nashu M, et al. NK cell activating receptor ligand expression in lymphangioleiomyomatosis is associated with lung function decline. JCI Insight. 2016;1:e87270 pubmed publisher
  187. Lorenzen I, Lokau J, Korpys Y, Oldefest M, Flynn C, Künzel U, et al. Control of ADAM17 activity by regulation of its cellular localisation. Sci Rep. 2016;6:35067 pubmed publisher
  188. Mascarell L, Airouche S, Berjont N, Gary C, Gueguen C, Fourcade G, et al. The regulatory dendritic cell marker C1q is a potent inhibitor of allergic inflammation. Mucosal Immunol. 2017;10:695-704 pubmed publisher
  189. Oon S, Huynh H, Tai T, Ng M, Monaghan K, Biondo M, et al. A cytotoxic anti-IL-3Rα antibody targets key cells and cytokines implicated in systemic lupus erythematosus. JCI Insight. 2016;1:e86131 pubmed publisher
  190. Yeap W, Wong K, Shimasaki N, Teo E, Quek J, Yong H, et al. CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes. Sci Rep. 2016;6:34310 pubmed publisher
  191. Lu L, Chung A, Rosebrock T, Ghebremichael M, Yu W, Grace P, et al. A Functional Role for Antibodies in Tuberculosis. Cell. 2016;167:433-443.e14 pubmed publisher
  192. Wang Y, Ma C, Ling Y, Bousfiha A, Camcioglu Y, Jacquot S, et al. Dual T cell- and B cell-intrinsic deficiency in humans with biallelic RLTPR mutations. J Exp Med. 2016;213:2413-2435 pubmed
  193. Sugita S, Iwasaki Y, Makabe K, Kimura T, Futagami T, Suegami S, et al. Lack of T Cell Response to iPSC-Derived Retinal Pigment Epithelial Cells from HLA Homozygous Donors. Stem Cell Reports. 2016;7:619-634 pubmed publisher
  194. Kelly A, Robinson M, Roche G, Biron C, O Farrelly C, Ryan E. Immune Cell Profiling of IFN-? Response Shows pDCs Express Highest Level of IFN-?R1 and Are Directly Responsive via the JAK-STAT Pathway. J Interferon Cytokine Res. 2016;36:671-680 pubmed
  195. Fuchs S, Kaiser Labusch P, Bank J, Ammann S, Kolb Kokocinski A, Edelbusch C, et al. Tyrosine kinase 2 is not limiting human antiviral type III interferon responses. Eur J Immunol. 2016;46:2639-2649 pubmed publisher
  196. Lu X, Chen Q, Rong Y, Yang G, Li C, Xu N, et al. LECT2 drives haematopoietic stem cell expansion and mobilization via regulating the macrophages and osteolineage cells. Nat Commun. 2016;7:12719 pubmed publisher
  197. Zenarruzabeitia O, Vitallé J, Garcia Obregon S, Astigarraga I, Eguizabal C, Santos S, et al. The expression and function of human CD300 receptors on blood circulating mononuclear cells are distinct in neonates and adults. Sci Rep. 2016;6:32693 pubmed publisher
  198. Ilkovitch D, Ferris L. Myeloid-derived suppressor cells are elevated in patients with psoriasis and produce various molecules. Mol Med Rep. 2016;14:3935-40 pubmed publisher
  199. Muller Durovic B, Lanna A, Covre L, Mills R, Henson S, Akbar A. Killer Cell Lectin-like Receptor G1 Inhibits NK Cell Function through Activation of Adenosine 5'-Monophosphate-Activated Protein Kinase. J Immunol. 2016;197:2891-2899 pubmed publisher
  200. Watson D, Bayık D, Srivatsan A, Bergamaschi C, Valentin A, Niu G, et al. Efficient production and enhanced tumor delivery of engineered extracellular vesicles. Biomaterials. 2016;105:195-205 pubmed publisher
  201. Hervier B, Perez M, Allenbach Y, Devilliers H, Cohen F, Uzunhan Y, et al. Involvement of NK Cells and NKp30 Pathway in Antisynthetase Syndrome. J Immunol. 2016;197:1621-30 pubmed publisher
  202. Bronger H, Singer J, Windmüller C, Reuning U, Zech D, Delbridge C, et al. CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer. Br J Cancer. 2016;115:553-63 pubmed publisher
  203. Manickam C, Rajakumar P, Wachtman L, Kramer J, Martinot A, Varner V, et al. Acute Liver Damage Associated with Innate Immune Activation in a Small Nonhuman Primate Model of Hepacivirus Infection. J Virol. 2016;90:9153-62 pubmed publisher
  204. Cerny D, Thi Le D, The T, Zuest R, Kg S, Velumani S, et al. Complete human CD1a deficiency on Langerhans cells due to a rare point mutation in the coding sequence. J Allergy Clin Immunol. 2016;138:1709-1712.e11 pubmed publisher
  205. Paquin Proulx D, Gibbs A, Bachle S, Checa A, Introini A, Leeansyah E, et al. Innate Invariant NKT Cell Recognition of HIV-1-Infected Dendritic Cells Is an Early Detection Mechanism Targeted by Viral Immune Evasion. J Immunol. 2016;197:1843-51 pubmed publisher
  206. Debliquis A, Voirin J, Harzallah I, Maurer M, Lerintiu F, Drenou B, et al. Cytomorphology and flow cytometry of brain biopsy rinse fluid enables faster and multidisciplinary diagnosis of large B-cell lymphoma of the central nervous system. Cytometry B Clin Cytom. 2018;94:182-188 pubmed publisher
  207. Kritikou J, Dahlberg C, Baptista M, Wagner A, Banerjee P, Gwalani L, et al. IL-2 in the tumor microenvironment is necessary for Wiskott-Aldrich syndrome protein deficient NK cells to respond to tumors in vivo. Sci Rep. 2016;6:30636 pubmed publisher
  208. Chen H, Händel N, Ngeow J, Muller J, Huhn M, Yang H, et al. Immune dysregulation in patients with PTEN hamartoma tumor syndrome: Analysis of FOXP3 regulatory T cells. J Allergy Clin Immunol. 2017;139:607-620.e15 pubmed publisher
  209. Sullivan K, Lewis H, Hill A, Pandey A, Jackson L, Cabral J, et al. Trisomy 21 consistently activates the interferon response. elife. 2016;5: pubmed publisher
  210. Rölle A, Halenius A, Ewen E, Cerwenka A, Hengel H, Momburg F. CD2-CD58 interactions are pivotal for the activation and function of adaptive natural killer cells in human cytomegalovirus infection. Eur J Immunol. 2016;46:2420-2425 pubmed publisher
  211. Ashizawa T, Iizuka A, Nonomura C, Kondou R, Maeda C, Miyata H, et al. Antitumor Effect of Programmed Death-1 (PD-1) Blockade in Humanized the NOG-MHC Double Knockout Mouse. Clin Cancer Res. 2017;23:149-158 pubmed publisher
  212. Ugras N, Yerci O, Coşkun S, Ocakoglu G, Sarkut P, Dündar H. Retrospective analysis of clinicopathological features of solid pseudopapillary neoplasm of the pancreas. Kaohsiung J Med Sci. 2016;32:356-61 pubmed publisher
  213. Sadallah S, Schmied L, Eken C, Charoudeh H, Amicarella F, Schifferli J. Platelet-Derived Ectosomes Reduce NK Cell Function. J Immunol. 2016;197:1663-71 pubmed publisher
  214. Coccaro N, Tota G, Anelli L, Zagaria A, Casieri P, Cellamare A, et al. MYEOV gene overexpression in primary plasma cell leukemia with t(11;14)(q13;q32). Oncol Lett. 2016;12:1460-1464 pubmed
  215. Marshall D, Harried S, Murphy J, Hall C, Shekhani M, Pain C, et al. Extracellular Antibody Drug Conjugates Exploiting the Proximity of Two Proteins. Mol Ther. 2016;24:1760-1770 pubmed publisher
  216. DeGottardi M, Okoye A, Vaidya M, Talla A, Konfe A, Reyes M, et al. Effect of Anti-IL-15 Administration on T Cell and NK Cell Homeostasis in Rhesus Macaques. J Immunol. 2016;197:1183-98 pubmed publisher
  217. Suliman S, Geldenhuys H, Johnson J, Hughes J, Smit E, Murphy M, et al. Bacillus Calmette-Guérin (BCG) Revaccination of Adults with Latent Mycobacterium tuberculosis Infection Induces Long-Lived BCG-Reactive NK Cell Responses. J Immunol. 2016;197:1100-1110 pubmed publisher
  218. Di Liberto D, Mansueto P, D Alcamo A, Lo Pizzo M, Lo Presti E, Geraci G, et al. Predominance of Type 1 Innate Lymphoid Cells in the Rectal Mucosa of Patients With Non-Celiac Wheat Sensitivity: Reversal After a Wheat-Free Diet. Clin Transl Gastroenterol. 2016;7:e178 pubmed publisher
  219. Wittmann A, Lamprinaki D, Bowles K, Katzenellenbogen E, Knirel Y, Whitfield C, et al. Dectin-2 Recognizes Mannosylated O-antigens of Human Opportunistic Pathogens and Augments Lipopolysaccharide Activation of Myeloid Cells. J Biol Chem. 2016;291:17629-38 pubmed publisher
  220. Lo T, Silveira P, Fromm P, Verma N, Vu P, Kupresanin F, et al. Characterization of the Expression and Function of the C-Type Lectin Receptor CD302 in Mice and Humans Reveals a Role in Dendritic Cell Migration. J Immunol. 2016;197:885-98 pubmed publisher
  221. Heath J, Newhook N, Comeau E, Gallant M, Fudge N, Grant M. NKG2C(+)CD57(+) Natural Killer Cell Expansion Parallels Cytomegalovirus-Specific CD8(+) T Cell Evolution towards Senescence. J Immunol Res. 2016;2016:7470124 pubmed publisher
  222. Fu T, Yang W, Zhang X, Xu X. Peripheral T-cell lymphoma unspecified type presenting with a pneumothorax as the initial manifestation: A case report and literature review. Oncol Lett. 2016;11:4069-4076 pubmed
  223. Meinhardt G, Saleh L, Otti G, Haider S, Velicky P, Fiala C, et al. Wingless ligand 5a is a critical regulator of placental growth and survival. Sci Rep. 2016;6:28127 pubmed publisher
  224. Zanetti S, Ziblat A, Torres N, Zwirner N, Bouzat C. Expression and Functional Role of ?7 Nicotinic Receptor in Human Cytokine-stimulated Natural Killer (NK) Cells. J Biol Chem. 2016;291:16541-52 pubmed publisher
  225. Ramos C, Savoldo B, Torrano V, Ballard B, Zhang H, Dakhova O, et al. Clinical responses with T lymphocytes targeting malignancy-associated ? light chains. J Clin Invest. 2016;126:2588-96 pubmed publisher
  226. Quarta M, Brett J, DiMarco R, de Morrée A, Boutet S, Chacon R, et al. An artificial niche preserves the quiescence of muscle stem cells and enhances their therapeutic efficacy. Nat Biotechnol. 2016;34:752-9 pubmed publisher
  227. Vaccari M, Gordon S, Fourati S, Schifanella L, Liyanage N, Cameron M, et al. Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition. Nat Med. 2016;22:762-70 pubmed publisher
  228. Loyon R, Picard E, Mauvais O, Queiroz L, Mougey V, Pallandre J, et al. IL-21-Induced MHC Class II+ NK Cells Promote the Expansion of Human Uncommitted CD4+ Central Memory T Cells in a Macrophage Migration Inhibitory Factor-Dependent Manner. J Immunol. 2016;197:85-96 pubmed publisher
  229. Goodier M, Rodríguez Galán A, Lusa C, Nielsen C, Darboe A, Moldoveanu A, et al. Influenza Vaccination Generates Cytokine-Induced Memory-like NK Cells: Impact of Human Cytomegalovirus Infection. J Immunol. 2016;197:313-25 pubmed publisher
  230. Kwon H, Choi G, Ryu S, Kwon S, Kim S, Booth C, et al. Stepwise phosphorylation of p65 promotes NF-?B activation and NK cell responses during target cell recognition. Nat Commun. 2016;7:11686 pubmed publisher
  231. Reinisch A, Thomas D, Corces M, Zhang X, Gratzinger D, Hong W, et al. A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells. Nat Med. 2016;22:812-21 pubmed publisher
  232. Reches A, Nachmani D, Berhani O, Duev Cohen A, Shreibman D, Ophir Y, et al. HNRNPR Regulates the Expression of Classical and Nonclassical MHC Class I Proteins. J Immunol. 2016;196:4967-76 pubmed publisher
  233. Yin W, Tong S, Zhang Q, Shao J, Liu Q, Peng H, et al. Functional dichotomy of Vδ2 γδ T cells in chronic hepatitis C virus infections: role in cytotoxicity but not for IFN-γ production. Sci Rep. 2016;6:26296 pubmed publisher
  234. Gren S, Janciauskiene S, Sandeep S, Jonigk D, Kvist P, Gerwien J, et al. The protease inhibitor cystatin C down-regulates the release of IL-? and TNF-? in lipopolysaccharide activated monocytes. J Leukoc Biol. 2016;100:811-822 pubmed
  235. Theorell J, Bryceson Y. Analysis of Intracellular Ca(2+) Mobilization in Human NK Cell Subsets by Flow Cytometry. Methods Mol Biol. 2016;1441:117-30 pubmed publisher
  236. Kay A, Strauss Albee D, Blish C. Application of Mass Cytometry (CyTOF) for Functional and Phenotypic Analysis of Natural Killer Cells. Methods Mol Biol. 2016;1441:13-26 pubmed publisher
  237. Marafini I, Monteleone I, Di Fusco D, Sedda S, Cupi M, Fina D, et al. Celiac Disease-Related Inflammation Is Marked by Reduction of Nkp44/Nkp46-Double Positive Natural Killer Cells. PLoS ONE. 2016;11:e0155103 pubmed publisher
  238. Stikvoort A, Sundin M, Uzunel M, Gertow J, Sundberg B, Schaffer M, et al. Long-Term Stable Mixed Chimerism after Hematopoietic Stem Cell Transplantation in Patients with Non-Malignant Disease, Shall We Be Tolerant?. PLoS ONE. 2016;11:e0154737 pubmed publisher
  239. Tuşaliu M, Zainea V, Mogoantă C, Dragu A, GoanŢă C, Niţescu M, et al. Diagnostic and therapeutic aspects in malignant sinonasal lymphoma. Rom J Morphol Embryol. 2016;57:233-6 pubmed
  240. Fan W, Li X, Yao H, Deng J, Liu H, Cui Z, et al. Neural differentiation and synaptogenesis in retinal development. Neural Regen Res. 2016;11:312-8 pubmed publisher
  241. Zografos L, Tang J, Hesse F, Wanker E, Li K, Smit A, et al. Functional characterisation of human synaptic genes expressed in the Drosophila brain. Biol Open. 2016;5:662-7 pubmed publisher
  242. Stratigopoulos G, Burnett L, Rausch R, Gill R, Penn D, Skowronski A, et al. Hypomorphism of Fto and Rpgrip1l causes obesity in mice. J Clin Invest. 2016;126:1897-910 pubmed publisher
  243. Jourdan M, Cren M, Schafer P, Robert N, Duperray C, Vincent L, et al. Differential effects of lenalidomide during plasma cell differentiation. Oncotarget. 2016;7:28096-111 pubmed publisher
  244. Komori M, Lin Y, Cortese I, Blake A, Ohayon J, Cherup J, et al. Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis. Ann Clin Transl Neurol. 2016;3:166-79 pubmed publisher
  245. Almeida C, Fernandes S, Ribeiro Junior A, Keith Okamoto O, Vainzof M. Muscle Satellite Cells: Exploring the Basic Biology to Rule Them. Stem Cells Int. 2016;2016:1078686 pubmed publisher
  246. Dimitrova M, Zenarruzabeitia O, Borrego F, Simhadri V. CD300c is uniquely expressed on CD56 bright Natural Killer Cells and differs from CD300a upon ligand recognition. Sci Rep. 2016;6:23942 pubmed publisher
  247. Aswad H, Jalabert A, Rome S. Depleting extracellular vesicles from fetal bovine serum alters proliferation and differentiation of skeletal muscle cells in vitro. BMC Biotechnol. 2016;16:32 pubmed publisher
  248. Wang Y, Sun J, Ma C, Gao W, Song B, Xue H, et al. Reduced Expression of Galectin-9 Contributes to a Poor Outcome in Colon Cancer by Inhibiting NK Cell Chemotaxis Partially through the Rho/ROCK1 Signaling Pathway. PLoS ONE. 2016;11:e0152599 pubmed publisher
  249. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  250. Gao J, Duan Z, Zhang L, Huang X, Long L, Tu J, et al. Failure recovery of circulating NKG2D+CD56dimNK cells in HBV-associated hepatocellular carcinoma after hepatectomy predicts early recurrence. Oncoimmunology. 2016;5:e1048061 pubmed
  251. Offersen R, Nissen S, Rasmussen T, Østergaard L, Denton P, Søgaard O, et al. A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells. J Virol. 2016;90:4441-4453 pubmed publisher
  252. Bhide G, Fernandes N, Colley K. Sequence Requirements for Neuropilin-2 Recognition by ST8SiaIV and Polysialylation of Its O-Glycans. J Biol Chem. 2016;291:9444-57 pubmed publisher
  253. Chang C, Hale S, Cox C, Blair A, Kronsteiner B, Grabowska R, et al. Junctional Adhesion Molecule-A Is Highly Expressed on Human Hematopoietic Repopulating Cells and Associates with the Key Hematopoietic Chemokine Receptor CXCR4. Stem Cells. 2016;34:1664-78 pubmed publisher
  254. Ludigs K, Jandus C, Utzschneider D, Staehli F, Bessoles S, Dang A, et al. NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions. Nat Commun. 2016;7:10554 pubmed publisher
  255. Abdelgawad M, Delaisse J, Hinge M, Jensen P, Alnaimi R, Rolighed L, et al. Early reversal cells in adult human bone remodeling: osteoblastic nature, catabolic functions and interactions with osteoclasts. Histochem Cell Biol. 2016;145:603-15 pubmed publisher
  256. Beltran H, Prandi D, Mosquera J, Benelli M, Puca L, Cyrta J, et al. Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer. Nat Med. 2016;22:298-305 pubmed publisher
  257. Vallera D, Felices M, McElmurry R, McCullar V, Zhou X, Schmohl J, et al. IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function. Clin Cancer Res. 2016;22:3440-50 pubmed publisher
  258. Roan F, Stoklasek T, Whalen E, Molitor J, Bluestone J, Buckner J, et al. CD4+ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis. J Immunol. 2016;196:2051-2062 pubmed publisher
  259. Somasundaram V, Soni S, Chopra A, Rai S, Mahapatra M, Kumar R, et al. Value of Quantitative assessment of Myeloid Nuclear Differentiation Antigen expression and other flow cytometric parameters in the diagnosis of Myelodysplastic syndrome. Int J Lab Hematol. 2016;38:141-50 pubmed publisher
  260. Allenbach Y, Leroux G, Suárez Calvet X, Preusse C, Gallardo E, Hervier B, et al. Dermatomyositis With or Without Anti-Melanoma Differentiation-Associated Gene 5 Antibodies: Common Interferon Signature but Distinct NOS2 Expression. Am J Pathol. 2016;186:691-700 pubmed publisher
  261. Arentson Lantz E, English K, Paddon Jones D, Fry C. Fourteen days of bed rest induces a decline in satellite cell content and robust atrophy of skeletal muscle fibers in middle-aged adults. J Appl Physiol (1985). 2016;120:965-75 pubmed publisher
  262. Soh K, Tario J, Colligan S, Maguire O, Pan D, Minderman H, et al. Simultaneous, Single-Cell Measurement of Messenger RNA, Cell Surface Proteins, and Intracellular Proteins. Curr Protoc Cytom. 2016;75:7.45.1-7.45.33 pubmed publisher
  263. García Prat L, Martínez Vicente M, Perdiguero E, Ortet L, Rodríguez Ubreva J, Rebollo E, et al. Autophagy maintains stemness by preventing senescence. Nature. 2016;529:37-42 pubmed publisher
  264. Lisenko K, Schönland S, Hegenbart U, Wallenwein K, Braun U, Mai E, et al. Potential therapeutic targets in plasma cell disorders: A flow cytometry study. Cytometry B Clin Cytom. 2017;92:145-152 pubmed publisher
  265. Lee W, Richard J, Lichtfuss M, Smith A, Park J, Courter J, et al. Antibody-Dependent Cellular Cytotoxicity against Reactivated HIV-1-Infected Cells. J Virol. 2016;90:2021-30 pubmed publisher
  266. Westman J, Papareddy P, Dahlgren M, Chakrakodi B, Norrby Teglund A, Smeds E, et al. Extracellular Histones Induce Chemokine Production in Whole Blood Ex Vivo and Leukocyte Recruitment In Vivo. PLoS Pathog. 2015;11:e1005319 pubmed publisher
  267. Gururajan M, Cavassani K, Sievert M, Duan P, Lichterman J, Huang J, et al. SRC family kinase FYN promotes the neuroendocrine phenotype and visceral metastasis in advanced prostate cancer. Oncotarget. 2015;6:44072-83 pubmed publisher
  268. Nakamura A, Mitsuhashi T, Takano Y, Miyoshi H, Kameda H, Nomoto H, et al. Usefulness of the octreotide test in Japanese patients for predicting the presence/absence of somatostatin receptor 2 expression in insulinomas. Endocr J. 2016;63:135-42 pubmed publisher
  269. Labani Motlagh A, Israelsson P, Ottander U, Lundin E, Nagaev I, Nagaeva O, et al. Differential expression of ligands for NKG2D and DNAM-1 receptors by epithelial ovarian cancer-derived exosomes and its influence on NK cell cytotoxicity. Tumour Biol. 2016;37:5455-66 pubmed publisher
  270. Jackson J, Taylor J, Witek M, Hunsucker S, Waugh J, Fedoriw Y, et al. Microfluidics for the detection of minimal residual disease in acute myeloid leukemia patients using circulating leukemic cells selected from blood. Analyst. 2016;141:640-51 pubmed publisher
  271. Eskicioğlu F, Özdemir A, Özdemir R, Turan G, Akan Z, Hasdemir S. The association of HLA-G and immune markers in recurrent miscarriages. J Matern Fetal Neonatal Med. 2016;29:3056-60 pubmed publisher
  272. Deisting W, Raum T, Kufer P, Baeuerle P, Münz M. Impact of Diverse Immune Evasion Mechanisms of Cancer Cells on T Cells Engaged by EpCAM/CD3-Bispecific Antibody Construct AMG 110. PLoS ONE. 2015;10:e0141669 pubmed publisher
  273. Holtzinger A, Streeter P, Sarangi F, Hillborn S, Niapour M, Ogawa S, et al. New markers for tracking endoderm induction and hepatocyte differentiation from human pluripotent stem cells. Development. 2015;142:4253-65 pubmed publisher
  274. Popov L, Marceau C, Starkl P, Lumb J, Shah J, Guerrera D, et al. The adherens junctions control susceptibility to Staphylococcus aureus α-toxin. Proc Natl Acad Sci U S A. 2015;112:14337-42 pubmed publisher
  275. Fujino K, Motooka Y, Hassan W, Ali Abdalla M, Sato Y, Kudoh S, et al. Insulinoma-Associated Protein 1 Is a Crucial Regulator of Neuroendocrine Differentiation in Lung Cancer. Am J Pathol. 2015;185:3164-77 pubmed publisher
  276. Schulz A, Mälzer J, Domingo C, Jürchott K, Grützkau A, Babel N, et al. Low Thymic Activity and Dendritic Cell Numbers Are Associated with the Immune Response to Primary Viral Infection in Elderly Humans. J Immunol. 2015;195:4699-711 pubmed publisher
  277. Zhu X, Chen Y, Zhang N, Zheng Z, Zhao F, Liu N, et al. Molecular characterization and expression analyses of ST8Sia II and IV in piglets during postnatal development: lack of correlation between transcription and posttranslational levels. Glycoconj J. 2015;32:715-28 pubmed publisher
  278. Okoye Okafor U, Bartholdy B, Cartier J, Gao E, Pietrak B, Rendina A, et al. New IDH1 mutant inhibitors for treatment of acute myeloid leukemia. Nat Chem Biol. 2015;11:878-86 pubmed publisher
  279. Rosario M, Liu B, Kong L, Collins L, Schneider S, Chen X, et al. The IL-15-Based ALT-803 Complex Enhances FcγRIIIa-Triggered NK Cell Responses and In Vivo Clearance of B Cell Lymphomas. Clin Cancer Res. 2016;22:596-608 pubmed publisher
  280. Kaese M, Galuska C, Simon P, Braun B, Cabrera Fuentes H, Middendorff R, et al. Polysialylation takes place in granulosa cells during apoptotic processes of atretic tertiary follicles. FEBS J. 2015;282:4595-606 pubmed publisher
  281. Caldow M, Thomas E, Dale M, Tomkinson G, Buckley J, Cameron Smith D. Early myogenic responses to acute exercise before and after resistance training in young men. Physiol Rep. 2015;3: pubmed publisher
  282. Denkovskij J, Rudys R, Bernotiene E, Minderis M, Bagdonas S, Kirdaite G. Cell surface markers and exogenously induced PpIX in synovial mesenchymal stem cells. Cytometry A. 2015;87:1001-11 pubmed publisher
  283. Marković Lipkovski J, Životić M, Müller C, Tampe B, Ćirović S, Vještica J, et al. Variable Expression of Neural Cell Adhesion Molecule Isoforms in Renal Tissue: Possible Role in Incipient Renal Fibrosis. PLoS ONE. 2015;10:e0137028 pubmed publisher
  284. Olsson K, Cheng A, Alam S, Al Ameri M, Rullman E, Westerblad H, et al. Intracellular Ca(2+)-handling differs markedly between intact human muscle fibers and myotubes. Skelet Muscle. 2015;5:26 pubmed publisher
  285. Djurisic S, Skibsted L, Hviid T. A Phenotypic Analysis of Regulatory T Cells and Uterine NK Cells from First Trimester Pregnancies and Associations with HLA-G. Am J Reprod Immunol. 2015;74:427-44 pubmed publisher
  286. Nilsen T, Thorsen L, Fosså S, Wiig M, Kirkegaard C, Skovlund E, et al. Effects of strength training on muscle cellular outcomes in prostate cancer patients on androgen deprivation therapy. Scand J Med Sci Sports. 2016;26:1026-35 pubmed publisher
  287. Fernandez L, Valentin J, Zalacain M, Leung W, Patino Garcia A, Perez Martinez A. Activated and expanded natural killer cells target osteosarcoma tumor initiating cells in an NKG2D-NKG2DL dependent manner. Cancer Lett. 2015;368:54-63 pubmed publisher
  288. Dunham J, Lee L, van Driel N, Laman J, Ni I, Zhai W, et al. Blockade of CD127 Exerts a Dichotomous Clinical Effect in Marmoset Experimental Autoimmune Encephalomyelitis. J Neuroimmune Pharmacol. 2016;11:73-83 pubmed publisher
  289. Evans T, Li H, Schafer J, Klatt N, Hao X, Traslavina R, et al. SIV-induced Translocation of Bacterial Products in the Liver Mobilizes Myeloid Dendritic and Natural Killer Cells Associated With Liver Damage. J Infect Dis. 2016;213:361-9 pubmed publisher
  290. Boag S, Das R, Shmeleva E, Bagnall A, Egred M, Howard N, et al. T lymphocytes and fractalkine contribute to myocardial ischemia/reperfusion injury in patients. J Clin Invest. 2015;125:3063-76 pubmed publisher
  291. Pojero F, Flores Montero J, Sanoja L, Pérez J, Puig N, Paiva B, et al. Utility of CD54, CD229, and CD319 for the identification of plasma cells in patients with clonal plasma cell diseases. Cytometry B Clin Cytom. 2016;90:91-100 pubmed publisher
  292. Adoro S, Cubillos Ruiz J, Chen X, Deruaz M, Vrbanac V, Song M, et al. IL-21 induces antiviral microRNA-29 in CD4 T cells to limit HIV-1 infection. Nat Commun. 2015;6:7562 pubmed publisher
  293. Ceyran A, Şenol S, Şimşek B, Sağıroğlu J, Aydın A. Role of cd56 and e-cadherin expression in the differential diagnosis of papillary thyroid carcinoma and suspected follicular-patterned lesions of the thyroid: the prognostic importance of e-cadherin. Int J Clin Exp Pathol. 2015;8:3670-80 pubmed
  294. Stenger E, Chiang K, Haight A, Qayed M, Kean L, Horan J. Use of Alefacept for Preconditioning in Multiply Transfused Pediatric Patients with Nonmalignant Diseases. Biol Blood Marrow Transplant. 2015;21:1845-52 pubmed publisher
  295. Zerboni L, Arvin A. Neuronal Subtype and Satellite Cell Tropism Are Determinants of Varicella-Zoster Virus Virulence in Human Dorsal Root Ganglia Xenografts In Vivo. PLoS Pathog. 2015;11:e1004989 pubmed publisher
  296. Wu D, Thomas A, Fromm J. Reactive T cells by flow cytometry distinguish Hodgkin lymphomas from T cell/histiocyte-rich large B cell lymphoma. Cytometry B Clin Cytom. 2016;90:424-32 pubmed publisher
  297. Yawata N, Selva K, Liu Y, Tan K, Lee A, Siak J, et al. Dynamic change in natural killer cell type in the human ocular mucosa in situ as means of immune evasion by adenovirus infection. Mucosal Immunol. 2016;9:159-70 pubmed publisher
  298. Perriard G, Mathias A, Enz L, Canales M, Schluep M, Gentner M, et al. Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes. J Neuroinflammation. 2015;12:119 pubmed publisher
  299. Chang D, Moniz R, Xu Z, Sun J, Signoretti S, Zhu Q, et al. Human anti-CAIX antibodies mediate immune cell inhibition of renal cell carcinoma in vitro and in a humanized mouse model in vivo. Mol Cancer. 2015;14:119 pubmed publisher
  300. Lee J, Breton G, Aljoufi A, Zhou Y, PUHR S, Nussenzweig M, et al. Clonal analysis of human dendritic cell progenitor using a stromal cell culture. J Immunol Methods. 2015;425:21-6 pubmed publisher
  301. Rasmussen T, Andersen T, Bak R, Yiu G, Sørensen C, Stengaard Pedersen K, et al. Overexpression of microRNA-155 increases IL-21 mediated STAT3 signaling and IL-21 production in systemic lupus erythematosus. Arthritis Res Ther. 2015;17:154 pubmed publisher
  302. Grieco A, Billett H, Green N, Driscoll M, Bouhassira E. Variation in Gamma-Globin Expression before and after Induction with Hydroxyurea Associated with BCL11A, KLF1 and TAL1. PLoS ONE. 2015;10:e0129431 pubmed publisher
  303. Mathur R, Sehgal L, Braun F, Berkova Z, Romaguerra J, Wang M, et al. Targeting Wnt pathway in mantle cell lymphoma-initiating cells. J Hematol Oncol. 2015;8:63 pubmed publisher
  304. Kim S, Theunissen J, Balibalos J, Liao Chan S, Babcock M, Wong T, et al. A novel antibody-drug conjugate targeting SAIL for the treatment of hematologic malignancies. Blood Cancer J. 2015;5:e316 pubmed publisher
  305. Boisson B, Laplantine E, Dobbs K, Cobat A, Tarantino N, Hazen M, et al. Human HOIP and LUBAC deficiency underlies autoinflammation, immunodeficiency, amylopectinosis, and lymphangiectasia. J Exp Med. 2015;212:939-51 pubmed publisher
  306. Vanoli A, Argenti F, Vinci A, La Rosa S, Viglio A, Riboni R, et al. Hepatoid carcinoma of the pancreas with lymphoid stroma: first description of the clinical, morphological, immunohistochemical, and molecular characteristics of an unusual pancreatic carcinoma. Virchows Arch. 2015;467:237-45 pubmed publisher
  307. Wang Z, Wan Y, Qiu C, Quiñones Parra S, Zhu Z, Loh L, et al. Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8⁺ T cells. Nat Commun. 2015;6:6833 pubmed publisher
  308. Boer M, Prins C, van Meijgaarden K, van Dissel J, Ottenhoff T, Joosten S. Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults. Clin Vaccine Immunol. 2015;22:778-88 pubmed publisher
  309. Kinder M, Greenplate A, Strohl W, Jordan R, Brezski R. An Fc engineering approach that modulates antibody-dependent cytokine release without altering cell-killing functions. MAbs. 2015;7:494-504 pubmed publisher
  310. Berent Maoz B, Montecino Rodriguez E, Fice M, Casero D, Seet C, Crooks G, et al. The expansion of thymopoiesis in neonatal mice is dependent on expression of high mobility group a 2 protein (Hmga2). PLoS ONE. 2015;10:e0125414 pubmed publisher
  311. DaFonseca S, Niessl J, Pouvreau S, Wacleche V, Gosselin A, Cleret Buhot A, et al. Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART. Retrovirology. 2015;12:38 pubmed publisher
  312. Miracco C, Toscano M, Butorano M, Baldino G, Tacchini D, Barone A, et al. Unusual clear cell, lymphoplasmacyte-rich, dural-based tumor with divergent differentiation: a tricky case mimicking a meningioma. Hum Pathol. 2015;46:1050-6 pubmed publisher
  313. Jeon Y, Kim J, Sung J, Han J, Ko Y. Epstein-Barr virus-positive nodal T/NK-cell lymphoma: an analysis of 15 cases with distinct clinicopathological features. Hum Pathol. 2015;46:981-90 pubmed publisher
  314. Dyring Andersen B, Bonefeld C, Bzorek M, Løvendorf M, Lauritsen J, Skov L, et al. The Vitamin D Analogue Calcipotriol Reduces the Frequency of CD8+ IL-17+ T Cells in Psoriasis Lesions. Scand J Immunol. 2015;82:84-91 pubmed publisher
  315. Metcalf Pate K, Pohlmeyer C, Walker Sperling V, Foote J, Najarro K, Cryer C, et al. A Murine Viral Outgrowth Assay to Detect Residual HIV Type 1 in Patients With Undetectable Viral Loads. J Infect Dis. 2015;212:1387-96 pubmed publisher
  316. Kadota K, Nitadori J, Rekhtman N, Jones D, Adusumilli P, Travis W. Reevaluation and reclassification of resected lung carcinomas originally diagnosed as squamous cell carcinoma using immunohistochemical analysis. Am J Surg Pathol. 2015;39:1170-80 pubmed publisher
  317. Wu Z, Frascaroli G, Bayer C, Schmal T, Mertens T. Interleukin-2 from Adaptive T Cells Enhances Natural Killer Cell Activity against Human Cytomegalovirus-Infected Macrophages. J Virol. 2015;89:6435-41 pubmed publisher
  318. Zhou J, Amran F, Kramski M, Angelovich T, Elliott J, Hearps A, et al. An NK Cell Population Lacking FcRγ Is Expanded in Chronically Infected HIV Patients. J Immunol. 2015;194:4688-97 pubmed publisher
  319. Boerman G, van Ostaijen Ten Dam M, Kraal K, Santos S, Ball L, Lankester A, et al. Role of NKG2D, DNAM-1 and natural cytotoxicity receptors in cytotoxicity toward rhabdomyosarcoma cell lines mediated by resting and IL-15-activated human natural killer cells. Cancer Immunol Immunother. 2015;64:573-83 pubmed publisher
  320. Richter E, Harms M, Ventz K, Gierok P, Chilukoti R, Hildebrandt J, et al. A multi-omics approach identifies key hubs associated with cell type-specific responses of airway epithelial cells to staphylococcal alpha-toxin. PLoS ONE. 2015;10:e0122089 pubmed publisher
  321. Hong M, Sandalova E, Low D, Gehring A, Fieni S, Amadei B, et al. Trained immunity in newborn infants of HBV-infected mothers. Nat Commun. 2015;6:6588 pubmed publisher
  322. Ohnuma K, Hatano R, Aune T, Otsuka H, Iwata S, Dang N, et al. Regulation of pulmonary graft-versus-host disease by IL-26+CD26+CD4 T lymphocytes. J Immunol. 2015;194:3697-712 pubmed publisher
  323. Obiero J, Shekalaghe S, Hermsen C, Mpina M, Bijker E, Roestenberg M, et al. Impact of malaria preexposure on antiparasite cellular and humoral immune responses after controlled human malaria infection. Infect Immun. 2015;83:2185-96 pubmed publisher
  324. Choi J, Kang H, Lee J, Ju H, Hong C, Kim H, et al. Very late relapse of bilateral retinoblastoma. J Pediatr Hematol Oncol. 2015;37:e264-7 pubmed publisher
  325. Chen Q, Gu Y, Liu B. Clinicopathological characteristics of kidney mucinous tubular and spindle cell carcinoma. Int J Clin Exp Pathol. 2015;8:1007-12 pubmed
  326. Tomasini D, Niccoli A, Crivelli F. Pagetoid reticulosis tumor cells with double expression of TCRγδ and TCRαβ: an off-target phenomenon or genuine expression?. J Cutan Pathol. 2015;42:427-34 pubmed publisher
  327. Tsai C, Liong K, Gunalan M, Li N, Lim D, Fisher D, et al. Type I IFNs and IL-18 regulate the antiviral response of primary human γδ T cells against dendritic cells infected with Dengue virus. J Immunol. 2015;194:3890-900 pubmed publisher
  328. Claiborne D, Prince J, Scully E, Macharia G, Micci L, Lawson B, et al. Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4+ T cells, and disease progression. Proc Natl Acad Sci U S A. 2015;112:E1480-9 pubmed publisher
  329. Chijioke O, Marcenaro E, Moretta A, Capaul R, Münz C. Role of the 2B4 Receptor in CD8+ T-Cell-Dependent Immune Control of Epstein-Barr Virus Infection in Mice With Reconstituted Human Immune System Components. J Infect Dis. 2015;212:803-7 pubmed publisher
  330. Sharivkin R, Walker M, Soen Y. Functional proteomics screen enables enrichment of distinct cell types from human pancreatic islets. PLoS ONE. 2015;10:e0115100 pubmed publisher
  331. Rizzo A, Vasco C, Girgenti V, Fugnanesi V, Calatozzolo C, Canazza A, et al. Melanoma cells homing to the brain: an in vitro model. Biomed Res Int. 2015;2015:476069 pubmed publisher
  332. Lee J, Breton G, Oliveira T, Zhou Y, Aljoufi A, PUHR S, et al. Restricted dendritic cell and monocyte progenitors in human cord blood and bone marrow. J Exp Med. 2015;212:385-99 pubmed publisher
  333. Agley C, Rowlerson A, Velloso C, Lazarus N, Harridge S. Isolation and quantitative immunocytochemical characterization of primary myogenic cells and fibroblasts from human skeletal muscle. J Vis Exp. 2015;:52049 pubmed publisher
  334. Chang N, Gu J, Gu S, Osorio R, Concepcion W, Gu E. Arterial flow regulator enables transplantation and growth of human fetal kidneys in rats. Am J Transplant. 2015;15:1692-700 pubmed publisher
  335. Zimmermann M, Aguilera F, Castellucci M, Rossato M, Costa S, Lunardi C, et al. Chromatin remodelling and autocrine TNFα are required for optimal interleukin-6 expression in activated human neutrophils. Nat Commun. 2015;6:6061 pubmed publisher
  336. Johnson P, Challis R, Chowdhury F, Gao Y, Harvey M, Geldart T, et al. Clinical and biological effects of an agonist anti-CD40 antibody: a Cancer Research UK phase I study. Clin Cancer Res. 2015;21:1321-8 pubmed publisher
  337. Ma R, Latif R, Davies T. Human embryonic stem cells form functional thyroid follicles. Thyroid. 2015;25:455-61 pubmed publisher
  338. Yu A, Snowhite I, Vendrame F, Rosenzwajg M, Klatzmann D, Pugliese A, et al. Selective IL-2 responsiveness of regulatory T cells through multiple intrinsic mechanisms supports the use of low-dose IL-2 therapy in type 1 diabetes. Diabetes. 2015;64:2172-83 pubmed publisher
  339. Afshar M, Richards S, Mann D, Cross A, Smith G, Netzer G, et al. Acute immunomodulatory effects of binge alcohol ingestion. Alcohol. 2015;49:57-64 pubmed publisher
  340. Bigley V, McGovern N, Milne P, Dickinson R, Pagan S, Cookson S, et al. Langerin-expressing dendritic cells in human tissues are related to CD1c+ dendritic cells and distinct from Langerhans cells and CD141high XCR1+ dendritic cells. J Leukoc Biol. 2015;97:627-34 pubmed publisher
  341. Hagberg N, Theorell J, Hjorton K, Spee P, Eloranta M, Bryceson Y, et al. Functional anti-CD94/NKG2A and anti-CD94/NKG2C autoantibodies in patients with systemic lupus erythematosus. Arthritis Rheumatol. 2015;67:1000-11 pubmed publisher
  342. Weihrauch M, Richly H, von Bergwelt Baildon M, Becker H, Schmidt M, Hacker U, et al. Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours. Eur J Cancer. 2015;51:146-56 pubmed publisher
  343. O Connell K, Guo W, Serra C, Beck M, Wachtman L, Hoggatt A, et al. The effects of an ActRIIb receptor Fc fusion protein ligand trap in juvenile simian immunodeficiency virus-infected rhesus macaques. FASEB J. 2015;29:1165-75 pubmed publisher
  344. Renauer P, Coit P, Sawalha A. The DNA methylation signature of human TCRαβ+CD4-CD8- double negative T cells reveals CG demethylation and a unique epigenetic architecture permissive to a broad stimulatory immune response. Clin Immunol. 2015;156:19-27 pubmed publisher
  345. Stacchini A, Pacchioni D, Demurtas A, Aliberti S, Cassenti A, Isolato G, et al. Utilility of flow cytometry as ancillary study to improve the cytologic diagnosis of thyroid lymphomas. Cytometry B Clin Cytom. 2015;88:320-9 pubmed publisher
  346. Williams D, Anastos K, Morgello S, Berman J. JAM-A and ALCAM are therapeutic targets to inhibit diapedesis across the BBB of CD14+CD16+ monocytes in HIV-infected individuals. J Leukoc Biol. 2015;97:401-12 pubmed publisher
  347. Presnell S, Al Attar A, Cichocki F, Miller J, Lutz C. Human natural killer cell microRNA: differential expression of MIR181A1B1 and MIR181A2B2 genes encoding identical mature microRNAs. Genes Immun. 2015;16:89-98 pubmed publisher
  348. Vogelpoel L, Hansen I, Rispens T, Muller F, van Capel T, Turina M, et al. Fc gamma receptor-TLR cross-talk elicits pro-inflammatory cytokine production by human M2 macrophages. Nat Commun. 2014;5:5444 pubmed publisher
  349. Boltjes A, van Montfoort N, Biesta P, Op den Brouw M, Kwekkeboom J, van der Laan L, et al. Kupffer cells interact with hepatitis B surface antigen in vivo and in vitro, leading to proinflammatory cytokine production and natural killer cell function. J Infect Dis. 2015;211:1268-78 pubmed publisher
  350. Milne P, Bigley V, Gunawan M, Haniffa M, Collin M. CD1c+ blood dendritic cells have Langerhans cell potential. Blood. 2015;125:470-3 pubmed publisher
  351. Fujita T, Burwitz B, Chew G, Reed J, Pathak R, Seger E, et al. Expansion of dysfunctional Tim-3-expressing effector memory CD8+ T cells during simian immunodeficiency virus infection in rhesus macaques. J Immunol. 2014;193:5576-83 pubmed publisher
  352. Kapogiannis D, Boxer A, Schwartz J, Abner E, Biragyn A, Masharani U, et al. Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural-derived blood exosomes of preclinical Alzheimer's disease. FASEB J. 2015;29:589-96 pubmed publisher
  353. Sakakura K, Takahashi H, Kaira K, Toyoda M, Oyama T, Chikamatsu K. Immunological significance of the accumulation of autophagy components in oral squamous cell carcinoma. Cancer Sci. 2015;106:1-8 pubmed publisher
  354. Liu H, Yang B, Sun T, Lin L, Hu Y, Deng M, et al. Specific growth inhibition of ErbB2‑expressing human breast cancer cells by genetically modified NK‑92 cells. Oncol Rep. 2015;33:95-102 pubmed publisher
  355. Luetke Eversloh M, Hammer Q, Durek P, Nordström K, Gasparoni G, Pink M, et al. Human cytomegalovirus drives epigenetic imprinting of the IFNG locus in NKG2Chi natural killer cells. PLoS Pathog. 2014;10:e1004441 pubmed publisher
  356. Lim D, Yawata N, Selva K, Li N, Tsai C, Yeong L, et al. The combination of type I IFN, TNF-α, and cell surface receptor engagement with dendritic cells enables NK cells to overcome immune evasion by dengue virus. J Immunol. 2014;193:5065-75 pubmed publisher
  357. Ziblat A, Domaica C, Spallanzani R, Iraolagoitia X, Rossi L, Avila D, et al. IL-27 stimulates human NK-cell effector functions and primes NK cells for IL-18 responsiveness. Eur J Immunol. 2015;45:192-202 pubmed publisher
  358. Armour K, Smith C, Ip N, Ellison C, Kirton C, Wilkes A, et al. Clearance of human IgG1-sensitised red blood cells in vivo in humans relates to the in vitro properties of antibodies from alternative cell lines. PLoS ONE. 2014;9:e109463 pubmed publisher
  359. Jansen D, Hameetman M, van Bergen J, Huizinga T, van der Heijde D, Toes R, et al. IL-17-producing CD4+ T cells are increased in early, active axial spondyloarthritis including patients without imaging abnormalities. Rheumatology (Oxford). 2015;54:728-35 pubmed publisher
  360. Maney N, Reynolds G, Krippner Heidenreich A, Hilkens C. Dendritic cell maturation and survival are differentially regulated by TNFR1 and TNFR2. J Immunol. 2014;193:4914-4923 pubmed publisher
  361. Balasa B, Yun R, Belmar N, Fox M, Chao D, Robbins M, et al. Elotuzumab enhances natural killer cell activation and myeloma cell killing through interleukin-2 and TNF-α pathways. Cancer Immunol Immunother. 2015;64:61-73 pubmed publisher
  362. Lundholm M, Schröder M, Nagaeva O, Baranov V, Widmark A, Mincheva Nilsson L, et al. Prostate tumor-derived exosomes down-regulate NKG2D expression on natural killer cells and CD8+ T cells: mechanism of immune evasion. PLoS ONE. 2014;9:e108925 pubmed publisher
  363. Gurzu S, Ciortea D, Tamasi A, Golea M, Bodi A, Sahlean D, et al. The immunohistochemical profile of granular cell (Abrikossoff) tumor suggests an endomesenchymal origin. Arch Dermatol Res. 2015;307:151-7 pubmed publisher
  364. Kasem K, Lam A. Adrenal oncocytic phaeochromocytoma with putative adverse histologic features: a unique case report and review of the literature. Endocr Pathol. 2014;25:416-21 pubmed publisher
  365. Alnabhan R, Madrigal A, Saudemont A. Differential activation of cord blood and peripheral blood natural killer cells by cytokines. Cytotherapy. 2015;17:73-85 pubmed publisher
  366. Brandau S, Jakob M, Bruderek K, Bootz F, Giebel B, Radtke S, et al. Mesenchymal stem cells augment the anti-bacterial activity of neutrophil granulocytes. PLoS ONE. 2014;9:e106903 pubmed publisher
  367. Yu J, Zuo Z, Zhang W, Yang Q, Zhang Y, Tang Y, et al. Identification of immunophenotypic subtypes with different prognoses in extranodal natural killer/T-cell lymphoma, nasal type. Hum Pathol. 2014;45:2255-62 pubmed publisher
  368. Ezzelarab M, Ekser B, Azimzadeh A, Lin C, Zhao Y, Rodriguez R, et al. Systemic inflammation in xenograft recipients precedes activation of coagulation. Xenotransplantation. 2015;22:32-47 pubmed publisher
  369. Gervois P, Struys T, Hilkens P, Bronckaers A, Ratajczak J, Politis C, et al. Neurogenic maturation of human dental pulp stem cells following neurosphere generation induces morphological and electrophysiological characteristics of functional neurons. Stem Cells Dev. 2015;24:296-311 pubmed publisher
  370. Chen W, Saparov A, Corselli M, Crisan M, Zheng B, Péault B, et al. Isolation of blood-vessel-derived multipotent precursors from human skeletal muscle. J Vis Exp. 2014;:e51195 pubmed publisher
  371. Chao Y, Kaliaperumal N, Chretien A, Tang S, Lee B, Poidinger M, et al. Human plasmacytoid dendritic cells regulate IFN-α production through activation-induced splicing of IL-18Rα. J Leukoc Biol. 2014;96:1037-46 pubmed publisher
  372. Madhavi V, Ana Sosa Batiz F, Jegaskanda S, Center R, Winnall W, Parsons M, et al. Antibody-dependent effector functions against HIV decline in subjects receiving antiretroviral therapy. J Infect Dis. 2015;211:529-38 pubmed publisher
  373. Davey M, Morgan M, Liuzzi A, Tyler C, Khan M, Szakmany T, et al. Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells. J Immunol. 2014;193:3704-3716 pubmed publisher
  374. Thompson L, Bauer J, Chiosea S, McHugh J, Seethala R, Miettinen M, et al. Canalicular adenoma: a clinicopathologic and immunohistochemical analysis of 67 cases with a review of the literature. Head Neck Pathol. 2015;9:181-95 pubmed publisher
  375. Jeon Y, Moon K, Park S, Chung D. Primary pulmonary myxoid sarcomas with EWSR1-CREB1 translocation might originate from primitive peribronchial mesenchymal cells undergoing (myo)fibroblastic differentiation. Virchows Arch. 2014;465:453-61 pubmed publisher
  376. Carpenter E, Rader J, Ruden J, Rappaport E, Hunter K, Hallberg P, et al. Dielectrophoretic capture and genetic analysis of single neuroblastoma tumor cells. Front Oncol. 2014;4:201 pubmed publisher
  377. Fiandaca M, Kapogiannis D, Mapstone M, Boxer A, Eitan E, Schwartz J, et al. Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study. Alzheimers Dement. 2015;11:600-7.e1 pubmed publisher
  378. Kurisaki Arakawa A, Saito T, Takahashi M, Mitani K, Yao T. A case of (123)I-MIBG scintigram-negative functioning pheochromocytoma: immunohistochemical and molecular analysis with review of literature. Int J Clin Exp Pathol. 2014;7:4438-47 pubmed
  379. Dori A, Lopate G, Keeling R, Pestronk A. Myovascular innervation: axon loss in small-fiber neuropathies. Muscle Nerve. 2015;51:514-21 pubmed publisher
  380. Meier D, Docena G, Ramisch D, Toscanini U, Berardi G, Gondolesi G, et al. Immunological status of isolated lymphoid follicles after intestinal transplantation. Am J Transplant. 2014;14:2148-58 pubmed publisher
  381. Wu D, Allen C, Fromm J. Flow cytometry of ALK-negative anaplastic large cell lymphoma of breast implant-associated effusion and capsular tissue. Cytometry B Clin Cytom. 2015;88:58-63 pubmed publisher
  382. Longman R, Diehl G, Victorio D, Huh J, Galan C, Miraldi E, et al. CX?CR1? mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22. J Exp Med. 2014;211:1571-83 pubmed publisher
  383. Campion S, Brodie T, Fischer W, Korber B, Rossetti A, Goonetilleke N, et al. Proteome-wide analysis of HIV-specific naive and memory CD4(+) T cells in unexposed blood donors. J Exp Med. 2014;211:1273-80 pubmed publisher
  384. Kubach J, Hubo M, Amendt C, Stroh C, Jonuleit H. IgG1 anti-epidermal growth factor receptor antibodies induce CD8-dependent antitumor activity. Int J Cancer. 2015;136:821-30 pubmed publisher
  385. Boudreau J, Le Luduec J, Hsu K. Development of a novel multiplex PCR assay to detect functional subtypes of KIR3DL1 alleles. PLoS ONE. 2014;9:e99543 pubmed publisher
  386. Kleppa E, Ramsuran V, Zulu S, Karlsen G, Bere A, Passmore J, et al. Effect of female genital schistosomiasis and anti-schistosomal treatment on monocytes, CD4+ T-cells and CCR5 expression in the female genital tract. PLoS ONE. 2014;9:e98593 pubmed publisher
  387. Watanabe M, Kudo Y, Kawano M, Nakayama M, Nakamura K, Kameda M, et al. NKG2D functions as an activating receptor on natural killer cells in the common marmoset (Callithrix jacchus). Int Immunol. 2014;26:597-606 pubmed publisher
  388. Wilson E, Singh A, Hullsiek K, Gibson D, Henry W, Lichtenstein K, et al. Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection. J Infect Dis. 2014;210:1396-406 pubmed publisher
  389. Yang Y, Li Y, Liu Y, Yang M, Liu K. CD30+ extranodal natural killer/T-cell lymphoma mimicking phlegmonous myositis: A case report. Oncol Lett. 2014;7:1419-1421 pubmed
  390. Tarbox J, Keppel M, Topcagic N, Mackin C, Ben Abdallah M, Baszis K, et al. Elevated double negative T cells in pediatric autoimmunity. J Clin Immunol. 2014;34:594-9 pubmed publisher
  391. Ito S, Bollard C, Carlsten M, Melenhorst J, Biancotto A, Wang E, et al. Ultra-low dose interleukin-2 promotes immune-modulating function of regulatory T cells and natural killer cells in healthy volunteers. Mol Ther. 2014;22:1388-1395 pubmed publisher
  392. Prinz P, Mendler A, Brech D, Masouris I, Oberneder R, Noessner E. NK-cell dysfunction in human renal carcinoma reveals diacylglycerol kinase as key regulator and target for therapeutic intervention. Int J Cancer. 2014;135:1832-41 pubmed publisher
  393. Bareja A, Holt J, Luo G, Chang C, Lin J, Hinken A, et al. Human and mouse skeletal muscle stem cells: convergent and divergent mechanisms of myogenesis. PLoS ONE. 2014;9:e90398 pubmed publisher
  394. Rodriguez A, Hodara V, Murthy K, Morrow L, Sanchez M, Bienvenu A, et al. T cell interleukin-15 surface expression in chimpanzees infected with human immunodeficiency virus. Cell Immunol. 2014;288:24-30 pubmed publisher
  395. Magri G, Miyajima M, Bascones S, Mortha A, Puga I, Cassis L, et al. Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. Nat Immunol. 2014;15:354-364 pubmed publisher
  396. Sousa Victor P, Gutarra S, García Prat L, Rodriguez Ubreva J, Ortet L, Ruiz Bonilla V, et al. Geriatric muscle stem cells switch reversible quiescence into senescence. Nature. 2014;506:316-21 pubmed publisher
  397. Poonia B, Pauza C. Levels of CD56+TIM-3- effector CD8 T cells distinguish HIV natural virus suppressors from patients receiving antiretroviral therapy. PLoS ONE. 2014;9:e88884 pubmed publisher
  398. Sereti I, Estes J, Thompson W, Morcock D, Fischl M, Croughs T, et al. Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration. PLoS Pathog. 2014;10:e1003890 pubmed publisher
  399. Chang S, Kohrt H, Maecker H. Monitoring the immune competence of cancer patients to predict outcome. Cancer Immunol Immunother. 2014;63:713-9 pubmed publisher
  400. Doi H, Tanoue S, Kaplan D. Peripheral CD27-CD21- B-cells represent an exhausted lymphocyte population in hepatitis C cirrhosis. Clin Immunol. 2014;150:184-91 pubmed publisher
  401. Trist H, Tan P, Wines B, Ramsland P, Orlowski E, Stubbs J, et al. Polymorphisms and interspecies differences of the activating and inhibitory Fc?RII of Macaca nemestrina influence the binding of human IgG subclasses. J Immunol. 2014;192:792-803 pubmed publisher
  402. Cairo C, Longinaker N, Cappelli G, Leke R, Ondo M, Djokam R, et al. Cord blood V?2V?2 T cells provide a molecular marker for the influence of pregnancy-associated malaria on neonatal immunity. J Infect Dis. 2014;209:1653-62 pubmed publisher
  403. Jones H, Gold M, Giannico G, Troutman A, Vnencak Jones C, Schultenover S, et al. Lymphoepithelioma-like carcinoma of the endometrium: immunophenotypic characterization of a rare tumor with microsatellite instability testing. Int J Gynecol Pathol. 2014;33:64-73 pubmed publisher
  404. Kumpel B, Hazell M, Guest A, Dixey J, Mushens R, Bishop D, et al. Accurate quantitation of D+ fetomaternal hemorrhage by flow cytometry using a novel reagent to eliminate granulocytes from analysis. Transfusion. 2014;54:1305-16 pubmed publisher
  405. Mackey A, Karlsen A, Couppe C, Mikkelsen U, Nielsen R, Magnusson S, et al. Differential satellite cell density of type I and II fibres with lifelong endurance running in old men. Acta Physiol (Oxf). 2014;210:612-27 pubmed publisher
  406. Krishnan S, Wilson E, Sheikh V, Rupert A, Mendoza D, Yang J, et al. Evidence for innate immune system activation in HIV type 1-infected elite controllers. J Infect Dis. 2014;209:931-9 pubmed publisher
  407. Lundgreen K, Lian O, Engebretsen L, Scott A. Lower muscle regenerative potential in full-thickness supraspinatus tears compared to partial-thickness tears. Acta Orthop. 2013;84:565-70 pubmed publisher
  408. Perlson E, Hendricks A, Lazarus J, Ben Yaakov K, Gradus T, Tokito M, et al. Dynein interacts with the neural cell adhesion molecule (NCAM180) to tether dynamic microtubules and maintain synaptic density in cortical neurons. J Biol Chem. 2013;288:27812-24 pubmed publisher
  409. Wilkens J, Male V, Ghazal P, Forster T, Gibson D, Williams A, et al. Uterine NK cells regulate endometrial bleeding in women and are suppressed by the progesterone receptor modulator asoprisnil. J Immunol. 2013;191:2226-35 pubmed publisher
  410. Stover A, Brick D, Nethercott H, Banuelos M, Sun L, O Dowd D, et al. Process-based expansion and neural differentiation of human pluripotent stem cells for transplantation and disease modeling. J Neurosci Res. 2013;91:1247-62 pubmed publisher
  411. Stacchini A, Aliberti S, Pacchioni D, Demurtas A, Isolato G, Gazzera C, et al. Flow cytometry significantly improves the diagnostic value of fine needle aspiration cytology of lymphoproliferative lesions of salivary glands. Cytopathology. 2014;25:231-40 pubmed publisher
  412. Karagkounis G, Argyrakos T, Charkiolakis G, Castana O, Rontogianni D. A Case of Distal Epithelioid Sarcoma of the Thumb Expressing Podoplanin, TLE1 and Ca 125. Case Rep Pathol. 2013;2013:312786 pubmed publisher
  413. Saclier M, Yacoub Youssef H, Mackey A, Arnold L, Ardjoune H, Magnan M, et al. Differentially activated macrophages orchestrate myogenic precursor cell fate during human skeletal muscle regeneration. Stem Cells. 2013;31:384-96 pubmed publisher
  414. He Y, He X, Guo P, Du M, Shao J, Li M, et al. The decidual stromal cells-secreted CCL2 induces and maintains decidual leukocytes into Th2 bias in human early pregnancy. Clin Immunol. 2012;145:161-73 pubmed publisher
  415. Zuo Z, Tang Y, Bi C, Zhang W, Zhao S, Wang X, et al. Extraosseous (extramedullary) plasmacytomas: a clinicopathologic and immunophenotypic study of 32 Chinese cases. Diagn Pathol. 2011;6:123 pubmed publisher
  416. Su X, Huang J, Jiang Y, Tang Y, Li G, Liu W. Serous effusion cytology of extranodal natural killer/T-cell lymphoma. Cytopathology. 2012;23:96-102 pubmed publisher
  417. Lee D, Yang J, Lee S, Won C, Chang S, Lee M, et al. Subcutaneous panniculitis-like T-cell lymphoma: a clinical and pathologic study of 14 korean patients. Ann Dermatol. 2011;23:329-37 pubmed publisher
  418. Petrilli G, Lorenzi L, Paracchini R, Ubiali A, Schumacher R, Cabassa P, et al. Epstein-Barr virus-associated adrenal smooth muscle tumors and disseminated diffuse large B-cell lymphoma in a child with common variable immunodeficiency: a case report and review of the literature. Int J Surg Pathol. 2014;22:712-21 pubmed publisher
  419. Yong Jiang -, Huawei Liu -, Hu Long -, Yingying Yang -, Dianying Liao -, Xiuhui Zhang -. Goblet cell carcinoid of the appendix: a clinicopathological and immunohistochemical study of 26 cases from southwest china. Int J Surg Pathol. 2010;18:488-92 pubmed publisher
  420. Elsner L, Flügge P, Lozano J, Muppala V, Eiz Vesper B, Demiroglu S, et al. The endogenous danger signals HSP70 and MICA cooperate in the activation of cytotoxic effector functions of NK cells. J Cell Mol Med. 2010;14:992-1002 pubmed publisher
  421. Silva S, Sousa A, Haddad A, Azevedo J, Soares V, Peixoto C, et al. Autologous bone-marrow mononuclear cell transplantation after acute myocardial infarction: comparison of two delivery techniques. Cell Transplant. 2009;18:343-52 pubmed publisher
  422. Grahmann P, Braun R. A new protocol for multiple inhalation of IFN-gamma successfully treats MDR-TB: a case study. Int J Tuberc Lung Dis. 2008;12:636-44 pubmed
  423. Wagner W, Wein F, Roderburg C, Saffrich R, Diehlmann A, Eckstein V, et al. Adhesion of human hematopoietic progenitor cells to mesenchymal stromal cells involves CD44. Cells Tissues Organs. 2008;188:160-9 pubmed
  424. Mselle T, Meadows S, Eriksson M, Smith J, SHEN L, Wira C, et al. Unique characteristics of NK cells throughout the human female reproductive tract. Clin Immunol. 2007;124:69-76 pubmed
  425. Mageed A, Pietryga D, DeHeer D, West R. Isolation of large numbers of mesenchymal stem cells from the washings of bone marrow collection bags: characterization of fresh mesenchymal stem cells. Transplantation. 2007;83:1019-26 pubmed
  426. Eriksson M, Meadows S, Basu S, Mselle T, Wira C, Sentman C. TLRs mediate IFN-gamma production by human uterine NK cells in endometrium. J Immunol. 2006;176:6219-24 pubmed
  427. Perin E, Dohmann H, Borojevic R, Silva S, Sousa A, Silva G, et al. Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation. 2004;110:II213-8 pubmed
  428. Baiker A, Fabel K, Cozzio A, Zerboni L, Fabel K, Sommer M, et al. Varicella-zoster virus infection of human neural cells in vivo. Proc Natl Acad Sci U S A. 2004;101:10792-7 pubmed
  429. Tan P, Chan C, Xue S, Dong R, Ananthesayanan B, Manunta M, et al. Phenotypic and functional differences between human saphenous vein (HSVEC) and umbilical vein (HUVEC) endothelial cells. Atherosclerosis. 2004;173:171-83 pubmed
  430. Steinberger P, Majdic O, Derdak S, Pfistershammer K, Kirchberger S, Klauser C, et al. Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains. J Immunol. 2004;172:2352-9 pubmed
  431. Doubrovina E, Doubrovin M, Vider E, Sisson R, O Reilly R, Dupont B, et al. Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma. J Immunol. 2003;171:6891-9 pubmed
  432. Nakatsuka S, Liu A, Dong Z, Nomura S, Takakuwa T, Miyazato H, et al. Simian virus 40 sequences in malignant lymphomas in Japan. Cancer Res. 2003;63:7606-8 pubmed
  433. Brdicková N, Brdicka T, Angelisová P, Horváth O, Spicka J, Hilgert I, et al. LIME: a new membrane Raft-associated adaptor protein involved in CD4 and CD8 coreceptor signaling. J Exp Med. 2003;198:1453-62 pubmed
  434. Rahimi K, Maerz H, Zotz R, Tarnok A. Pre-procedural expression of Mac-1 and LFA-1 on leukocytes for prediction of late restenosis and their possible correlation with advanced coronary artery disease. Cytometry B Clin Cytom. 2003;53:63-9 pubmed
  435. Perin E, Dohmann H, Borojevic R, Silva S, Sousa A, Mesquita C, et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation. 2003;107:2294-302 pubmed
  436. Kim C, Johnston B, Butcher E. Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among V alpha 24(+)V beta 11(+) NKT cell subsets with distinct cytokine-producing capacity. Blood. 2002;100:11-6 pubmed
  437. Sharron M, Pohlmann S, Price K, Lolis E, Tsang M, Kirchhoff F, et al. Expression and coreceptor activity of STRL33/Bonzo on primary peripheral blood lymphocytes. Blood. 2000;96:41-9 pubmed
  438. Schwaab T, Schned A, Heaney J, Cole B, Atzpodien J, Wittke F, et al. In vivo description of dendritic cells in human renal cell carcinoma. J Urol. 1999;162:567-73 pubmed
  439. Lee B, Sharron M, Montaner L, Weissman D, Doms R. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc Natl Acad Sci U S A. 1999;96:5215-20 pubmed
  440. Cunningham B, Hemperly J, Murray B, Prediger E, Brackenbury R, Edelman G. Neural cell adhesion molecule: structure, immunoglobulin-like domains, cell surface modulation, and alternative RNA splicing. Science. 1987;236:799-806 pubmed
  441. Lanier L, Testi R, Bindl J, Phillips J. Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule. J Exp Med. 1989;169:2233-8 pubmed